id,analyte_A260A280Ratio,vital_status,gender,race,ethnicity,disease_type,tcga_sample_id,cgc_case_uuid,primary_site,age_at_diagnosis,cgc_sample_uuid,cgc_aliquot_uuid,tcga_aliquot_id,reference_genome,tcga_case_id,investigation,days_to_death,tissue_source_site_label,country_of_sample_procurement,pathologic_t_label,pathologic_n_label,histological_diagnosis_label,pathologic_stage_label,PlateCenter,PlateCenterFlag,observed_otus
13722.58cfa82fe4b0c9d6adf6b62c,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-50-5941-01A,F3F024C2-52F1-400E-946C-398F5B72E6DC,Lung,55,91719392-76CE-479F-BA05-E43BF0201CC4,666720AF-64D9-4A63-BE57-2B8E49E79413,TCGA-50-5941-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5941,TCGA-LUAD,NA,University of Pittsburgh,United States,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1751-02,TRUE,13
13722.58cfa82ee4b0c9d6adf6af20,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4415-01A,D15B7B29-C5C5-41D8-B83B-7CC12FE92820,Lung,57,57E160F5-45FC-44EF-95C6-54E112E3B7F5,4CD99514-20D0-439F-9B9F-BDDCEE5D950F,TCGA-05-4415-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4415,TCGA-LUAD,91,Indivumed,Germany,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,1853-02,TRUE,23
13722.58cfa82fe4b0c9d6adf6b6d8,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5942-01A,75DD635E-8E0C-4C0B-B21C-20F77770218D,Lung,67,AED669E8-23B6-4786-9398-6BB048815DFA,8DC8F884-F58B-4EFA-AE96-C87AB7F6D991,TCGA-50-5942-01A-21D-1751-02,HG19_Broad_variant,TCGA-50-5942,TCGA-LUAD,NA,University of Pittsburgh,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1751-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b648,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-86-6562-01A,DCD066BA-5894-453E-B1DA-82092858C3DB,Lung,52,DE4BB1D0-8BD9-4614-85CA-C39D8C636BCC,3AB9FD95-4329-4DD3-823D-F2E050CBA3C1,TCGA-86-6562-01A-11D-1751-02,HG19_Broad_variant,TCGA-86-6562,TCGA-LUAD,NA,Asterand,Russia,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA,1751-02,TRUE,12
13722.58cfa82fe4b0c9d6adf6b60d,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-38-4631-01A,2483621A-4DB3-41AB-AA33-B9427EA8A0AF,Lung,72,13B0D336-205A-42AC-8A50-DB0EB065013D,B1FA802A-C88E-4B8D-88FF-4545DCF326DE,TCGA-38-4631-01A-01D-1751-02,HG19_Broad_variant,TCGA-38-4631,TCGA-LUAD,354,UNC,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,24
13722.58cfa82fe4b0c9d6adf6b748,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-44-6776-01A,C2A1DE2E-6451-4C95-8CE6-263F2B7E6EFF,Lung,60,64FB8EBA-A055-4128-92CA-695A3A6F8EBD,5BC01EC3-A1C2-41BB-A9C5-95946A066FA6,TCGA-44-6776-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6776,TCGA-LUAD,NA,Christiana Healthcare,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1853-02,TRUE,12
13722.58cfa82fe4b0c9d6adf6b680,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4488-01A,D721BFE0-90E3-415E-B9F3-1A270EFA5FBB,Lung,74,1AEA8530-43FD-47EA-A2F1-377267DC9D33,DA0D3199-053B-4789-A217-CA2BFB83D57E,TCGA-49-4488-01A-01D-1751-02,HG19_Broad_variant,TCGA-49-4488,TCGA-LUAD,869,Johns Hopkins,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1751-02,TRUE,6
13722.58cfa82fe4b0c9d6adf6b8c0,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-49-6743-01A,A391D49F-A822-460B-981C-6FBE1868EE38,Lung,81,5D7DAE28-FC9F-4160-83AA-122F999668B0,3B48B0C9-B9B9-4926-97CA-7232A360A0EE,TCGA-49-6743-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6743,TCGA-LUAD,NA,Johns Hopkins,United States,T1,N2,Lung Clear Cell Adenocarcinoma,Stage IIIA,1853-02,TRUE,11
13722.58cfa82fe4b0c9d6adf6b6fc,1.9,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-55-6712-01A,F17D3463-AF6C-42C2-A8E9-FAE45F69286F,Lung,71,EA75499C-7BF0-47BE-9B09-3C12AAA22F12,61ADB041-60CE-4263-BEB3-33A4DBBA217B,TCGA-55-6712-01A-11D-1853-02,HG19_Broad_variant,TCGA-55-6712,TCGA-LUAD,NA,International Genomics Consortium,United States,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA,1853-02,TRUE,61
13722.58cfa82fe4b0c9d6adf6b8d9,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5055-01A,CC3D9750-7CE0-489F-86D4-8017B7EBED29,Lung,79,68D19E88-7FBD-48CC-A09F-55C47BFAF6E7,323E338B-1BA7-49E2-811B-C1FEE673A926,TCGA-50-5055-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5055,TCGA-LUAD,NA,University of Pittsburgh,United States,T1,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA,1623-02,TRUE,12
13722.58cfa830e4b0c9d6adf6bb6a,1.9,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-6205-01A,9A63F744-4ED4-4B4D-AAC6-F9BDA66AA563,Lung,NA,D845174B-1A04-4D22-B34F-C48D7AE35233,A5D194B2-0A92-49A1-9AC3-FC4C1B6ADE92,TCGA-75-6205-01A-11D-1751-02,HG19_Broad_variant,TCGA-75-6205,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,12
13722.58cfa830e4b0c9d6adf6bdd4,1.9,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,TCGA-BH-A0BM-01A,C2AEEE6C-BA10-4CF9-B560-C739580F7BF3,Breast,54,5423B7F8-D2BB-47C8-9AF8-3D3E1276888C,FA99DD38-37F1-4B24-960E-617F92CDADD0,TCGA-BH-A0BM-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0BM,TCGA-BRCA,NA,University of Pittsburgh,None,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A060-02,TRUE,9
13722.58cfa82fe4b0c9d6adf6b6f8,1.8,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6593-01A,E10568FE-0436-43F2-9F0F-48F9903868C4,Lung,49,3B2ED302-D8F1-4078-95F0-3B5C5B322DEB,BC00F0B2-D91E-444A-91A4-08AC5F09CA1F,TCGA-50-6593-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6593,TCGA-LUAD,336,University of Pittsburgh,United States,T1,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,1751-02,TRUE,41
13722.58cfa830e4b0c9d6adf6be88,1.89,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A291-01A,D4C68C1C-A3F3-4E0C-B555-D457378A1D24,Thyroid,56,D1612961-A709-487B-A4D1-CE42F0B9AA54,E28A1E8B-41A3-44C0-ADBC-6A203C92DDF5,TCGA-BJ-A291-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A291,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,11
13722.58cfa830e4b0c9d6adf6beea,1.77,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LL-01A,D17668C4-5D66-4E16-8B70-B54616581AAE,Uterus,56,488A7462-8348-422C-91D3-7D9F0C39D25E,0D29C555-7C7C-4BBB-A4C6-E554CC758CA7,TCGA-AP-A0LL-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LL,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bcc6,2.18,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0L9-01A,7B9947D5-E86B-4006-8890-EA5209584A88,Uterus,71,53D0521F-10D6-4F70-9277-D99025A6B963,DAA573AF-564D-456D-8181-DF4C07B77672,TCGA-AP-A0L9-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0L9,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A043-02,TRUE,76
13722.58cfa830e4b0c9d6adf6bf44,1.84,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AX-A2HD-01A,A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B,Uterus,69,5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C,C24E7F27-2155-4727-B6D8-8E5BC16D9197,TCGA-AX-A2HD-01A-21D-A17E-02,HG19_Broad_variant,TCGA-AX-A2HD,TCGA-UCEC,NA,Gynecologic Oncology Group,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A17E-02,TRUE,28
13722.58cfa830e4b0c9d6adf6c062,1.92,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-B6-A0RI-01A,BFD55808-DDDD-44C3-97D7-41600497B992,Breast,44,973EE776-E287-4568-A43D-7B16CC0094A9,71542129-1393-4608-B81C-1767A5051763,TCGA-B6-A0RI-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RI,TCGA-BRCA,NA,Duke,United States,T4b,N1b,Infiltrating Ductal Carcinoma,Stage IIIB,A060-02,TRUE,10
13722.58cfa830e4b0c9d6adf6c134,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-B6-A0RG-01A,9B13927C-7357-44FD-8385-92AE6A656B7D,Breast,26,B98AA84F-5144-4062-BADC-32E89368D684,E71ED8ED-7371-4423-83C8-6075A6FC7C39,TCGA-B6-A0RG-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RG,TCGA-BRCA,NA,Duke,United States,T3,N0 (i-),Infiltrating Ductal Carcinoma,Stage IIB,A060-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c128,2.14,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-B6-A0RE-01A,08DA7C4C-3067-4BCF-9D7A-78566DF72E69,Breast,61,270BE245-2239-4E96-A917-79CCA40868BA,D5CE279A-3A7F-43E7-894C-265E9504C3FD,TCGA-B6-A0RE-01A-11D-A060-02,HG19_Broad_variant,TCGA-B6-A0RE,TCGA-BRCA,NA,Duke,United States,TX,N0 (i-),Infiltrating Ductal Carcinoma,Stage X,A060-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c1a0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-B7-5818-01A,6E03B415-84A1-4B91-8717-1A41EDD4A255,Stomach,62,FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166,0EBF1A63-C6E4-49FE-B21B-AE46FF14261D,TCGA-B7-5818-01A-11D-1598-02,HG19_Broad_variant,TCGA-B7-5818,TCGA-STAD,NA,Cureline,Russia,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB,1598-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c136,2,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0UJ-01A,FF82548A-F1BB-4DAA-A8F7-B3831B5843AD,Uterus,68,2EA1339F-A5EB-4552-AC13-858FA70E606E,15FDA615-0A79-4211-B5DE-F61741E8937A,TCGA-BS-A0UJ-01A-12D-A101-02,HG19_Broad_variant,TCGA-BS-A0UJ,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,16
13722.58cfa830e4b0c9d6adf6c1a6,2,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,TCGA-BH-A0HB-01A,0C1023C0-D2CE-4940-8047-7642F1DC3965,Breast,55,19193B8F-1E1B-448C-B934-93F25E60D45B,49556237-D73F-4DE9-B5D9-7169DB7A53C5,TCGA-BH-A0HB-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0HB,TCGA-BRCA,NA,University of Pittsburgh,None,T1c,N0 (i-),Infiltrating Ductal Carcinoma,Stage IA,A060-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c138,1.89,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0UF-01A,F77D7256-2CCF-42A7-9B30-332AC24CA812,Uterus,65,C805F55A-322F-4A11-AE0C-4BBC365D1BD6,D1F78FB2-7BB7-4BF7-8EC7-E2E08F579A38,TCGA-BS-A0UF-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UF,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c1e1,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MT-01A,082E32C5-7F82-466A-B52D-A3293A8F8E57,Uterus,64,91F629F5-6938-4F5C-BA2E-1F519CE6B255,23FB2C48-BE95-4169-BB10-00EA361C5687,TCGA-BG-A0MT-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MT,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,12
13722.58cfa830e4b0c9d6adf6bf40,1.91,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AX-A1CJ-01A,ABAF757B-F79F-40BD-96E3-E2C0F63061F0,Uterus,59,72D06DDF-9FB2-4577-BFDB-B0E463105B4A,A4EE1BB7-59FF-4034-ABA1-9AF4F62B42B0,TCGA-AX-A1CJ-01A-11D-A133-02,HG19_Broad_variant,TCGA-AX-A1CJ,TCGA-UCEC,NA,Gynecologic Oncology Group,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A133-02,FALSE,49
13722.58cfa830e4b0c9d6adf6c208,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5558-01A,6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2,Head and Neck,65,EB749281-B3DC-43E4-812E-F5F5004A21ED,41737268-345A-4F87-B2DB-E184247E1396,TCGA-BA-5558-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5558,TCGA-HNSC,NA,UNC,None,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1509-02,TRUE,27
13722.58cfa830e4b0c9d6adf6c236,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0Z3-01A,331CAE6E-2868-4C58-9302-709A9FF7D025,Thyroid,33,6BF032C1-B7D5-4B1C-BF41-C9BFEAFA5E7A,3D0982B1-944E-4C03-AAA4-F8FD4602D4C9,TCGA-BJ-A0Z3-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0Z3,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,21
13722.58cfa830e4b0c9d6adf6c23a,1.91,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20R-01A,F8780A4B-7F55-41D1-BF92-8513955D150E,Bladder,79,20231B7F-CB6A-4CD0-9C46-10D4E959D483,78460059-E3A1-40F1-89B5-2F69C6E2E0F1,TCGA-BT-A20R-01A-12D-A16N-02,HG19_Broad_variant,TCGA-BT-A20R,TCGA-BLCA,154,University of Pittsburgh,United States,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A16N-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c29c,1.98,Dead,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0T9-01A,4EB95566-0E73-4260-853E-F7DF650667A0,Uterus,39,3C9FF865-013F-427A-8D4D-C8E60EA346A1,CB5B905D-7287-41B3-9B49-B2F7FF7D2173,TCGA-BS-A0T9-01A-11D-A12F-02,HG19_Broad_variant,TCGA-BS-A0T9,TCGA-UCEC,1428,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,23
13722.58cfa830e4b0c9d6adf6c2a8,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4184-01A,0D4D23BA-066B-4244-A3A5-922CDCAAA28F,Stomach,70,5DB02C36-DCF0-4311-AD90-754E4EC579EE,501F74C8-6E77-429C-99BD-739D45A74ED1,TCGA-BR-4184-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4184,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1128-02,TRUE,21
13722.58cfa830e4b0c9d6adf6c2aa,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4201-01A,8520654B-2192-46CF-9D72-1DDB885A7C55,Stomach,66,B42CC87B-4BB0-433D-8AFB-CB314B8CBA30,FE12C75F-5A26-40A8-BEF0-742FAD4CD0E5,TCGA-BR-4201-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4201,TCGA-STAD,NA,Asterand,Russia,T2a,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,10
13722.58cfa830e4b0c9d6adf6c2db,1.77,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,TCGA-C4-A0F0-01A,40398C03-A9CC-476B-9EE9-AECF161BE43F,Bladder,60,54234A11-8674-4B01-B2EF-A4C6D772AA43,5584A4A7-2EA1-46D8-8960-8905689D5720,TCGA-C4-A0F0-01A-12D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F0,TCGA-BLCA,NA,Indivumed,Germany,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A10R-02,TRUE,13
13722.58cfa830e4b0c9d6adf6c31e,2.28,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CF-A27C-01A,7FEE9D6F-C0EA-43C2-89C2-66D965A077A8,Bladder,52,EAD6792B-4E52-4C28-891C-6D8696873A13,1E553EB3-8C42-48A1-87A7-BFA8541CE568,TCGA-CF-A27C-01A-11D-A16N-02,HG19_Broad_variant,TCGA-CF-A27C,TCGA-BLCA,NA,ILSbio,Vietnam,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A16N-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c366,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5720-01A,7C9EA4FA-4CBC-4941-945A-E531E1D48304,Stomach,71,1B2E1B50-8D4E-4E62-9B1B-B484936BD6EB,98CE6D0E-465C-40FA-9408-33AA7A25FBB2,TCGA-CG-5720-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5720,TCGA-STAD,30,Indivumed,Germany,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1598-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c37e,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5719-01A,263F67E0-0A28-42E6-B3F3-1DDD0D397220,Stomach,54,606573EE-ED11-4DB5-ABAF-E842EC575EEE,9008E364-B8F3-4923-B0CC-6ED34AA7BAC3,TCGA-CG-5719-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5719,TCGA-STAD,NA,Indivumed,Germany,T4,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1598-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c3b8,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5724-01A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Stomach,59,4D624B21-5AEE-42B8-B192-8AFECB51434D,8611C0AC-38E4-4BFD-A1C4-56CABFCF6374,TCGA-CG-5724-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5724,TCGA-STAD,366,Indivumed,Germany,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1598-02,TRUE,4
13722.58cfa831e4b0c9d6adf6c3d6,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5734-01A,2A227292-C73D-45FC-AB68-CDFAF7AEF9E7,Stomach,68,A0237637-3859-47D9-A60E-0AF8C6884B4A,12BCC59A-0A89-4087-B976-A22F66D8190C,TCGA-CG-5734-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5734,TCGA-STAD,243,Indivumed,Germany,T3,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1598-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c3dc,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5726-01A,863AD936-E2A0-471C-8D95-3A548BB94AFA,Stomach,73,C881739A-982C-436F-9BE2-4638DB792C53,D472F361-BC94-44A5-9158-5BD999C96C27,TCGA-CG-5726-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5726,TCGA-STAD,881,Indivumed,Germany,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA,1598-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c3f0,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,TCGA-C5-A2LX-01A,B82F4C6D-530F-4B0E-8F33-995633CB254A,Cervix,54,41BEBEA3-11C2-4748-8E60-082CFB8E0251,F4772B1E-699C-4C3D-9E0B-1BD4634A7F36,TCGA-C5-A2LX-01A-11D-A18I-02,HG19_Broad_variant,TCGA-C5-A2LX,TCGA-CESC,NA,Medical College of Wisconsin,United States,T2,N1,Cervical Squamous Cell Carcinoma,Not available,A18I-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c3fc,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5788-01A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Prostate,69,144E0265-C04E-4538-A721-94DEF2570486,ADB6611D-7A44-4FFE-A48B-FF8E24696B38,TCGA-CH-5788-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5788,TCGA-PRAD,NA,Indivumed,Germany,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c39a,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5721-01A,588ABAEA-AB16-42F4-9457-5901EE791B5F,Stomach,58,B79123B9-5094-426D-8267-FD4A1C9F2778,8DE4E4AE-4C98-4D4E-BC77-2C205D817E01,TCGA-CG-5721-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5721,TCGA-STAD,NA,Indivumed,Germany,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1598-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c5c8,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4469-01A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Stomach,70,2A3D7538-D377-4D94-BB61-BF77BA56BE1B,9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6,TCGA-CG-4469-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,Indivumed,Germany,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1154-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c214,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4077-01B,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Head and Neck,45,327BBCA7-FA25-4A92-BE27-21A4C184C760,8428602A-5EEC-4D09-B187-02B1CFF24EB5,TCGA-BA-4077-01B-01D-1431-02,HG19_Broad_variant,TCGA-BA-4077,TCGA-HNSC,1134,UNC,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c61a,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4305-01A,E0E35051-FBB4-4389-AEDB-87BDE84D21AD,Stomach,69,6B64B4A0-EDC8-4DC3-B527-D320DED81351,A01B1633-2A30-4379-80AC-72799C14B5C7,TCGA-CG-4305-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4305,TCGA-STAD,NA,Indivumed,Germany,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1154-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c670,1.9,Alive,MALE,WHITE,Not available,Brain Lower Grade Glioma,TCGA-CS-4944-01A,64CD17EB-C778-45E9-B994-02B68182E51B,Brain,50,F1AA24E4-BC7F-427F-9CEB-8CAAFABFE535,63B56E68-639B-483B-B777-EAD4BDDC112C,TCGA-CS-4944-01A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4944,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Astrocytoma,Not available,1465-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c5ed,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4306-01A,73D177F7-8C0A-42F6-A73D-8073C0E6142B,Stomach,90,78785DB9-C3D5-4C26-BBEF-E741C4AAE429,42E4D7EE-860D-498E-AA00-D2AB42EB4ECA,TCGA-CG-4306-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4306,TCGA-STAD,31,Indivumed,Germany,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1154-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c73a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6524-01A,7EF3F065-1928-4A58-B5A6-76DDDB8488CF,Stomach,53,6F14723A-AF83-402D-AB98-B4ED29A93AAF,48540EAA-46FD-4C0A-9893-1FF69D205F79,TCGA-D7-6524-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6524,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage II,1798-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c6be,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4742-01A,444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9,Head and Neck,48,507B9A1D-BFBF-43F8-86D2-665A488441AF,A9768535-FE1C-4B4F-B709-DED0809BA592,TCGA-CN-4742-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4742,TCGA-HNSC,397,University of Pittsburgh,None,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,18
13722.58cfa831e4b0c9d6adf6c702,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5966-01A,0D0731E2-8D82-4B6D-9258-2896A770A868,Head and Neck,63,E71C33E9-1F74-4CF6-B6BF-985D0C96F71E,84D0CA61-132A-4B85-A343-0C55DE088B0C,TCGA-CV-5966-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5966,TCGA-HNSC,545,MD Anderson Cancer Center,None,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c7aa,1.88,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17R-01A,73A0DD38-115D-48FB-B683-04AA5D612F2A,Uterus,58,205DE3E7-B078-4904-82C3-3D0F757D94A8,DF3E4C9B-67D4-46FF-BFE0-4F55A72CA179,TCGA-D1-A17R-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17R,TCGA-UCEC,339,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c7b1,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-6996-01A,49B94421-FE82-4F24-8EF2-820674142418,Head and Neck,58,2C3790CE-A54D-431B-B76C-FA25441AA41C,5367CF72-E404-4203-AD7D-CF7663072EA7,TCGA-CN-6996-01A-11D-1911-02,HG19_Broad_variant,TCGA-CN-6996,TCGA-HNSC,NA,University of Pittsburgh,United States,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c7c8,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17K-01A,5C22C8D6-5805-455C-8E1C-E6B8006738E4,Uterus,74,CA213835-EFC5-4216-A762-A6B320B516BF,3E67F5BD-C5A6-4CDD-8D71-78038D316447,TCGA-D1-A17K-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17K,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c78a,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5439-01A,3EE863DA-7991-414F-82D8-2B6502D4C061,Head and Neck,62,C94D8E61-8A15-4702-90EF-37616F1C015B,A1170138-A1B1-4D13-B66B-0507D3DE897B,TCGA-CV-5439-01A-01D-1681-02,HG19_Broad_variant,TCGA-CV-5439,TCGA-HNSC,546,MD Anderson Cancer Center,None,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c7f7,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17C-01A,6F4F0CDD-8387-45D0-A9E8-EFCE6260159D,Uterus,78,2D5AC7FC-BED4-4C7F-927D-9B44846324C4,99444E9D-219B-4653-9410-B258D28DEEB7,TCGA-D1-A17C-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17C,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c803,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16N-01A,DBBBDDAE-D711-40F5-BD10-863735885B1F,Uterus,51,6D916A47-DCFF-4C98-9E88-348AAA353F98,133CBA56-19C9-47AE-AB5E-37FF35A7E71E,TCGA-D1-A16N-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16N,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c836,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6521-01A,6DE6B8E2-03EB-4F32-B5A3-BEA73FC632B4,Stomach,65,C3D9FC3B-EF2A-4D02-B7A4-5D1463AD5EF3,0F49F6E2-C6C8-4F3E-8755-BAA962453E71,TCGA-D7-6521-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6521,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2b,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,1798-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c82b,1.86,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17Q-01A,CA8DBBFD-8928-4E25-94C6-B875DE631BBD,Uterus,54,B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C,59FB249D-4C77-40B1-A557-98281869AC91,TCGA-D1-A17Q-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17Q,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,34
13722.58cfa831e4b0c9d6adf6c8c4,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5373-01A,546F01D5-AED5-4FB8-91C0-0FD5E0FDE935,Head and Neck,55,9D73D061-F1E1-47BA-929D-FEEB6C191279,3FE7F18F-8AA4-4AFE-8AF0-256876F7E86E,TCGA-CN-5373-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5373,TCGA-HNSC,NA,University of Pittsburgh,None,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,1431-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c8e8,1.9,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6441-01A,59398D50-45CF-4812-A24E-0C00C0199971,Head and Neck,60,192C9F36-08EC-4F7F-8137-1A9BD0282D98,FE879D88-4817-4ED8-9FB2-EE92AF1A582F,TCGA-CV-6441-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-6441,TCGA-HNSC,292,MD Anderson Cancer Center,United States,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1681-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c91f,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AB-01A,F027D254-EC01-4882-A8A7-964AE90B7D49,Bladder,74,253F84AB-FCE2-4E2D-955B-0B8D13A9E4F0,D1F85B58-EBF8-4A73-A5E0-8DFE62CF1164,TCGA-DK-A1AB-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AB,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13U-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c8f2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5976-01A,23062172-7361-4E61-8EE6-B0A613D72A24,Head and Neck,50,EEF68956-D624-4CD0-9C48-28FAF052C5F9,2581BC16-0DEF-40BC-8A97-54A1AE577E26,TCGA-CV-5976-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5976,TCGA-HNSC,NA,MD Anderson Cancer Center,None,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,12
13722.58cfa831e4b0c9d6adf6c93f,1.95,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,TCGA-DK-A1AC-01A,36C14E9D-1863-4C55-BBBB-F8C9DD418932,Bladder,72,CD2FB6B8-5DB9-42B4-A407-A5B6F7B8665F,221E5DDE-BAB0-456C-87BE-DB54998FE197,TCGA-DK-A1AC-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AC,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,22
13722.58cfa831e4b0c9d6adf6ca71,1.77,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DO-A1JZ-01A,169F045F-1739-4B0B-9BDC-028AACA420F8,Thyroid,23,2EEB72CD-8A11-4ED1-87B0-3CF0C1BF1FB5,C69C86EC-D4E4-422B-88F8-AF3CE8B14148,TCGA-DO-A1JZ-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DO-A1JZ,TCGA-THCA,NA,Medical College of Georgia,United States,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A13U-02,TRUE,17
13722.58cfa831e4b0c9d6adf6ca93,1.39,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16R-01A,40F43483-B504-4EA7-AD24-40682B10CAAC,Uterus,39,F57EB4ED-4393-4DC3-9362-A4757EF8B21D,93FEF054-0782-4A27-A27B-22176874E805,TCGA-D1-A16R-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16R,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,29
13722.58cfa831e4b0c9d6adf6cb25,1.94,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-E8-A242-01A,4D9DE9A1-7DF1-412E-9F16-15DD51B4C5F5,Thyroid,56,225B76AD-DB11-457A-9A77-E1F333895E5C,EA178797-16FB-41AB-B71F-3B397153CE63,TCGA-E8-A242-01A-21D-A16N-02,HG19_Broad_variant,TCGA-E8-A242,TCGA-THCA,NA,Asterand,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A16N-02,TRUE,7
13722.58cfa831e4b0c9d6adf6ca01,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-DQ-5625-01A,53D9A130-4A3A-4491-85CD-9A44415A1632,Head and Neck,52,74856E66-109F-4A68-A496-8FA66729FE1F,9641D13E-BE95-46BB-8330-6128EE15D47C,TCGA-DQ-5625-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5625,TCGA-HNSC,NA,University of Michigan,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1868-02,TRUE,14
13722.58cfa831e4b0c9d6adf6cbd9,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5515-01A,19CF56B2-A85B-43E7-971F-5680B9B1A67A,Prostate,60,5FBA6E4A-3D7D-478E-AFA6-E66C816E7852,C124D41D-EBD2-4DAE-A344-8518DB3354A4,TCGA-EJ-5515-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5515,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,3
13722.58cfa831e4b0c9d6adf6cba8,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5525-01A,554A7381-46FD-4301-B91B-5AF7F173C350,Prostate,67,351AF15C-B213-4621-8BCB-3F4DDCF72553,333DDE15-F4B2-4301-A6AC-59C7F4CD6639,TCGA-EJ-5525-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5525,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cc23,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5503-01A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Prostate,50,627B9FF8-2557-4470-824A-B76A8BCD1E9F,68211C41-2971-4B41-8EEE-75FFB78175BC,TCGA-EJ-5503-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5503,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cc76,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A194-01A,2BBF00F4-7798-4DAD-9894-96202C9132BE,Skin,77,EA15A5B0-8BA7-4114-853F-E3396E81CCEB,411370DC-4C66-484F-AC7E-42A19E486DFC,TCGA-ER-A194-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A194,TCGA-SKCM,1354,University of Pittsburgh,United States,Not available,N0,Not available,Not available,A18Y-02,TRUE,16
13722.58cfa831e4b0c9d6adf6cdb6,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-5963-01A,68F550CA-3A33-45E4-B1C9-14F99E543263,Brain,23,41C647E8-6A53-464B-9EFC-78547C514519,166F687B-F395-4AC7-A06A-78826A0722E7,TCGA-FG-5963-01A-11D-1703-02,HG19_Broad_variant,TCGA-FG-5963,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cdba,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A19K-01A,F9E36BC2-484F-48E8-82BA-99026957277A,Skin,79,E358B11D-2A35-45AE-8910-AE2DC06D39F4,EB5E15F5-55E7-433C-8DD2-AA3DF568F0CF,TCGA-ER-A19K-01A-21D-A18Y-02,HG19_Broad_variant,TCGA-ER-A19K,TCGA-SKCM,469,University of Pittsburgh,United States,T4b,N0,Not available,Stage IIC,A18Y-02,TRUE,13
13722.58cfa832e4b0c9d6adf6ce8a,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2EL-01A,30C7445E-D0C4-4A0F-96A4-27E4259EE10B,Bladder,77,90F1D206-3E97-4C88-922C-FE4773C37CAA,D850DDCD-6E04-4EB4-887C-E1AE410C301C,TCGA-G2-A2EL-01A-12D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EL,TCGA-BLCA,819,MD Anderson,United States,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A18D-02,TRUE,13
13722.58cfa832e4b0c9d6adf6ce96,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2EC-01A,28E25FFB-8B0C-4839-A735-ED7B78E3213A,Bladder,58,2DA969E6-9A63-4C03-8347-01A51496C224,09ED2111-236D-47C1-A82D-7919C8EEA5B2,TCGA-G2-A2EC-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EC,TCGA-BLCA,NA,MD Anderson,United States,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A17R-02,TRUE,14
13722.58cfa831e4b0c9d6adf6cd7a,1.81,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-EY-A1GC-01A,EBC25A41-BECB-4395-AE33-483A304B07D8,Uterus,62,06BE0E15-E48E-4243-AD8D-86CCA9DA68F9,C8E60958-98D8-4EE6-BAA1-DEEEECFF141F,TCGA-EY-A1GC-01A-11D-A13I-02,HG19_Broad_variant,TCGA-EY-A1GC,TCGA-UCEC,NA,University of North Carolina,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A13I-02,FALSE,50
13722.58cfa832e4b0c9d6adf6cf7a,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6499-01A,ACD5CEEF-C5CF-4E95-9394-C50FDBC70C8D,Prostate,66,424FB9D8-F70E-4A36-B895-A766176EEE7C,24062AD0-10DD-4BFB-B805-CA18C57D1FA0,TCGA-G9-6499-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6499,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,11
13722.58cfa832e4b0c9d6adf6cf82,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6348-01A,8AD78C4F-C84C-4F9E-88C9-42A05EB65498,Prostate,68,A692E125-CCFC-4376-9CEA-2410511882BF,68D451D5-F3A1-46C9-BD28-05D71D2C94FC,TCGA-G9-6348-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6348,TCGA-PRAD,NA,Roswell Park,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,7
13722.58cfa832e4b0c9d6adf6cfdc,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7232-01A,CE3585D3-7388-4D05-84C8-64E0883003B3,Prostate,66,0F4B7D00-1C4C-4634-A45E-10F8949ABB43,E847C3F1-CE33-494C-8D95-F82314C95F01,TCGA-HC-7232-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7232,TCGA-PRAD,NA,International Genomics Consortium,United States,T3b,Not available,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,9
13722.58cfa832e4b0c9d6adf6d018,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FT-A3EE-01A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Bladder,80,2356F78C-0653-468F-83DB-6CF6107BD259,0C871E11-F5FB-4B9E-B286-163187A68992,TCGA-FT-A3EE-01A-11D-A204-02,HG19_Broad_variant,TCGA-FT-A3EE,TCGA-BLCA,99,BLN - University of Miami,United States,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A204-02,TRUE,35
13722.58cfa832e4b0c9d6adf6d04e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6329-01A,A08FD0A6-A89A-4ADB-B641-D4C1238ABB71,Prostate,67,E004F38D-C874-4E03-830B-4E554EF3E274,46BEFA09-3AF0-415C-994E-330B07586058,TCGA-G9-6329-01A-13D-1957-02,HG19_Broad_variant,TCGA-G9-6329,TCGA-PRAD,NA,Roswell Park,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,8
13722.58cfa832e4b0c9d6adf6d044,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-GD-A2C5-01A,5D54C742-5A8E-4C40-8D62-95E75E210AB8,Bladder,53,2CD62676-762C-461D-B111-1F81E7CD5877,EEB315EA-D1B6-4F92-91B0-9AAAC7083D68,TCGA-GD-A2C5-01A-12D-A17R-02,HG19_Broad_variant,TCGA-GD-A2C5,TCGA-BLCA,NA,ABS - IUPUI,United States,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A17R-02,TRUE,15
13722.58cfa832e4b0c9d6adf6d10e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HW-7489-01A,6957D45E-7CCB-457D-800D-C2A2037F4F01,Brain,38,B4E032D1-B12E-4DC0-8978-899760F0A245,BBCC5F2C-08F5-424D-8A66-099084F3C47E,TCGA-HW-7489-01A-11D-2022-02,HG19_Broad_variant,TCGA-HW-7489,TCGA-LGG,NA,MSKCC,United States,Not available,Not available,Oligoastrocytoma,Not available,2022-02,TRUE,4
13722.58cfa832e4b0c9d6adf6d194,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6377-01A,007F9081-5093-4323-B4F8-CD510BF20705,Prostate,61,8F105D0D-0630-46FC-8168-DCBA11A5197F,811D74B4-6F98-4B1F-9ADD-CB949E4B5B20,TCGA-G9-6377-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6377,TCGA-PRAD,NA,Roswell Park,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,8
13722.58cfa832e4b0c9d6adf6d1b5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HI-7170-01A,6394E00A-1F6F-4EA2-B885-373BBB59DEF9,Prostate,58,70BF0C3E-0C06-4168-996C-46783752FA37,1C5E0781-5295-427A-B94A-062B2708B62C,TCGA-HI-7170-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7170,TCGA-PRAD,NA,Fox Chase,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,8
13722.58cfa832e4b0c9d6adf6d288,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7476-01A,27D0D3CB-16C0-4BA8-9662-95917F665004,Brain,26,50823838-03B8-4CD8-A40D-8439011C9B38,06ABBC57-F759-43B4-AD0A-3CEE74E012B5,TCGA-HT-7476-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7476,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,7
13722.58cfa82ee4b0c9d6adf6b092,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4417-01A,A244A99A-D7CC-4FB1-BC76-B66886481621,Lung,51,9AB40E48-6979-43CB-9ACF-1D4F474CAD4D,B7C6B0BD-AB9E-4211-8B3A-786B45C43F3D,TCGA-05-4417-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4417,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1853-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b62e,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-6206-01A,C4C1469D-752F-42B6-8686-714AD4A8AC97,Lung,NA,4AFC6152-819B-4E55-817D-DF8A42EB0D36,B6836DCC-F7D7-45BF-AE7C-DE6F2140779E,TCGA-75-6206-01A-11D-1751-02,HG19_Broad_variant,TCGA-75-6206,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b701,1.9,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6775-01A,3C4FF061-D214-4D1C-8D2E-3034F207C252,Lung,72,7C606F64-69A1-465C-9F4E-2EB1EBEDA5D7,8B286297-0077-44ED-9093-6F13E2CA4EBA,TCGA-44-6775-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6775,TCGA-LUAD,NA,Christiana Healthcare,United States,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b8d4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5049-01A,9944F46F-9FA8-4E2C-A806-776BEC7F8803,Lung,70,21B2F32E-CCEA-4B20-86D3-6647E99825CF,26ED24EC-1AD1-492D-B2CB-46314B47919E,TCGA-50-5049-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5049,TCGA-LUAD,NA,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1623-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b896,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-6742-01A,21FB46F9-4BBB-441C-AF19-A687E9138344,Lung,70,F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7,04467FAB-BB2F-4F26-AF9E-39C09D920A63,TCGA-49-6742-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6742,TCGA-LUAD,NA,Johns Hopkins,United States,T2a,N1,Mucinous (Colloid) Carcinoma,Stage IIA,1853-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b8f2,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5932-01A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Lung,75,7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4,B9ACEF1D-8029-47AB-9830-06B2FF147CDB,TCGA-50-5932-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5932,TCGA-LUAD,1235,University of Pittsburgh,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1751-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b697,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-5643-01A,27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0,Lung,53,ED5B47C1-569F-492B-8D6C-155E3BA79ACB,98EAE374-5F58-4544-BB02-BF605A09AD15,TCGA-44-5643-01A-01D-1623-02,HG19_Broad_variant,TCGA-44-5643,TCGA-LUAD,NA,Christiana Healthcare,United States,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1623-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b942,1.81,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GN-01A,A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA,Uterus,65,F6F9C40B-1E58-47A3-B518-9694FB5FF2CF,41896FDE-677E-419C-B8B9-0171D6669A4A,TCGA-A5-A0GN-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GN,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,38
13722.58cfa82fe4b0c9d6adf6b904,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4512-01A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Lung,69,D809A778-D1AC-4406-AB09-67CC70F1F0C2,6D2569C8-4E18-423B-852D-315DDC3AE2F7,TCGA-49-4512-01A-21D-1853-02,HG19_Broad_variant,TCGA-49-4512,TCGA-LUAD,905,Johns Hopkins,United States,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1853-02,TRUE,24
13722.58cfa82fe4b0c9d6adf6ba08,2.03,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0G2-01A,4ABBD258-0F0C-4428-901D-625D47AD363A,Uterus,57,771811E3-740E-42FE-BE9C-FD485997EAAE,579C21E4-83BD-4DAE-B030-53E0930DEACA,TCGA-A5-A0G2-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G2,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A043-02,TRUE,35
13722.58cfa82fe4b0c9d6adf6ba48,2,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0G5-01A,4806D9A6-E65D-4A82-B422-1B287980A0C6,Uterus,73,FA7392E8-335E-4465-9272-4A19DC99412E,EDFD99A3-38A2-4E43-A3D1-B1D19EA818E5,TCGA-A5-A0G5-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G5,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A043-02,TRUE,22
13722.58cfa82fe4b0c9d6adf6b9c6,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4658-01A,AFB91740-2668-46D7-BA01-BB26153AD1C7,Lung,80,BFDE37F2-AB6F-4426-A33D-EF9D21772F02,6A3AFDA7-56BB-4120-AB92-6EDA217BC214,TCGA-73-4658-01A-01D-1751-02,HG19_Broad_variant,TCGA-73-4658,TCGA-LUAD,1600,Roswell Park,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,17
13722.58cfa830e4b0c9d6adf6bc7a,1.89,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-AO-A0JL-01A,D5D8E76E-2F2A-49BC-BA0A-D51283611B16,Breast,59,834D2E25-DA72-413B-BB0E-3BEB24D46472,A34C3F47-AD37-4777-A733-07AE8F4B4BFF,TCGA-AO-A0JL-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JL,TCGA-BRCA,NA,MSKCC,None,T2,N2a,Infiltrating Ductal Carcinoma,Stage IIIA,A060-02,TRUE,8
13722.58cfa830e4b0c9d6adf6bd78,1.87,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-AO-A0JJ-01A,BEF7B135-A727-45E8-850A-CC4CD56C49AA,Breast,54,008DAFDD-A3D1-4801-8C0A-8714E2B58E48,ED24B69D-599E-42ED-BBE3-5C4F59FABED4,TCGA-AO-A0JJ-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JJ,TCGA-BRCA,NA,MSKCC,None,T2,N1a,Infiltrating Lobular Carcinoma,Stage IIB,A060-02,TRUE,10
13722.58cfa830e4b0c9d6adf6bdcc,2.03,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,TCGA-BH-A0H6-01A,AEB6A3A6-B57A-4C53-90E6-E833777DD2A1,Breast,82,B2921C9D-C655-46F3-86E5-2FC2BED1ED33,57D73BC9-950E-42A3-B9FB-6045117112B7,TCGA-BH-A0H6-01A-21D-A060-02,HG19_Broad_variant,TCGA-BH-A0H6,TCGA-BRCA,NA,University of Pittsburgh,None,T1b,NX,Infiltrating Ductal Carcinoma,Stage I,A060-02,TRUE,6
13722.58cfa830e4b0c9d6adf6ba9b,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GJ-01A,94817E78-78F5-4556-9394-610DF65605E2,Uterus,44,48FA5B7D-E488-4743-A7CE-ACEB9945F00B,A5D63CC4-892C-4357-B8A1-2BF50CF425DC,TCGA-A5-A0GJ-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GJ,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,31
13722.58cfa830e4b0c9d6adf6be6c,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BL-A13J-01A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Bladder,65,CF23846D-A7D2-40A9-8B51-49A27967D101,782CEFE1-C28F-40BA-93A2-66279184EEF6,TCGA-BL-A13J-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BL-A13J,TCGA-BLCA,81,Christiana Healthcare,United States,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A10R-02,TRUE,38
13722.58cfa830e4b0c9d6adf6be82,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BL-A0C8-01A,A6003B1C-56A9-430A-A5E2-B70AF3F81BDB,Bladder,73,5FEED572-07C0-4DA0-8649-CA8F8682657A,AB020F79-BA66-457C-9D77-DDD87C799538,TCGA-BL-A0C8-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BL-A0C8,TCGA-BLCA,NA,Christiana Healthcare,United States,T1,NX,Not available,Stage I,A10R-02,TRUE,28
13722.58cfa830e4b0c9d6adf6c02c,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZC-01A,6675C581-297D-44CD-B80F-AE7E53D48228,Thyroid,55,1F945AFF-7BC2-40F5-87DB-92313E541243,0E4A0528-883D-47A5-B399-57B1B15EC412,TCGA-BJ-A0ZC-01A-12D-A13U-02,HG19_Broad_variant,TCGA-BJ-A0ZC,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,13
13722.58cfa830e4b0c9d6adf6c120,1.98,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZG-01A,A3810F36-D2B4-4A45-AD08-A4DBFB9D27AA,Thyroid,80,3AC025C9-FEC6-4997-8630-085750DC84E0,D030DC18-6E50-4679-8BF9-26A1DAEC8F79,TCGA-BJ-A0ZG-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZG,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A10R-02,TRUE,16
13722.58cfa830e4b0c9d6adf6c192,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5149-01A,CB99FB14-641C-4FB3-BF1D-17EFB8CD982A,Head and Neck,47,E5A9FE30-E292-47DC-8EF5-565894B02A62,0F1EEC01-B772-47F6-8A14-0F651FC2F84E,TCGA-BA-5149-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5149,TCGA-HNSC,NA,UNC,None,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,22
13722.58cfa830e4b0c9d6adf6c228,1.64,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20X-01A,BE8B3F36-AAA1-4302-B28E-DE1996FACEAF,Bladder,56,4D7D3354-6588-4E02-9354-AB5044BA1AB3,B9EE2E33-FF09-41FE-901C-453588041DCE,TCGA-BT-A20X-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BT-A20X,TCGA-BLCA,251,University of Pittsburgh,United States,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A16N-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c298,2.08,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,TCGA-BH-A0GY-01A,7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5,Breast,67,A7E71EAC-1768-4FC2-8EBA-1576D22E0F43,F5C72179-9BDA-4BC6-B006-93EB616804BC,TCGA-BH-A0GY-01A-11D-A060-02,HG19_Broad_variant,TCGA-BH-A0GY,TCGA-BRCA,NA,University of Pittsburgh,None,T2,N1,Infiltrating Ductal Carcinoma,Stage IIA,A060-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c32f,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,A3D7BAF1-387C-4094-957E-24BD2A78ED8D,TCGA-CG-4474-01A-02D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,Indivumed,Germany,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,6
13722.58cfa830e4b0c9d6adf6c12e,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0UM-01A,A7C565FC-C711-4B63-9549-4CD74D1F57C2,Uterus,64,6F70F18E-5C53-4F1F-A63D-62BD27039B8D,6CD1B997-3123-4934-A06C-14A5CF1BEBFC,TCGA-BS-A0UM-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UM,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,33
13722.58cfa831e4b0c9d6adf6c332,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4472-01A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Stomach,49,A474CFDD-0822-42E8-A478-C0895A409CCD,8363DF43-B859-4A78-8CDE-3E06C6230EB2,TCGA-CG-4472-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,Indivumed,Germany,T4,N1,Not available,Stage IV,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c33c,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4475-01A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Stomach,76,3E5D09C6-8F98-4701-BD24-FCA581343DE8,86D8A371-57BB-4DC7-9872-0EB4542208DC,TCGA-CG-4475-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,Indivumed,Germany,T3,N1,Not available,Stage IIB,1154-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c33e,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,A3D7BAF1-387C-4094-957E-24BD2A78ED8D,TCGA-CG-4474-01A-02D-1154-02,HG19_Broad_variant,TCGA-CG-4474,TCGA-STAD,NA,Indivumed,Germany,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c342,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4475-01A,CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D,Stomach,76,3E5D09C6-8F98-4701-BD24-FCA581343DE8,86D8A371-57BB-4DC7-9872-0EB4542208DC,TCGA-CG-4475-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4475,TCGA-STAD,NA,Indivumed,Germany,T3,N1,Not available,Stage IIB,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c39e,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,TCGA-C5-A2M1-01A,8911C80C-C903-48E4-AF5B-FFEDEF9ABC47,Cervix,37,065BB06F-5BB7-4F79-B374-97A3011F22AE,E2DAD681-2B26-43A0-804B-0F2DD17B1EFE,TCGA-C5-A2M1-01A-11D-A18I-02,HG19_Broad_variant,TCGA-C5-A2M1,TCGA-CESC,NA,Medical College of Wisconsin,United States,T1b1,N0,Endocervical Type of Adenocarcinoma,Not available,A18I-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c388,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5723-01A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Stomach,83,4CCD9CCB-BF50-44EB-AA55-133D8824C433,9A2DC75A-E7BE-4226-9D8C-940946F75958,TCGA-CG-5723-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5723,TCGA-STAD,NA,Indivumed,Germany,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1598-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c3ec,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5748-01A,0AF98331-9305-41E9-AF55-30390016D65E,Prostate,64,A499BF51-B137-4DA9-87A3-D1B1A0F04695,24A0496A-CA69-4AE3-BF8A-92289C738E9F,TCGA-CH-5748-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5748,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c3dd,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5744-01A,4E76DE8E-CB0D-4B83-8AB4-53BC67A7A9D3,Prostate,64,DCCEAF54-0BCE-4650-9980-9843ABCE0C41,B3198EFA-5613-4B16-BA05-4F0AACCCC00F,TCGA-CH-5744-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5744,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c3fe,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5792-01A,8A5F2D7F-835C-4726-B238-F82D6A7F25BD,Prostate,57,DA5F8107-7B69-45B5-8BEB-21D17B066CB4,5975F57F-2918-46C2-B59F-38FAA67A49BA,TCGA-CH-5792-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5792,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c467,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5751-01A,721E76D0-4B1D-4E78-ADB8-1344B8030062,Prostate,68,6D8CE214-3A06-4F7C-858B-709A40EBBE25,FC06702A-2C27-42FD-A925-D0DB20C358E7,TCGA-CH-5751-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5751,TCGA-PRAD,NA,Indivumed,Germany,T4,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c446,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5750-01A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Prostate,72,0386D0E9-7BD8-467F-BA97-A379C1D67A83,E1FEA0C9-E1D6-49C2-9DFF-9DC87F7776E9,TCGA-CH-5750-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5750,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c420,2.07,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20T-01A,096B4F32-10C1-4737-A0DD-CAE04C54EE33,Bladder,63,52F538EF-B05D-4C76-9976-CE6D49158016,3929BC99-B4FC-4EB9-BDEA-1986EA49AF2A,TCGA-BT-A20T-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20T,TCGA-BLCA,453,University of Pittsburgh,United States,T3b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A14U-02,TRUE,44
13722.58cfa831e4b0c9d6adf6c590,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4472-01A,306F0222-8734-44CA-9A31-86E4E62B0A1B,Stomach,49,A474CFDD-0822-42E8-A478-C0895A409CCD,8363DF43-B859-4A78-8CDE-3E06C6230EB2,TCGA-CG-4472-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4472,TCGA-STAD,NA,Indivumed,Germany,T4,N1,Not available,Stage IV,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c558,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4733-01A,DEDD71B4-8537-4947-839E-90ACEDDD0893,Head and Neck,61,A1FD1C9D-C763-488A-8649-FF069F56D2BE,1CB41C9B-FB04-438D-A9FB-89D6186E0D37,TCGA-CN-4733-01A-02D-1868-02,HG19_Broad_variant,TCGA-CN-4733,TCGA-HNSC,NA,University of Pittsburgh,None,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1868-02,TRUE,22
13722.58cfa830e4b0c9d6adf6c0fe,2.03,Alive,FEMALE,Not available,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K4-01A,A8F38E37-978B-4435-B676-E8D4C34DA909,Uterus,51,A4AC1F6E-3411-47AE-9592-513B3D32223F,4612DB59-3A8E-4F32-968A-76BCE0D4F042,TCGA-B5-A0K4-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K4,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c6ea,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4442-01A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Stomach,85,51927F82-2585-465B-92ED-36EF46D44FAB,7597FC80-5A3C-4999-97B2-4DCB55609CC2,TCGA-CG-4442-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4442,TCGA-STAD,NA,Indivumed,Germany,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1154-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c6a2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6223-01A,D9E8C707-E61A-4813-8DC0-2472E9CCF12B,Head and Neck,69,775DB365-3533-41D9-B635-582292B22700,6CE8A7EC-2730-49E4-81F0-47B03A54EA1A,TCGA-CQ-6223-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6223,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1911-02,TRUE,34
13722.58cfa831e4b0c9d6adf6c6ad,1.9,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5970-01A,1F6167D9-C99D-4873-8D6E-E62A1C964135,Head and Neck,59,4DF92618-5E63-46D7-8526-846932BCE3C2,7EBDEF16-0A0E-4DB2-AB6A-7B6115A7B739,TCGA-CV-5970-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5970,TCGA-HNSC,406,MD Anderson Cancer Center,None,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c6fc,1.8,Dead,MALE,WHITE,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5431-01A,64BB5550-2735-4401-A0DB-58EC1020A32D,Head and Neck,73,BE567C0A-3833-45D7-B846-D229A8E16E16,D751368D-5948-42EF-8C61-D24595CAC1E9,TCGA-CV-5431-01A-01D-1509-02,HG19_Broad_variant,TCGA-CV-5431,TCGA-HNSC,522,MD Anderson Cancer Center,None,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,26
13722.58cfa831e4b0c9d6adf6c748,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6959-01A,EF3CE0E5-D2E8-4616-8B1A-A78C591CF235,Head and Neck,48,07FB167A-3F61-4517-A79E-BA2042F10A3A,E1D21CB1-4329-447E-AC5B-EC31BF045495,TCGA-CV-6959-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6959,TCGA-HNSC,256,MD Anderson Cancer Center,United States,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1911-02,TRUE,26
13722.58cfa831e4b0c9d6adf6c889,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6525-01A,82F9A197-040D-4C5E-89D9-D87A7AA0168D,Stomach,58,C1AC6717-828B-4289-9755-7C56A6FC1392,26A09728-CA75-4E29-A222-0826899E0800,TCGA-D7-6525-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6525,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,1798-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c7dd,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6933-01A,2A749317-0156-4213-8482-B2C2D6E52E9B,Head and Neck,53,8C57C9E6-75BD-442C-984D-3709D2AC4CEC,662EA9EC-86E3-46EE-91C9-6972DA5B5CA1,TCGA-CV-6933-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6933,TCGA-HNSC,2741,MD Anderson Cancer Center,United States,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1911-02,TRUE,12
13722.58cfa831e4b0c9d6adf6c8a6,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6519-01A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Stomach,64,FA7426E1-FCFB-4B08-AD50-1D9E903A81FB,D7D0FD1C-F540-4BE1-A10B-160F59970FFF,TCGA-D7-6519-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6519,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB,1798-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c8a2,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-DQ-5631-01A,10B3F56A-E61E-486B-8D3C-176668D5DC34,Head and Neck,52,2E4AA773-6094-46BD-A97F-9694E80C71CF,5B9E894B-444B-4DCF-9E6C-C1F398A52A81,TCGA-DQ-5631-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5631,TCGA-HNSC,548,University of Michigan,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1868-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c8c8,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6952-01A,7ED006E8-461F-4664-BFFF-55FA6812743C,Head and Neck,65,18E70193-5D78-41DD-9FCA-AF5E54594AD3,EAA6BAF6-1D90-471D-BBFF-2230B87339E4,TCGA-CV-6952-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6952,TCGA-HNSC,185,MD Anderson Cancer Center,United States,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,16
13722.58cfa831e4b0c9d6adf6c90c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A2HX-01A,C728FAC9-5452-4759-A4ED-A366E0F757CB,Bladder,80,537F3FE6-4E8E-4570-827A-0F5CAB193BE0,4BAFEFB4-28D5-4126-B6B7-AE5B0D03F05D,TCGA-DK-A2HX-01A-12D-A18D-02,HG19_Broad_variant,TCGA-DK-A2HX,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A18D-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c912,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A2I2-01A,234086DD-5A74-4FF1-94AB-BAD43EE69D5C,Bladder,63,45F8E4B6-5D36-47D7-A77D-E5E4C15848B3,767D7AA5-093D-48AB-BCDA-92729F4B95B7,TCGA-DK-A2I2-01A-11D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I2,TCGA-BLCA,237,Memorial Sloan Kettering,United States,T3,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A17R-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c91b,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A2I1-01A,036B9681-AB58-4734-A8FD-E0D5D078BF5A,Bladder,73,F9BD70B2-6CDE-48E5-9F0D-55D86CCFEBA8,010259EE-2667-4B8E-BB20-0F75F53A64BA,TCGA-DK-A2I1-01A-11D-A17R-02,HG19_Broad_variant,TCGA-DK-A2I1,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A17R-02,TRUE,24
13722.58cfa831e4b0c9d6adf6c936,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16E-01A,E70465F6-1922-4EB7-B646-8B01AD3CE77B,Uterus,73,58FC1E66-39C4-44D1-BDD3-338E0D833792,0651FC75-DFFC-4271-8832-2DB47C642804,TCGA-D1-A16E-01A-22D-A12F-02,HG19_Broad_variant,TCGA-D1-A16E,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,24
13722.58cfa831e4b0c9d6adf6ca1b,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A2I6-01A,DE810AF0-4C18-4E8F-9836-F8ABC425E3EB,Bladder,81,A536F8F9-3A68-4792-880D-387D78FD0C66,B791021D-173E-4B08-8769-A9F289818D11,TCGA-DK-A2I6-01A-12D-A18D-02,HG19_Broad_variant,TCGA-DK-A2I6,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A18D-02,TRUE,19
13722.58cfa831e4b0c9d6adf6cae8,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6522-01A,8BB3FACB-1933-4350-9F78-74537559E000,Stomach,58,825AE87A-69C0-44AC-A1AF-D1FAD7746C05,030D9DF5-48AB-46F4-AC23-F299A069191C,TCGA-D7-6522-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6522,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB,1798-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cba0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5519-01A,5313A055-C2D7-4CBD-A8C1-57AC85912D89,Prostate,64,EEE1828E-D25F-462B-9735-89CA2ECCC7E1,4C2E88A3-B668-40A8-B625-B6D7A48DEAF5,TCGA-EJ-5519-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5519,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cc40,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,TCGA-EK-A2R7-01A,D7A75BF5-5189-4978-99D9-FCEF91C9FBD2,Cervix,45,EE9A22DF-8612-4B71-AF3A-6B16C73197EA,9C763A04-CC5B-41E1-A5AC-2CB06B9E80C3,TCGA-EK-A2R7-01A-11D-A18I-02,HG19_Broad_variant,TCGA-EK-A2R7,TCGA-CESC,NA,Gynecologic Oncology Group,United States,T1b1,N1,Cervical Squamous Cell Carcinoma,Not available,A18I-02,TRUE,8
13722.58cfa831e4b0c9d6adf6cc5c,1.9,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,TCGA-EJ-5502-01A,48E83A4C-C602-494A-80CD-E2F4B4DD701E,Prostate,50,D36A0B54-6E09-4EE2-923B-C1516D78BB03,0432A271-DB73-434C-971A-B3B2C3FD2285,TCGA-EJ-5502-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5502,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cba4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5521-01A,D44D4BCB-BEB1-4464-ACD2-9972751F5018,Prostate,63,9EEBD2EC-AF9D-493C-A006-A436C28D4CD3,83248990-416D-48F0-B6F4-59C4C7CEEBD8,TCGA-EJ-5521-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5521,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cca9,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A196-01A,A9EB1022-FFD3-42DE-A39D-2126FC7EC0CE,Skin,64,239F69F7-E78A-4B09-BF00-E521F63A3BB4,77937F29-C94F-4251-A0AB-9D07DED92796,TCGA-ER-A196-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-ER-A196,TCGA-SKCM,NA,University of Pittsburgh,United States,T4b,N0,Not available,Stage IIC,A18Y-02,TRUE,13
13722.58cfa831e4b0c9d6adf6cd84,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A235-01A,C781B49E-D08F-49E6-B774-7CFE4100E92D,Thyroid,26,377A0CBF-6A82-43FA-BC95-DADECED8916D,F3F4F8FB-6FAD-46B7-85D0-C591EB926DD7,TCGA-FE-A235-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A235,TCGA-THCA,NA,Ohio State University,United States,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,9
13722.58cfa832e4b0c9d6adf6ce02,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5524-01A,4048C139-1329-4E6A-8D2F-C0AA104A68EE,Prostate,57,C197A81D-2AA5-4285-88E3-761798E2C190,4B173FC3-DBE0-47AA-8ACC-D36466B5522D,TCGA-EJ-5524-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5524,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cd7c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FD-A3B3-01A,4B5D873B-BFDA-482E-92A0-BF84C0F9032A,Bladder,74,769EE027-5ED7-4EC2-86B5-FE40F9D6FB5A,57731F40-BBEF-4C7B-BFDC-CE75DA6EB1EB,TCGA-FD-A3B3-01A-12D-A204-02,HG19_Broad_variant,TCGA-FD-A3B3,TCGA-BLCA,NA,BLN - University Of Chicago,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A204-02,TRUE,10
13722.58cfa832e4b0c9d6adf6ceb7,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5522-01A,214884EF-A932-4FC3-B6FF-16CE5164DA3E,Prostate,51,8AC1E1E7-8266-48E0-8D4C-D78873111341,2312B3FC-1F68-43D5-8B19-D449089F153C,TCGA-EJ-5522-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5522,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,3
13722.58cfa832e4b0c9d6adf6ced1,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5542-01A,5A92EC4C-36EE-4588-ACA2-E3303F29C7AD,Prostate,60,DFFC7994-E957-4451-A9DB-56D4560D6547,185234ED-0A19-490C-86D8-19762FB13C1A,TCGA-EJ-5542-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5542,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,8
13722.58cfa832e4b0c9d6adf6ced3,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5527-01A,BA0C9096-5F35-4F0A-AE98-EE1A695B55F0,Prostate,69,15A638FE-4DFD-4280-AD40-5E0D5FDE3812,AE85C536-0580-4A34-B686-161D337E7951,TCGA-EJ-5527-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5527,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa832e4b0c9d6adf6cf07,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7079-01A,10FBE481-F111-4F88-AE45-4D67CB265567,Prostate,51,190EF71A-5B5D-4009-B707-68F10147CB65,3935531A-0F99-4617-A5B6-6774E74CEE5E,TCGA-HC-7079-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7079,TCGA-PRAD,NA,International Genomics Consortium,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,7
13722.58cfa832e4b0c9d6adf6cf34,1.8,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6363-01A,B5B3871C-078C-46A7-AC50-EF916D4A6781,Prostate,64,65D588FF-58E3-4932-A7F4-25EF23C433D5,DBF42C34-D2E5-4136-83F5-093453913D5B,TCGA-G9-6363-01A-21D-1784-02,HG19_Broad_variant,TCGA-G9-6363,TCGA-PRAD,NA,Roswell Park,United States,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,4
13722.58cfa832e4b0c9d6adf6cfe4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6333-01A,64BF32C9-9466-404A-A147-E7A0B9E91E34,Prostate,66,98013499-4FAC-4378-9D7E-B3686003A4FC,F6373E03-914F-44B2-954D-E63DE95F89E8,TCGA-G9-6333-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6333,TCGA-PRAD,NA,Roswell Park,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,4
13722.58cfa832e4b0c9d6adf6d015,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6332-01A,C46022F8-B122-4367-836B-EC1AE641A87D,Prostate,55,30558AEB-76B7-4D27-99C0-E3EE21A00BD1,B9FAA261-1FA4-4870-B98F-60153ED7AD8C,TCGA-G9-6332-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6332,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,4
13722.58cfa832e4b0c9d6adf6d06c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7211-01A,EC3870C9-4930-4AF7-B2EB-1E16C9EC9F14,Prostate,62,79BF8C2C-470E-4BE8-8144-9C0B366ECADD,226F7F0E-AC30-4F20-87A2-EB8128402BE4,TCGA-HC-7211-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7211,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,4
13722.58cfa832e4b0c9d6adf6d1a2,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HI-7168-01A,25D70934-01A5-45A2-9960-68D3058B6965,Prostate,62,DD410832-95AA-4FA6-A2B9-3FECA6F70E1D,9FD5990D-22E1-4D64-996D-543BCD447500,TCGA-HI-7168-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7168,TCGA-PRAD,NA,Fox Chase,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,8
13722.58cfa832e4b0c9d6adf6d12c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2EK-01A,5DA1CB68-C438-4DDC-999F-90AED0C4BD7A,Bladder,57,FF1691F2-DF11-4068-8D8D-A778F384EC60,8A75CF19-7645-489D-AAEC-5D9AD293C4B1,TCGA-G2-A2EK-01A-22D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EK,TCGA-BLCA,NA,MD Anderson,United States,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A18D-02,TRUE,21
13722.58cfa832e4b0c9d6adf6d279,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7475-01A,41456932-436E-4CDB-BFE8-97D089656786,Brain,67,5E11FC94-CCDB-4E53-9A9D-5D7707157674,B59DECE1-1DE9-46D3-B5CD-0EFD8F453F8D,TCGA-HT-7475-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7475,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligoastrocytoma,Not available,2022-02,TRUE,5
13722.58cfa82ee4b0c9d6adf6aee7,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4410-01A,D28E465C-E553-4C53-8BB7-3D8199B9A8A5,Lung,62,F8961F5C-E28B-44A2-8E4E-B5759FE2D849,51E2038A-2D9D-481D-A3B6-D5D5D6B33E4F,TCGA-05-4410-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4410,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1853-02,TRUE,17
13722.58cfa82ee4b0c9d6adf6ae6c,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4405-01A,F587C9AB-2949-4410-80D6-A050865D48AA,Lung,74,9CE83CC4-7B9B-4CE7-98F5-5CE8A8D70902,8A9ADFB9-6266-490D-B1B6-F66F43F3F657,TCGA-05-4405-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4405,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1853-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b5dc,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5939-01A,12B79B4F-C28C-418E-A1E7-E622F33FDCC2,Lung,85,6A27F5F8-F4EE-45C7-B953-DDD7D0291DBB,08D803D0-A294-4F70-9560-563357172BBB,TCGA-50-5939-01A-11D-1623-02,HG19_Broad_variant,TCGA-50-5939,TCGA-LUAD,460,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1623-02,TRUE,12
13722.58cfa82ee4b0c9d6adf6afae,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4425-01A,69B23036-ADD9-42C9-941F-02FB74D9B08C,Lung,70,98BEE17E-0B07-40D8-A70F-3163DBFD9C79,C0DC5772-8A3E-43BE-9059-FC524A5183C9,TCGA-05-4425-01A-01D-1751-02,HG19_Broad_variant,TCGA-05-4425,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IV,1751-02,TRUE,39
13722.58cfa82fe4b0c9d6adf6b720,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-67-6217-01A,108A71CF-B9DB-47CD-AA74-C03EC989B41B,Lung,73,BC0FE45C-3249-46D7-8991-C6888F0B9579,565E717D-310B-4FB1-B79A-5F40FF12BBB8,TCGA-67-6217-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6217,TCGA-LUAD,NA,St Joseph's Medical Center (MD),United States,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA,1751-02,TRUE,29
13722.58cfa82fe4b0c9d6adf6b81e,2,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GE-01A,A587E62E-430E-4F1B-82B7-6FBE856FDAF1,Uterus,38,20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8,3E23FB82-C875-460A-B19D-5EF9DCC58B9A,TCGA-A5-A0GE-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GE,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,22
13722.58cfa82ee4b0c9d6adf6ae60,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4390-01A,B8475929-2D9D-4909-BD62-59684A140BD7,Lung,58,C7F76210-D0F2-4FB8-80F1-35098DBE03DE,4BC393B5-F924-4D66-BC93-58A3CB2EBBC5,TCGA-05-4390-01A-02D-1751-02,HG19_Broad_variant,TCGA-05-4390,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1751-02,TRUE,51
13722.58cfa82fe4b0c9d6adf6b674,1.9,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-71-6725-01A,4B7CD595-E7F9-45A8-B736-A8C7C42D9539,Lung,48,83973755-FA6A-460A-A042-385B34698C39,1AD7566E-B9DD-43A3-94DC-96F525007EAA,TCGA-71-6725-01A-11D-1853-02,HG19_Broad_variant,TCGA-71-6725,TCGA-LUAD,NA,ILSbio,Vietnam,T2,N0,Lung Papillary Adenocarcinoma,Stage IB,1853-02,TRUE,66
13722.58cfa82fe4b0c9d6adf6b92a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6828-01A,9536E32D-2707-48D2-A36D-08C521665BB9,Lung,70,CFE0F0E4-D8BF-40CE-99F1-2BF99CECA18B,2C0D4A9F-857D-4C6F-B616-304AB5922A2F,TCGA-91-6828-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6828,TCGA-LUAD,NA,ABS - IUPUI,United States,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1853-02,TRUE,12
13722.58cfa82fe4b0c9d6adf6b9ab,1.9,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-44-6777-01A,349E6F38-2C67-4A69-A777-B9173A2A27CF,Lung,85,174E4405-4848-4E5E-93CC-0CDF2795C91A,AAAAE42F-88A5-4E99-8057-A92D6759BE19,TCGA-44-6777-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6777,TCGA-LUAD,987,Christiana Healthcare,United States,T2,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,21
13722.58cfa82fe4b0c9d6adf6b932,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6836-01A,0B31DBDF-0623-48E4-A0EC-017650DCEDA7,Lung,52,49A0AB8A-F379-4394-ACCF-0B4B08D2DCC6,0D6B80DD-76A1-4174-9275-731B4A347213,TCGA-91-6836-01A-21D-1853-02,HG19_Broad_variant,TCGA-91-6836,TCGA-LUAD,NA,ABS - IUPUI,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,18
13722.58cfa830e4b0c9d6adf6ba81,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6831-01A,DB0B9E63-4272-4F29-BF0E-1EC0FE79A9D7,Lung,66,7B1D8B50-F3DF-4AAB-A654-C3810D8D576D,0D0D96AE-A83B-4C09-8ED9-4A568E816EFC,TCGA-91-6831-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6831,TCGA-LUAD,NA,ABS - IUPUI,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,80
13722.58cfa830e4b0c9d6adf6be70,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A28R-01A,524A39EE-8FA3-418E-98A2-A6A90E9C8064,Thyroid,38,F4906B86-3971-4ED3-AC3C-69635311FB45,A5170F7D-F298-4330-8272-8DACFF7775A1,TCGA-BJ-A28R-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28R,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b8c6,2.06,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GX-01A,553F0CCD-4E6F-4AE2-9B39-97529EB3D826,Uterus,53,983A35A9-C825-4961-86C0-4C6133B5C9C1,FE0654FE-39AA-4993-8F36-768C7D829092,TCGA-A5-A0GX-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GX,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bd92,1.92,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0LW-01A,68181BC9-AA8B-44EC-8601-564B30EA0561,Uterus,47,6527EC31-1D41-49C2-93FF-11615A6CBA8B,5D88ADF5-468B-4377-B3E3-DF986C613D24,TCGA-BG-A0LW-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0LW,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,47
13722.58cfa830e4b0c9d6adf6bda2,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-BF-A1PX-01A,197AC33E-D5DF-40DE-92F2-6EF7FE2AD6DD,Skin,56,EE2F9863-0DAE-4830-A780-E7745414BC3D,98B49A52-61EC-4A87-B2DD-EEFD6E0E028F,TCGA-BF-A1PX-01A-12D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PX,TCGA-SKCM,282,Cureline,Russia,T4b,N2a,Not available,Stage IIIB,A18Z-02,TRUE,18
13722.58cfa830e4b0c9d6adf6bee2,2.13,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LO-01A,A081DA6F-51F3-4555-A6B8-736F8C6CDA39,Uterus,45,9846D8F3-5B22-48E9-B972-A0FE9F509FB4,A91FCC79-7AE0-4BD1-BCAE-543E49E2D62E,TCGA-AP-A0LO-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LO,TCGA-UCEC,1016,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,13
13722.58cfa830e4b0c9d6adf6bf52,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4280-01A,E0916597-E489-45EF-A8F7-653A3C6591EF,Stomach,78,797D2D3A-F01C-4985-B27C-4E4C2838D34D,7F073E1B-E936-44FF-B3C0-8F4C26ECC3A9,TCGA-BR-4280-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4280,TCGA-STAD,NA,Asterand,Russia,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III,1128-02,TRUE,7
13722.58cfa830e4b0c9d6adf6bbf4,2.12,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GW-01A,5B6B9D0F-787C-4AE9-AFD4-DE7CE6C57A42,Uterus,46,E84D0533-E892-4C1E-9415-99F92AA9A360,3DCC9DC1-990D-4053-967E-B8E4EE752C4E,TCGA-A5-A0GW-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GW,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,23
13722.58cfa830e4b0c9d6adf6bf32,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4188-01A,151257D7-BA5B-49A0-94F5-50E28F9F46F1,Stomach,53,26398996-4EB5-4C24-BA78-3CA9A3B6EBC0,549B1391-8EBF-49D0-BF3A-6CAF92A8DC00,TCGA-BR-4188-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4188,TCGA-STAD,NA,Asterand,Russia,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,16
13722.58cfa830e4b0c9d6adf6bfdf,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6801-01A,24FED326-BDCF-4C20-A06E-7C1C3D6C9CC5,Stomach,70,713F11EE-D285-4A3B-B421-1D416E5F8E52,FDD2EE8C-C74B-49B8-A530-8CC171C34804,TCGA-BR-6801-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6801,TCGA-STAD,NA,Asterand,Russia,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1880-02,TRUE,3
13722.58cfa830e4b0c9d6adf6bf08,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4183-01A,33503349-BA7A-43F4-BCB2-AC8D16808432,Stomach,55,C17A8996-14C4-4A17-A55B-925172A45211,B5E3A2A5-71FD-4ED8-98DB-0CB725638C26,TCGA-BR-4183-01A-02D-1128-02,HG19_Broad_variant,TCGA-BR-4183,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1128-02,TRUE,17
13722.58cfa830e4b0c9d6adf6c07c,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZH-01A,866CA8AD-ADC9-45D4-AD92-9F8F1A161DDF,Thyroid,52,01EE736B-F907-465B-9142-C50BE0A3461B,8B8B2852-9D53-4654-A37C-2749C0F264ED,TCGA-BJ-A0ZH-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZH,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA,A10R-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c1de,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A0YX-01A,22473AD4-DF39-4716-B558-3C1409D5FA0E,Bladder,70,DA614214-F84C-43AB-983C-D9D76CF2D6AE,DC052DFC-26A8-4393-8849-FA954913C622,TCGA-BT-A0YX-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BT-A0YX,TCGA-BLCA,NA,University of Pittsburgh,None,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A10R-02,TRUE,23
13722.58cfa830e4b0c9d6adf6c0e2,2.02,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZF-01A,8BEEE000-ECAB-4A49-9C9D-BB8E677AE199,Thyroid,54,83A66A9D-916A-44E8-A7E6-A1385DB504DB,14EE09BE-144A-4461-8F5A-A738CC5D955E,TCGA-BJ-A0ZF-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZF,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Other  specify,Stage II,A10R-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c206,1.98,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20W-01A,4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7,Bladder,71,CA14F475-1BE4-450C-80C3-7094D23D0B3D,A32E59E0-242F-465D-8277-E0FE26124091,TCGA-BT-A20W-01A-21D-A14U-02,HG19_Broad_variant,TCGA-BT-A20W,TCGA-BLCA,254,University of Pittsburgh,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A14U-02,TRUE,17
13722.58cfa830e4b0c9d6adf6c319,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6705-01A,B14F2FCB-E869-475E-BC7C-ADAF6E7E636F,Stomach,68,DB8D0AC1-23B7-49AB-8BB3-44782156F038,F55A158B-F7DB-4786-9553-65DEBCAE80BA,TCGA-BR-6705-01A-12D-1880-02,HG19_Broad_variant,TCGA-BR-6705,TCGA-STAD,NA,Asterand,Ukraine,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB,1880-02,TRUE,5
13722.58cfa830e4b0c9d6adf6c310,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6710-01A,012E99FE-E3E8-4BB0-BB74-5B0C9992187C,Stomach,41,25E9E880-4EA1-40CF-BBB6-0F961C735C97,999D0F8C-6A89-4753-AD18-F44304EA78F9,TCGA-BR-6710-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6710,TCGA-STAD,NA,Asterand,Ukraine,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1880-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c338,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4476-01A,442D7415-D095-4962-8296-A14390BAD40A,Stomach,69,37F5444F-A58D-4899-A11B-9C09ECD357FC,0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7,TCGA-CG-4476-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,Indivumed,Germany,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c3e2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5743-01A,2DEE4BD8-B00E-4F8A-BFEA-5D8D1A068202,Prostate,66,6BD8573D-535F-4F6D-8EAF-60918B5DA578,EE5F51E6-F989-4380-A86F-29CBF50BA03A,TCGA-CH-5743-01A-21D-1572-02,HG19_Broad_variant,TCGA-CH-5743,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c3b2,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4476-01A,442D7415-D095-4962-8296-A14390BAD40A,Stomach,69,37F5444F-A58D-4899-A11B-9C09ECD357FC,0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7,TCGA-CG-4476-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4476,TCGA-STAD,NA,Indivumed,Germany,T4b,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c3e6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5745-01A,AC67D0DF-7DC0-4A1A-8B47-BEEC9B94DE86,Prostate,68,BDA91E83-643B-4FAE-BFE9-B4660F3BDF02,780758FF-58EE-4B4B-AC71-DE15C89C4625,TCGA-CH-5745-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5745,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c412,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5794-01A,A80D3EE7-60DD-49BB-B049-9335AFC035F5,Prostate,65,D1A1CCFE-1215-4B34-94A9-C9765264F617,9D7EACBC-B476-4813-9215-AC0073382A25,TCGA-CH-5794-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5794,TCGA-PRAD,NA,Indivumed,Germany,T2b,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c438,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5772-01A,ECF9F8BE-7830-4626-8617-694C68EF4074,Prostate,63,068AC08D-1A9E-4C71-B436-4ED861A9DCF8,5C9AAB80-29D2-4D85-A9FE-99FA22222CA4,TCGA-CH-5772-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5772,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c44a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5741-01A,B3BF57D4-E31A-4740-B438-FA826FB79550,Prostate,56,B22CBB75-E6E5-443D-AB4E-1CFD0079C69A,6AC2CA6C-FC79-4E5D-B08F-029A4AC2577B,TCGA-CH-5741-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5741,TCGA-PRAD,NA,Indivumed,Germany,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6c531,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5768-01A,F6C61A22-A711-416D-9E65-6A1B957E5B2E,Prostate,72,C4FF48C4-E953-4267-AB9C-3A09A97A88C4,9813DF8A-57D6-4D59-8534-3942B7FE672E,TCGA-CH-5768-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5768,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c278,2.05,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K1-01A,40A3ED98-3892-449C-B07E-7B7612BD997E,Uterus,69,B514F636-DEE3-45F3-BB31-197CA6A171F1,D4814366-AEF2-453B-8DC7-A731B5E53FE8,TCGA-B5-A0K1-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K1,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,37
13722.58cfa831e4b0c9d6adf6c59e,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4465-01A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Stomach,69,89DAB798-0B26-470C-82AF-1B23C83FE4F5,2CCE681F-F5C6-496E-96C3-21046ECEAA56,TCGA-CG-4465-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,Indivumed,Germany,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c5a0,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4465-01A,C9AB5BF4-092A-420F-9B90-87DEEA58104C,Stomach,69,89DAB798-0B26-470C-82AF-1B23C83FE4F5,2CCE681F-F5C6-496E-96C3-21046ECEAA56,TCGA-CG-4465-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4465,TCGA-STAD,274,Indivumed,Germany,T4,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c56b,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5746-01A,618272C0-C2ED-4BFB-BB4B-404F0987F822,Prostate,57,54AD063E-68D9-4104-856A-2BD3905FA971,ABAFDCA6-6109-4686-A058-BDBEB9ADD1E7,TCGA-CH-5746-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5746,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c60a,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6220-01A,96D0CEFE-7949-4736-A7DC-1E4FA94765EC,Head and Neck,69,E0E75203-3982-40B2-A057-FAA8433DFB7A,C7EABDCF-81F2-4C87-946A-B5BA42056B04,TCGA-CQ-6220-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6220,TCGA-HNSC,985,"University Health Network, Toronto",Canada,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1911-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c602,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6225-01A,90F44998-3C05-44B2-9501-BBD0F43C5147,Head and Neck,65,E907D8D4-C4C6-441F-9F19-FF3746E5D13E,40BFD664-E699-4F0D-9670-30D0F5CC8728,TCGA-CQ-6225-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6225,TCGA-HNSC,403,"University Health Network, Toronto",Canada,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1911-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c667,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,Indivumed,Germany,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1154-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c69c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6229-01A,A091822C-447A-49A5-8C20-E329DF79599C,Head and Neck,61,F01165B0-911A-45B0-BA7D-7CD0E723A2E4,4AF0777A-6FE3-49AE-B3B9-4AB077DDB007,TCGA-CQ-6229-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6229,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1911-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c70c,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5973-01A,8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB,Head and Neck,62,5078222F-B257-4286-A29A-BC1E395149BC,55E8AEAC-4C0E-49DF-8F57-605E7C820B89,TCGA-CV-5973-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5973,TCGA-HNSC,NA,MD Anderson Cancer Center,None,T3,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1681-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c6a0,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6224-01A,D86FD392-FA5C-4142-A647-440E6C32D478,Head and Neck,52,AD242EAC-A5AE-42B7-85CE-3E4D0DD308D6,3FAD44AE-89FC-4BB4-BA86-15A0EF7E2C3A,TCGA-CQ-6224-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6224,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c746,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6817-01A,6FFEFB3F-3919-4FEF-AB15-5D32D8F51D57,Stomach,63,9E01F1D4-7BA6-42B7-A43C-833195EF4B49,10358672-8D99-4098-8B0A-71D4960A45FA,TCGA-D7-6817-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6817,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2b,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA,1880-02,TRUE,2
13722.58cfa831e4b0c9d6adf6c768,1.84,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A1O0-01A,A98BBE29-8817-4380-A738-3C1BF9F8E0CC,Uterus,77,E113E0F0-3AE5-48A3-A226-AD920F41259E,8DF3928E-65CE-4578-96A4-BA3AE51E764C,TCGA-D1-A1O0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A1O0,TCGA-UCEC,NA,Mayo Clinic,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A17E-02,TRUE,32
13722.58cfa831e4b0c9d6adf6c74d,1.36,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A177-01A,E8C58D8B-51D7-4599-AF79-469EE6F269DB,Uterus,70,97587FD4-0F6F-4AF5-AC0A-7328ABB40E9C,2F6D7D10-84AA-48A6-9B8E-9CBB257C653D,TCGA-D1-A177-01A-21D-A12F-02,HG19_Broad_variant,TCGA-D1-A177,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c7a3,1.9,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6954-01A,402FD96C-76D3-4AC2-9F64-77BD34BE0ADB,Head and Neck,59,F72D39EA-7DB5-47C6-9428-3E26454C9A9A,7FA6660F-0B18-4F4D-AEA1-17C22A9DBAA6,TCGA-CV-6954-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6954,TCGA-HNSC,2002,MD Anderson Cancer Center,United States,T4a,NX,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c7f3,1.87,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-5577-01A,2DC154AA-C478-404B-A92E-86ABCC8DBDB7,Stomach,53,93BBD9FD-2385-46C3-AF21-E46C72A8A75D,8FCA6D2A-04D8-4A60-AEA3-298853E74752,TCGA-D7-5577-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5577,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N3,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA,1598-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c80f,2,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6938-01A,FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE,Head and Neck,87,9EB292E6-AE4D-4613-98EE-0197FD97B633,87E1BCCB-5B03-40AF-A262-0B2B5E6A08D2,TCGA-CV-6938-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6938,TCGA-HNSC,144,MD Anderson Cancer Center,United States,T2,NX,Head and Neck Squamous Cell Carcinoma,Stage II,1911-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c858,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6517-01A,EBE99910-E9F2-43DC-AD57-AC2F610B60C8,Head and Neck,59,8C099F45-3FD6-4966-8CDB-CA4B9288B1A2,97962F6C-B2FB-4618-A5A4-7B376714EC62,TCGA-D6-6517-01A-11D-1868-02,HG19_Broad_variant,TCGA-D6-6517,TCGA-HNSC,NA,Greater Poland Cancer Center,Poland,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1868-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c826,1.96,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17U-01A,6397C4A1-0A29-4C2C-B8CB-CE73AF93DD0B,Uterus,53,1F1945EE-4CF3-43A3-9998-1C4528C7A511,1B9EB26F-48E0-4EBF-9094-5013E3DF2FBD,TCGA-D1-A17U-01A-21D-A12F-02,HG19_Broad_variant,TCGA-D1-A17U,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c98e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6520-01A,3C573AF6-6298-49DE-8DE0-6A7F9CE9B000,Stomach,53,7C162352-903E-4723-AF91-6FDD8E8EAD3B,F1CB7996-BD0E-4123-84E9-D359E5DB7700,TCGA-D7-6520-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6520,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2b,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA,1798-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c246,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4078-01A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Head and Neck,83,2027EDE3-13F5-40F6-BEF6-16704981D676,66A9CFF2-397E-415E-BF54-9A75CCC80BDE,TCGA-BA-4078-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,UNC,None,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c9d4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DB-5276-01A,9D0C1552-00A7-4F0A-A04A-A82E721EE4E3,Brain,32,11CB167F-CD54-409F-BFEA-511E620C96FC,5396382E-9FBC-43DA-9C88-DF17FFDA1E2B,TCGA-DB-5276-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5276,TCGA-LGG,NA,Mayo Clinic - Rochester,United States,Not available,Not available,Oligoastrocytoma,Not available,1465-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c9d3,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A3-01A,C5B20CCC-523D-491C-8536-008E05C57212,Bladder,60,954E46BA-514F-4708-AD3C-ECBF8CEF005A,DC0A234A-9177-4E2A-B218-212F1278B4A1,TCGA-DK-A1A3-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A3,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13U-02,TRUE,12
13722.58cfa831e4b0c9d6adf6c9c7,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-DQ-5630-01A,91A712B5-A724-48D0-BA06-4F6857683463,Head and Neck,73,A0CDB208-E66F-4AD7-86FA-5077145A4A68,4C2960DA-103B-4620-ABCD-0EE586F39E0D,TCGA-DQ-5630-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5630,TCGA-HNSC,NA,University of Michigan,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1868-02,TRUE,10
13722.58cfa831e4b0c9d6adf6cac2,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13R-01A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Thyroid,50,27B0FF79-4213-4B57-B6E0-A393B8983D20,7B0104C8-1264-4580-94D1-C7C39D79C6E6,TCGA-DJ-A13R-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13R,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A10R-02,TRUE,15
13722.58cfa831e4b0c9d6adf6ca92,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-DQ-5624-01A,B4A41682-4ACA-4F1D-BACD-66F5E6EC7466,Head and Neck,43,39A74037-6C20-4713-A6AA-E972218EFF90,45F819EB-F6B5-4B82-9E47-060B2E111851,TCGA-DQ-5624-01A-01D-1868-02,HG19_Broad_variant,TCGA-DQ-5624,TCGA-HNSC,NA,University of Michigan,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1868-02,TRUE,12
13722.58cfa82fe4b0c9d6adf6b7fa,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-38-4629-01A,127BF818-F7E5-46B5-A9DE-39F6D96B8B83,Lung,68,EB822F95-8B15-4C86-B5E5-B0AFE9C32E0C,51FF3351-1A43-458F-9BD9-99BD39FDDAF3,TCGA-38-4629-01A-02D-1203-02,HG19_Broad_variant,TCGA-38-4629,TCGA-LUAD,864,UNC,None,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1203-02,TRUE,66
13722.58cfa831e4b0c9d6adf6cb9a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7317-01A,68FC3693-0910-4EE8-8997-99C6333B65F4,Prostate,71,AEEA2F28-0766-42D7-9E6A-C14BEB03E692,B25F2F78-DB49-49DF-9150-DF43F23589A4,TCGA-EJ-7317-01A-31D-2111-02,HG19_Broad_variant,TCGA-EJ-7317,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cbca,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5517-01A,4B9AA301-D2E3-47F3-B724-A34F420B2B6B,Prostate,55,B5FE6254-D1C6-4BA2-BD75-5CAF4FB2E2B7,62E5A068-01A5-40EC-8FF9-097D627127A0,TCGA-EJ-5517-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5517,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cbc7,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7327-01A,E90AB72A-4BBB-4C37-B48A-8A1A85D79D04,Prostate,61,992415EF-53DE-4C52-A538-07931E68182B,0FC53595-F61A-4171-B982-335AEE13CC85,TCGA-EJ-7327-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7327,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cbdd,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5532-01A,AE3A0C92-148D-4F1C-8563-06AC1050F53E,Prostate,57,F32F7738-BAD4-40C9-B49F-084BB098A05A,E5F35020-2A9F-47B3-8271-FEF8E1883567,TCGA-EJ-5532-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5532,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cca3,1.9,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5499-01A,FD1AA612-DF86-4D48-892D-2ACEBD76EA96,Prostate,61,22C4F5C2-1B1E-4212-8110-09DBD5CE10A9,0F4314C9-967C-4EF1-9CF2-A7B206E6129E,TCGA-EJ-5499-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5499,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cca6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5497-01A,DEE02265-D8DD-4379-AE08-72D72B03A570,Prostate,47,317BE3B2-B7C1-4772-9E33-D55EB4B9FAA9,0B2246C7-CE2E-427D-BA10-4A2C942D0986,TCGA-EJ-5497-01A-02D-1572-02,HG19_Broad_variant,TCGA-EJ-5497,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6cccc,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5530-01A,E4A755E3-4938-4321-B5A9-27A445036791,Prostate,61,27D61473-39D6-478A-A576-427D1AEDA01F,CBA52846-FAD3-4D21-8949-0105BD2AE713,TCGA-EJ-5530-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5530,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cd62,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5498-01A,79EC7468-9AAF-4BB0-94C7-72BE4F497868,Prostate,56,AAF0AF43-DAE0-4AA7-9D4C-6CAF1F039857,24F583BD-C378-4981-A661-97B8E39CE600,TCGA-EJ-5498-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5498,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa832e4b0c9d6adf6ce6a,1.91,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-H2-A26U-01A,E61FB24B-613A-4B6D-BB2B-00CCEDBD3DBC,Thyroid,54,A4240AB1-970E-4A99-989E-8968903E3A25,79850C4D-71D0-4905-946A-F309DCDDA59F,TCGA-H2-A26U-01A-11D-A16N-02,HG19_Broad_variant,TCGA-H2-A26U,TCGA-THCA,NA,Christiana Healthcare,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A16N-02,TRUE,16
13722.58cfa832e4b0c9d6adf6cea9,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5516-01A,1FD06207-54E0-4ABA-819C-C7F671871F39,Prostate,49,84D2D822-204E-4031-AF83-E188BB72F3AF,7DBAAFC9-A93D-4FFB-9FF0-85FACD567555,TCGA-EJ-5516-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5516,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,9
13722.58cfa832e4b0c9d6adf6cf48,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7075-01A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Prostate,63,1FA3E5C2-E415-42FA-AEA3-F6C84959522A,CFC425B3-7570-4FD2-8DB6-611EF4D627DF,TCGA-HC-7075-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7075,TCGA-PRAD,NA,International Genomics Consortium,United States,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,1
13722.58cfa832e4b0c9d6adf6cefc,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-H4-A2HQ-01A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Bladder,64,CBEDC0DB-39FD-4661-9531-CC24D422FAC4,CD60EBC2-EF2A-4B47-8D42-C864AA095B8D,TCGA-H4-A2HQ-01A-11D-A17R-02,HG19_Broad_variant,TCGA-H4-A2HQ,TCGA-BLCA,NA,Medical College of Georgia,United States,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A17R-02,TRUE,11
13722.58cfa832e4b0c9d6adf6cf86,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6343-01A,36B87D12-9F96-460F-A3B5-A4C08CBF5B07,Prostate,62,084C6D1F-047E-4B0E-9034-3B0FC18D510D,CB58EB3E-4769-4050-BB51-AE248D0FABAA,TCGA-G9-6343-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6343,TCGA-PRAD,NA,Roswell Park,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,6
13722.58cfa832e4b0c9d6adf6ce92,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2EJ-01A,C6227D39-D9E8-4E28-9E70-D7F720AB25E4,Bladder,56,FBAD20BA-EE08-4D46-825B-870126AAD539,8D99E3A4-DECB-49D7-9727-C5D7606D60DF,TCGA-G2-A2EJ-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2EJ,TCGA-BLCA,NA,MD Anderson,United States,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A17R-02,TRUE,7
13722.58cfa832e4b0c9d6adf6d0f0,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7077-01A,92252560-5984-41F6-A4B5-A3AA8654C0C8,Prostate,64,F3E4CC00-D6FE-4291-BB07-8E501E772CE1,EFC4EC34-58ED-40DE-8E0D-BCBA6320BF4C,TCGA-HC-7077-01A-11D-1957-02,HG19_Broad_variant,TCGA-HC-7077,TCGA-PRAD,NA,International Genomics Consortium,United States,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,12
13722.58cfa832e4b0c9d6adf6d0f2,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7213-01A,26EEFAA1-1666-4CE1-8CF4-F6FABFF81FD2,Prostate,53,0CB3DFFD-1521-4887-B19C-94DCD340D306,6D368C2B-4F13-4006-A487-7DB0ADA55C6A,TCGA-HC-7213-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7213,TCGA-PRAD,NA,International Genomics Consortium,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,4
13722.58cfa832e4b0c9d6adf6d174,NA,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,TCGA-HC-7231-01A,B182BDA9-3D9F-4958-96EB-BD6CC441830C,Prostate,66,6AC7857C-5446-4297-95A9-5F2C11C28220,9826D5D9-D6D3-4216-9CA1-FE010711E13E,TCGA-HC-7231-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7231,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,8
13722.58cfa82ee4b0c9d6adf6ae64,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4396-01A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Lung,76,4D85772B-287E-4790-B1E8-CD1C0E88AD48,1F0C98A3-3EED-45E0-BF81-78632C02D375,TCGA-05-4396-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4396,TCGA-LUAD,303,Indivumed,Germany,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,1853-02,TRUE,9
13722.58cfa82ee4b0c9d6adf6af9e,1.8,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4427-01A,78A24C56-576C-4245-BB42-6603B3D19897,Lung,65,785B0C56-BED5-4D19-B7B3-D1A0CEB5D648,6B6663FE-F439-4546-B256-0024F66F748D,TCGA-05-4427-01A-21D-1853-02,HG19_Broad_variant,TCGA-05-4427,TCGA-LUAD,NA,Indivumed,Germany,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1853-02,TRUE,27
13722.58cfa82fe4b0c9d6adf6b687,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6148-01A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Lung,60,C0FE5FFE-C0A3-4E62-AA55-2BC18788E505,F8A1C395-E730-48F9-BF82-E8931E4AF154,TCGA-44-6148-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6148,TCGA-LUAD,NA,Christiana Healthcare,United States,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA,1751-02,TRUE,9
13722.58cfa82ee4b0c9d6adf6ae54,1.9,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4250-01A,F98ECD8A-B878-4F53-B911-20CD8E17281C,Lung,79,8F274178-7A8E-46B6-8D2C-900338BBB946,A444B1E8-9FE9-492B-A361-93CAAB3681BC,TCGA-05-4250-01A-01D-1103-02,HG19_Broad_variant,TCGA-05-4250,TCGA-LUAD,121,Indivumed,Germany,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1103-02,TRUE,12
13722.58cfa82ee4b0c9d6adf6b0a5,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4249-01A,4ADDF05F-3668-4B3F-A17F-C0227329CA52,Lung,67,80F196FE-1EAF-40CB-AB58-C84795ACC5C7,E3F50937-D6CF-423B-9DD3-31D715892FC7,TCGA-05-4249-01A-01D-1103-02,HG19_Broad_variant,TCGA-05-4249,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1103-02,TRUE,12
13722.58cfa82fe4b0c9d6adf6b80c,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-4112-01A,68B86559-38B2-41F2-B66E-C3C2B628B14D,Lung,60,6C206676-E511-4281-91F5-BFE91B3279A4,68185A4B-CC12-494D-99F5-84F5888A24F9,TCGA-44-4112-01A-01D-1103-02,HG19_Broad_variant,TCGA-44-4112,TCGA-LUAD,NA,Christiana Healthcare,None,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1103-02,TRUE,23
13722.58cfa82fe4b0c9d6adf6b88f,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4676-01A,195A5AFB-B79F-44D2-9D12-884487630C2B,Lung,45,22434A49-EB8A-43AC-8C08-AE6DCBE6FBB8,A79111BF-CB9D-4790-AE9F-6CB13C9334E2,TCGA-73-4676-01A-01D-1751-02,HG19_Broad_variant,TCGA-73-4676,TCGA-LUAD,NA,Roswell Park,United States,T2a,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA,1751-02,TRUE,5
13722.58cfa82fe4b0c9d6adf6b991,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6597-01A,0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0,Lung,79,C5363830-3DB9-4C0C-AA47-B32FDC888C60,84D15DBA-6689-4A93-B2CA-999BF7F97E96,TCGA-50-6597-01A-11D-1853-02,HG19_Broad_variant,TCGA-50-6597,TCGA-LUAD,NA,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,47
13722.58cfa82fe4b0c9d6adf6ba42,1.8,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01R-01A,97F6C8D3-09A0-4128-8F10-41E736648A5F,Colorectal,47,73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB,F8021A03-B35B-4E6C-B196-2948789AFCF3,TCGA-AA-A01R-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01R,TCGA-COAD,NA,Indivumed,Germany,T3,N2,Colon Mucinous Adenocarcinoma,Stage III,A079-02,TRUE,18
13722.58cfa830e4b0c9d6adf6ba54,1.73,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01Q-01A,4BE66108-E72A-406B-BB4B-F58FF2877336,Colorectal,48,5D1D7C40-F636-46C6-9540-4DF11A466B15,D84E59D4-7777-4922-990F-622BD246A9F1,TCGA-AA-A01Q-01A-01D-A077-02,HG18_Broad_variant,TCGA-AA-A01Q,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,A077-02,TRUE,13
13722.58cfa830e4b0c9d6adf6bb7e,2,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GB-01A,2F4458B6-3CAF-4E33-890E-A04722BADD1B,Uterus,65,130744CA-A9A2-4C99-8ABB-20FE76E0A955,A025733C-E300-4C47-B2EF-D9C978B58BFD,TCGA-A5-A0GB-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GB,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,16
13722.58cfa830e4b0c9d6adf6bad4,2,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01V-01A,0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9,Colorectal,59,8816F14D-9FBB-4033-9CA4-6CA0DB66161A,D13F4522-90DC-41C8-A274-FBD9C0CD2E60,TCGA-AA-A01V-01A-23D-A079-02,HG18_Broad_variant,TCGA-AA-A01V,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,A079-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc4e,2.3,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A05P-01A,3CB83517-78A4-47B8-8B1E-57E765DBDD2E,Uterus,54,F51F7B0E-3EA6-4232-9DE4-A4DD63B23BB5,E08A6886-B019-4920-ACC3-73A4CAF18E3F,TCGA-AP-A05P-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A05P,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,13
13722.58cfa830e4b0c9d6adf6bd8f,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BB-4223-01A,05F01280-BF77-4682-A7A8-20DD0EAC77BD,Head and Neck,48,82DB742D-885D-4788-B509-474715AE183B,007F0F41-C370-45F9-8053-2C774ADDED49,TCGA-BB-4223-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4223,TCGA-HNSC,NA,Johns Hopkins,United States,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,12
13722.58cfa830e4b0c9d6adf6babc,2.03,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01T-01A,F87C6DCC-1A9E-4DF5-962C-1F946E2611F8,Colorectal,63,BFC99C6D-7791-4037-9C74-A74BE68E616A,8F61B113-0E19-403E-9637-48E9D9733692,TCGA-AA-A01T-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01T,TCGA-COAD,NA,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage III,A079-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bd2e,1.86,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01P-01A,13AE9D83-A22F-451F-88BB-686051725CF3,Colorectal,80,133C13DE-6C6B-45E2-A611-A5C5A4AEBAA6,7788130D-F341-4900-B7E0-95EAD3063A9F,TCGA-AA-A01P-01A-21D-A079-02,HG18,TCGA-AA-A01P,TCGA-COAD,1158,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage III,A079-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bdc4,1.96,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A18A-01A,FEB3E930-3638-44B4-AC0F-A5DCB01FED76,Uterus,74,8FD0971D-40BA-46C2-B3C4-8E48A3E6C122,518AFA21-9E19-49DE-A2A6-387828A10837,TCGA-BG-A18A-01A-21D-A12F-02,HG19_Broad_variant,TCGA-BG-A18A,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,11
13722.58cfa830e4b0c9d6adf6be01,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M8-01A,E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E,Uterus,50,9CFB7290-EF60-4FDA-ABD7-9552AE11E4E7,D45D62ED-7BC6-4682-BB4B-2CA6EBBCE717,TCGA-BG-A0M8-01A-12D-A101-02,HG19_Broad_variant,TCGA-BG-A0M8,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa830e4b0c9d6adf6be06,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MQ-01A,12D36A1D-9922-4311-BBDA-71F32AC2C03B,Uterus,71,3D1FA321-D2E8-4460-AE87-356AB1CA6281,08F01B17-0386-4C7E-B926-1736CEC043D2,TCGA-BG-A0MQ-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MQ,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,8
13722.58cfa830e4b0c9d6adf6be04,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M9-01A,4FD1CB59-6C50-4355-9D37-A341E1F4FAD9,Uterus,73,DC487BBF-555B-423B-B7C0-3E92DEFA5A79,3D712314-6FDC-41C7-9CE1-5F9BB85929EE,TCGA-BG-A0M9-01A-21D-A101-02,HG19_Broad_variant,TCGA-BG-A0M9,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,12
13722.58cfa830e4b0c9d6adf6be2e,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MS-01A,A798A8CC-4E72-4A8C-9E20-74A14DEAFD12,Uterus,53,EF7F78EB-314B-4CF2-B45B-810C84C6AA7B,463D0533-A168-4F50-8EA9-7812D01B5115,TCGA-BG-A0MS-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MS,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa830e4b0c9d6adf6be6e,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A190-01A,04FFF86A-B6F5-4900-9E37-C1F0B881B160,Thyroid,55,2EB89D79-861E-41C2-BDD5-6F16D2A84B25,42FE4D84-B54D-42B8-81F8-92191723D057,TCGA-BJ-A190-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A190,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II,A13U-02,TRUE,25
13722.58cfa830e4b0c9d6adf6c16c,1.9,Alive,FEMALE,Not available,HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5557-01A,7E0575CE-670B-4035-8A90-4D35279707B2,Head and Neck,41,67D75889-E868-41F2-8255-5D5D1AA0A854,0DDC26B3-2D83-4539-A934-4B0FEF8D1F69,TCGA-BA-5557-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5557,TCGA-HNSC,NA,UNC,None,T1,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1509-02,TRUE,12
13722.58cfa830e4b0c9d6adf6bb3e,1.8,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01S-01A,84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008,Colorectal,47,5743700C-CBD3-4F87-8109-6349A96EB605,DC9E606A-12D6-4AA6-9780-1D999EB72C5A,TCGA-AA-A01S-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A01S,TCGA-COAD,NA,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage III,A079-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c17e,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4074-01A,A63CA97D-EF31-4118-9547-A6730967290F,Head and Neck,69,7BC6B159-19B4-4711-961D-830BC9E56493,4786A24C-D127-43FB-9D9C-FF59622B7B24,TCGA-BA-4074-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4074,TCGA-HNSC,462,UNC,None,T2,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,19
13722.58cfa830e4b0c9d6adf6c1db,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BB-4224-01A,58574E35-8A30-4207-B127-59FFF7C87A43,Head and Neck,52,077ACD68-8C30-41A6-BB7E-5B014866B807,E2FF93EB-AE22-4C6B-B4D5-181B9393BC64,TCGA-BB-4224-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4224,TCGA-HNSC,NA,Johns Hopkins,United States,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c2e0,2.03,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20P-01A,F48937ED-E294-41F0-8872-7010391167A9,Bladder,81,6B43EEEC-4FEB-4062-827A-E63ED8CE3820,022AEFEC-CBAC-46C1-9F17-AC087BD7164E,TCGA-BT-A20P-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20P,TCGA-BLCA,544,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A14U-02,TRUE,16
13722.58cfa831e4b0c9d6adf6c3c2,2.11,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20Q-01A,419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F,Bladder,73,F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7,72AF980B-98A8-4572-8AF9-EFD4294700F9,TCGA-BT-A20Q-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20Q,TCGA-BLCA,593,University of Pittsburgh,United States,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A14U-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c522,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4731-01A,50E25A4B-2EB2-4770-9A2D-8922A1E0AB56,Head and Neck,63,CD4E9D8C-B1F9-486A-ADCD-BD4B77A50326,981D992B-B92F-4E42-AA43-FC48068648A8,TCGA-CN-4731-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4731,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c5d8,1.9,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5363-01A,291B069C-9DDE-4E1E-8430-85146BC94338,Head and Neck,48,5E4E1E21-8016-4E27-8F72-2411714203E8,BEB17091-BD47-4666-8E3A-7A397977EA41,TCGA-CN-5363-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5363,TCGA-HNSC,253,University of Pittsburgh,None,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB,1431-02,TRUE,30
13722.58cfa831e4b0c9d6adf6c60c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5360-01A,5793879B-F663-4A10-9BD9-1ACD2E189650,Head and Neck,68,0C00768E-8B13-4B8E-80FC-B344740845F1,7EE362C2-86AD-462C-B478-21255D96ED90,TCGA-CN-5360-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5360,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,32
13722.58cfa831e4b0c9d6adf6c5fc,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5369-01A,B98867D7-7D5A-4C58-8878-37BEE6F2F4FA,Head and Neck,90,B4C02606-0F86-46E4-9DAF-DC7DBCD60D78,1A532CA9-E72F-4906-867B-272A18CFEC79,TCGA-CN-5369-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5369,TCGA-HNSC,380,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,31
13722.58cfa831e4b0c9d6adf6c60e,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-6219-01A,0CA3D25A-22E9-4E40-834B-65F402535005,Head and Neck,50,2AAD293C-B3ED-4BD7-971D-EA8A5EFC66AD,215B7B8C-E4D0-4CD2-B2B8-9CDC222EBF25,TCGA-CQ-6219-01A-11D-1911-02,HG19_Broad_variant,TCGA-CQ-6219,TCGA-HNSC,479,"University Health Network, Toronto",Canada,T3,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,22
13722.58cfa831e4b0c9d6adf6c661,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4443-01A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Stomach,68,F4FB736A-42C9-4367-A327-D0D1C4CBA359,0FCF9057-D05B-480B-A17F-5FE35BFEB0CA,TCGA-CG-4443-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4443,TCGA-STAD,NA,Indivumed,Germany,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c5de,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5364-01A,13F63218-0949-41E6-A661-C844414C45B5,Head and Neck,55,38A4AC42-BE08-4187-98C2-AF861218C3DB,6CE3D597-51F1-4807-A28F-271F25F95ED4,TCGA-CN-5364-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5364,TCGA-HNSC,493,University of Pittsburgh,None,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c67d,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4469-01A,2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA,Stomach,70,2A3D7538-D377-4D94-BB61-BF77BA56BE1B,9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6,TCGA-CG-4469-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4469,TCGA-STAD,215,Indivumed,Germany,T3,N3,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1154-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c66d,2,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CU-A0YN-01A,679A6869-2CE9-4472-8DB1-8869E2C1A440,Bladder,60,DBCC2FCB-A103-46DA-9893-6EC689D2F98E,98E994A3-9823-472B-AED1-38876DEA7F24,TCGA-CU-A0YN-01A-21D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YN,TCGA-BLCA,393,UNC,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A10R-02,TRUE,22
13722.58cfa831e4b0c9d6adf6c698,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5366-01A,30EB06A5-8E88-4C46-BEBB-FB93CA07F108,Head and Neck,51,62FDF8F3-A028-453F-B27C-C2506BE68CBE,AE791AB1-78E2-4E8B-AB05-4435D9C67AA3,TCGA-CN-5366-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5366,TCGA-HNSC,360,University of Pittsburgh,None,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c718,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6528-01A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Stomach,70,DF817250-9A2C-42E8-AD90-0D9E13FE37B3,7DA37A25-E2DE-4193-AD71-2182B6DA5C26,TCGA-D7-6528-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6528,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB,1798-02,TRUE,4
13722.58cfa831e4b0c9d6adf6c71e,1.8,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6518-01A,40E507FB-E285-424B-A98B-362E47A53E4A,Stomach,75,B6B986E2-6770-4C59-9D0F-AEA3F3BA26E9,2BAFD8B4-962F-411F-89C6-BB5C7E2A1E78,TCGA-D7-6518-01A-11D-1798-02,HG19_Broad_variant,TCGA-D7-6518,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,1798-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c6c2,1.9,Alive,FEMALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4740-01A,E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF,Head and Neck,79,2311DEEC-8DBC-4449-BE09-FCD4E3BAFD87,9DD678DF-BCE7-46C2-8454-3DE815FB85ED,TCGA-CN-4740-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4740,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c75a,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6515-01A,8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0,Head and Neck,82,4453D224-F846-4CEE-972F-8438C964913B,D6E287D9-D7C4-496C-829F-F7D7980D77A2,TCGA-D6-6515-01A-21D-1868-02,HG19_Broad_variant,TCGA-D6-6515,TCGA-HNSC,403,Greater Poland Cancer Center,Poland,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1868-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c774,1.37,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A174-01A,FC7315B0-9F48-4206-B197-2268C0518EB4,Uterus,51,AD5A9CB6-B3F9-4651-B6D1-13C78010BD88,D661CFB9-248A-49E6-B0DB-865CA257E8DC,TCGA-D1-A174-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A174,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c778,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17D-01A,7DDEDDD1-B2AD-425F-94A2-9C476B959F2A,Uterus,58,9EC5A25B-9CE1-4FDE-9341-13DA39BC74B0,0F6ECDCA-5659-426A-8DAC-3211183597BD,TCGA-D1-A17D-01A-12D-A12F-02,HG19_Broad_variant,TCGA-D1-A17D,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c7e5,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A169-01A,9A599F57-0E8D-4E1F-A181-791F5FDEADB7,Uterus,63,9B36F264-55C3-4E08-A151-4B356871520C,B3A7C237-92C3-448A-A87E-8C8B1061A79F,TCGA-D1-A169-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A169,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,27
13722.58cfa831e4b0c9d6adf6c988,2.05,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,TCGA-DJ-A1QE-01A,DCCBA97D-4E81-42FB-93B3-90BE68A034FB,Thyroid,62,E8BF40C4-8F4D-4032-B18B-D61A87A2DD1A,FB93D33F-510B-45BD-8E70-8FD3A0EA5DBE,TCGA-DJ-A1QE-01A-21D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QE,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A14U-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c998,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,2DDD46A0-5304-4CA3-9AE3-AC3787D3C86A,TCGA-DK-A1A7-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A7,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13U-02,TRUE,3
13722.58cfa831e4b0c9d6adf6c9a8,1.89,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AG-01A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Bladder,65,64668AA0-DDE5-4534-8CD0-378881E4A4E4,69A3B1DB-3463-456C-B3D1-6BE1FD7EE1D9,TCGA-DK-A1AG-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AG,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c9a0,1.78,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DO-A1K0-01A,B7A01148-5BAB-4268-986A-A9CF7BCA967F,Thyroid,30,C25AED9B-A1B7-48A9-8587-8D218F6A9562,7BC99883-45C3-4ADF-8761-40B4836552F2,TCGA-DO-A1K0-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DO-A1K0,TCGA-THCA,NA,Medical College of Georgia,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c9b4,1.97,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13S-01A,8AA99F35-C644-4F91-9EFF-A5D3FAE758B0,Thyroid,19,17952842-3447-4A38-90F4-D25B90C3233A,3C630C3D-343D-4F9F-8067-43B66466D382,TCGA-DJ-A13S-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13S,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A10R-02,TRUE,27
13722.58cfa831e4b0c9d6adf6ca43,1.96,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QL-01A,E4B08E66-0772-4956-8670-E5C6553EECBE,Thyroid,70,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,C5B8FBAE-98B5-437B-A8BD-D695C5E8CB4F,TCGA-DJ-A1QL-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QL,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14U-02,TRUE,20
13722.58cfa831e4b0c9d6adf6cad2,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-DI-A1BU-01A,53245616-E095-4616-89BB-6062669122DA,Uterus,55,241BFB1F-5CF8-458D-B335-18BABF507E85,085C72D3-C295-4D9B-A5CC-08F76CFF2284,TCGA-DI-A1BU-01A-11D-A133-02,HG19_Broad_variant,TCGA-DI-A1BU,TCGA-UCEC,NA,MD Anderson,United States,Not available,Not available,Mixed serous and endometrioid,Not available,A133-02,FALSE,30
13722.58cfa831e4b0c9d6adf6cc16,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7294-01A,3F6FFB08-32A9-4555-BFD1-243B7F526105,Brain,53,C2D0A3C8-2354-475C-9027-5DF9523391CE,E6552DAE-BDEA-4945-9BA9-9C88D34CEBBC,TCGA-DU-7294-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7294,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,2022-02,TRUE,14
13722.58cfa831e4b0c9d6adf6cbd0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7125-01A,ACA312AB-6DBD-4183-8B22-8F37834F3426,Prostate,44,08E17DE6-FE0D-4FF0-B588-1CF1AB03F594,4BAD4379-B8AB-4D28-968E-5729602757EB,TCGA-EJ-7125-01A-11D-1957-02,HG19_Broad_variant,TCGA-EJ-7125,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,8
13722.58cfa831e4b0c9d6adf6ccc6,1.88,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1CS-01A,E92BDB0D-969A-4D98-ADA8-5DFEC68119B5,Thyroid,55,C1DAF740-06E2-4509-86BE-5BFCC52B508A,67082C81-DE62-42A4-82B7-CB6BE2C961D3,TCGA-EM-A1CS-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CS,TCGA-THCA,NA,University Health Network,Canada,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,23
13722.58cfa831e4b0c9d6adf6cd39,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25L-01A,4481D84D-109E-44A0-BCB4-E6E61BDCE796,Thyroid,52,7D90939F-BAB7-4A39-8D57-79540142BB63,3490DBDC-8BFC-476F-BC1F-2D142365D9A2,TCGA-ET-A25L-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25L,TCGA-THCA,NA,Johns Hopkins,United States,T3,N1b,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage IVA,A16N-02,TRUE,16
13722.58cfa832e4b0c9d6adf6ceba,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FD-A3B4-01A,899F8D52-4C3A-4371-90EB-1F106001EDDC,Bladder,55,6895A68F-0EFD-4B0E-8CF2-9195833DBBA1,7E975842-6EB5-4D66-A2F1-7EA7E8E989FC,TCGA-FD-A3B4-01A-12D-A204-02,HG19_Broad_variant,TCGA-FD-A3B4,TCGA-BLCA,NA,BLN - University Of Chicago,United States,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A204-02,TRUE,15
13722.58cfa832e4b0c9d6adf6ce42,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25K-01A,2F9ED09D-2626-4C23-BA47-1850D36F812A,Thyroid,36,343311B1-D586-4F92-9984-32AF1AFB1F62,663173D3-A9EE-4E73-8444-52F01727BE6D,TCGA-ET-A25K-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25K,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,13
13722.58cfa832e4b0c9d6adf6cf97,1.8,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6362-01A,F228EF91-ECFB-4D1E-8E6A-B43D2185270E,Prostate,57,1A626C6C-3DD9-4D87-BB93-CB2FEB82FBE8,A9B195C5-0441-4C98-8314-C50ECA082994,TCGA-G9-6362-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6362,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,11
13722.58cfa832e4b0c9d6adf6d01a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6353-01A,BCC94953-CE79-428E-99C1-632E42C1B9BC,Prostate,58,4CBA0BA5-58C3-455C-9CD5-7D9428D27F8C,758712E3-95F1-4BB5-A83A-D01C4844122D,TCGA-G9-6353-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6353,TCGA-PRAD,NA,Roswell Park,United States,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,6
13722.58cfa832e4b0c9d6adf6d010,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6338-01A,2C48B1BF-4E49-4869-874B-F08787FA04B5,Prostate,61,21FC7F0F-FCB3-422F-AA73-0E09FD06DA35,BF3CC12E-1835-40C8-B29F-C685B828AB18,TCGA-G9-6338-01A-12D-1957-02,HG19_Broad_variant,TCGA-G9-6338,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,9
13722.58cfa832e4b0c9d6adf6d086,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7212-01A,907B64D6-A26A-4092-A247-AC9AF444D1C7,Prostate,56,92888479-B534-432D-8F70-CAE857E0074B,9BF25BFC-4E07-4979-9169-F6CDADDB3A90,TCGA-HC-7212-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7212,TCGA-PRAD,NA,International Genomics Consortium,United States,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,6
13722.58cfa832e4b0c9d6adf6d155,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6361-01A,71D14304-CCB0-4A4C-B935-8C014CA75FD0,Prostate,61,A369C190-964E-471C-878A-D8FADE7CF992,54B8E171-9BCC-469D-9315-114FE2C57DC1,TCGA-G9-6361-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6361,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,7
13722.58cfa82ee4b0c9d6adf6b00e,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4422-01A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Lung,68,DACBC55D-25C6-4E86-BD1B-38345B4DF7A7,09DD9098-5702-44A6-B9EA-F148ECE1E264,TCGA-05-4422-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4422,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1203-02,TRUE,20
13722.58cfa82fe4b0c9d6adf6b7b4,2,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5930-01A,368E23F0-E573-4547-BF5A-14080BAF737B,Lung,47,3E30DBD1-10BF-4450-8D19-6F44D3284E02,31047F3B-8F9D-47D9-87D3-BB2F8CF7E1EF,TCGA-50-5930-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5930,TCGA-LUAD,282,University of Pittsburgh,United States,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,1751-02,TRUE,10
13722.58cfa830e4b0c9d6adf6bc0a,2.13,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GV-01A,5E3B981E-73FE-4CC9-8C89-B420E8E2F426,Uterus,67,339926E1-61E6-4256-A808-F931AA2C17D2,721D7961-15F0-4A52-8D2C-885278D3B579,TCGA-A5-A0GV-01A-31D-A043-02,HG19_Broad_variant,TCGA-A5-A0GV,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,18
13722.58cfa82fe4b0c9d6adf6b72a,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-49-6767-01A,6BFFE800-EC2B-4638-9333-97FE85DCD91C,Lung,46,708A8742-F6D6-411D-9340-2C6C25885D22,FBCE84D6-2880-45F5-BD6F-B079C33C353E,TCGA-49-6767-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6767,TCGA-LUAD,NA,Johns Hopkins,United States,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1853-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b7f6,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4677-01A,03C3409A-9D16-41D0-9E26-F9FC2547A4C8,Lung,74,EF88B85A-61EE-44E1-BB63-1B4CE9154BFB,2E41BAD5-941E-4EE8-A1DC-5BBA14E89141,TCGA-73-4677-01A-01D-1203-02,GRCh37,TCGA-73-4677,TCGA-LUAD,38,Roswell Park,United States,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1203-02,TRUE,5
13722.58cfa82fe4b0c9d6adf6b8bc,1.9,Alive,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4668-01A,B2285924-9813-4F46-BB8F-91A0EFD8A9B6,Lung,66,FDBFDF52-C0CD-4FBB-A910-B747516DFEF4,DC227D17-FED3-489A-B5C6-3D4C910310FF,TCGA-73-4668-01A-01D-1203-02,GRCh37,TCGA-73-4668,TCGA-LUAD,NA,Roswell Park,United States,T2,N1,Lung Micropapillary Adenocarcinoma,Stage IIB,1203-02,TRUE,7
13722.58cfa82fe4b0c9d6adf6ba00,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3555-01A,36EAF209-C332-4321-B6AA-51A3368ECD79,Colorectal,81,9F9961F0-4EE2-4471-AE4A-A0122D630A28,099EA705-3D94-4746-AF72-E21B31D0425A,TCGA-AA-3555-01A-01D-1637-02,HG18,TCGA-AA-3555,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA,1637-02,FALSE,11
13722.58cfa82fe4b0c9d6adf6b9c8,1.72,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A00Q-01A,62D39BE5-F029-4EB8-8B00-46470E06A755,Colorectal,66,89FC5DB9-EDFF-480F-8FC4-ADDD28C6D615,D458CE34-22B1-41F7-9CE7-659107AD6F77,TCGA-AA-A00Q-01A-01D-A077-02,HG18,TCGA-AA-A00Q,TCGA-COAD,NA,Indivumed,Germany,T4,N1,Colon Adenocarcinoma,Stage IIIB,A077-02,TRUE,16
13722.58cfa82fe4b0c9d6adf6b9cc,1.73,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A00Z-01A,AF3A0634-4292-45BD-B948-6B6BD2D58090,Colorectal,70,75A6A64E-11F0-41C8-9CBA-179AE3333621,DF16D4D9-DD5E-4614-AE58-465EC09F2992,TCGA-AA-A00Z-01A-01D-A077-02,HG18,TCGA-AA-A00Z,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage IIA,A077-02,TRUE,38
13722.58cfa82fe4b0c9d6adf6ba16,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3549-01A,E6EC5A68-7555-4F26-BD7E-9CDB4C5F7004,Colorectal,69,86158696-60A3-45B7-8351-D800F57EF23B,C5D50597-F0E1-4C34-AB95-3718566AF540,TCGA-AA-3549-01A-02D-1167-02,HG18,TCGA-AA-3549,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,1167-02,TRUE,25
13722.58cfa830e4b0c9d6adf6baf8,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3514-01A,DDF69ED9-4C53-48B8-9F01-495BD60C3425,Colorectal,81,A657AFDB-5322-454F-8DD7-8397291401C5,C0486DD0-5BE4-4B64-8A8F-3CF47BD5A330,TCGA-AA-3514-01A-02D-1547-02,HG18_Broad_variant,TCGA-AA-3514,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,1547-02,FALSE,13
13722.58cfa830e4b0c9d6adf6ba75,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3812-01A,4563E4E0-A661-46DE-AD25-9C86A621E147,Colorectal,82,98AD41D5-FD77-4F30-94B5-03BF7B9C69B9,B4AA0837-42E8-41B7-B44B-F84D48155C3E,TCGA-AA-3812-01A-01D-1167-02,HG18,TCGA-AA-3812,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage IIA,1167-02,TRUE,22
13722.58cfa830e4b0c9d6adf6bbc8,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-4015-01A,1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0,Colorectal,85,3C910093-DF83-485B-86EF-26A0991D9A0B,2E183A8C-5755-4DC7-AEAB-6F7E9A9A5D1A,TCGA-AG-4015-01A-01D-1115-02,HG18,TCGA-AG-4015,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,1115-02,TRUE,22
13722.58cfa830e4b0c9d6adf6bc1c,1.96,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A020-01A,19E46A3D-18C5-4927-8501-2265E2D617B8,Colorectal,57,EEC9C9E3-6CB3-4589-B3A8-EA2337878599,140B186D-B7EC-4A31-8FE0-A490BBDAE19B,TCGA-AG-A020-01A-21D-A079-02,HG18_Broad_variant,TCGA-AG-A020,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Mucinous Adenocarcinoma,Stage III,A079-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc46,1.91,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-AO-A0JF-01A,F357FE19-5359-4662-8CE9-AA996132283B,Breast,68,DDEE0B07-2771-40C7-BDDA-C1100958F0D8,BDAA1600-1B4F-4BBA-B4D6-A4D169B029D6,TCGA-AO-A0JF-01A-11D-A060-02,HG19_Broad_variant,TCGA-AO-A0JF,TCGA-BRCA,NA,MSKCC,None,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A060-02,TRUE,9
13722.58cfa830e4b0c9d6adf6bc6c,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-4007-01A,8E00E7E7-FFAF-44F0-91A7-172671F18E08,Colorectal,87,E6FC3F28-1DE1-4587-9E0E-0861323E6772,E9D7A5C4-3E98-4C98-A953-B75EA555DD7D,TCGA-AG-4007-01A-01D-1115-02,HG18,TCGA-AG-4007,TCGA-READ,NA,Indivumed,Germany,T4,N2,Rectal Adenocarcinoma,Stage IV,1115-02,TRUE,33
13722.58cfa830e4b0c9d6adf6bcb2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4684-01A,CAC80259-3A26-4A99-B0D3-13454068E6ED,Colorectal,49,37AD61EA-96D1-40F1-B77A-56408E4243EA,6731F782-4435-497F-9626-C0199DAE8A8A,TCGA-AZ-4684-01A-01D-1405-02,HG18,TCGA-AZ-4684,TCGA-COAD,NA,University of Pittsburgh,None,T3,N2,Colon Adenocarcinoma,Stage IVA,1405-02,TRUE,22
13722.58cfa830e4b0c9d6adf6be13,1.91,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-BH-A0W5-01A,DA9C10EA-C13F-4D88-8B94-A0CBC106D036,Breast,77,050E66BB-438A-49D5-A005-7967A006B3F0,6C8B3A70-CD58-4BFC-9418-54182588CFCB,TCGA-BH-A0W5-01A-11D-A106-02,HG19_Broad_variant,TCGA-BH-A0W5,TCGA-BRCA,NA,University of Pittsburgh,None,T1c,N1a,Infiltrating Ductal Carcinoma,Stage IIA,A106-02,FALSE,6
13722.58cfa830e4b0c9d6adf6be2a,2.08,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Breast Invasive Carcinoma,TCGA-B6-A0X4-01A,4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08,Breast,62,45C3BD72-D260-4663-9091-5058E58F352D,062A41CC-4B23-49E2-AFF8-3CFE34DE9A36,TCGA-B6-A0X4-01A-11D-A106-02,HG19_Broad_variant,TCGA-B6-A0X4,TCGA-BRCA,860,Duke,United States,T2,N1b,Infiltrating Ductal Carcinoma,Stage IIB,A106-02,FALSE,8
13722.58cfa82fe4b0c9d6adf6b96f,1.9,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3666-01A,A512701F-88BB-4B05-8C94-FD285B9DD13E,Colorectal,68,F1064663-1462-4901-8BF7-9F50DA5EE7B1,CAD86B88-04E5-400F-B3EB-43D31A2D8358,TCGA-AA-3666-01A-02D-1167-02,HG18,TCGA-AA-3666,TCGA-COAD,61,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage III,1167-02,TRUE,17
13722.58cfa830e4b0c9d6adf6bd44,2.03,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A054-01A,D77E4DBC-B239-4742-8CB7-EFD427010D13,Uterus,64,DDFFB9C7-185F-402F-99B8-8058B40086D9,F5A9F85D-4E8E-4400-A109-C227D6B4C0A4,TCGA-AP-A054-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A054,TCGA-UCEC,709,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,27
13722.58cfa830e4b0c9d6adf6bea9,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3909-01A,769880AE-34D9-405E-8EA7-33BA47CF2DD2,Colorectal,69,12A43BEB-EDB6-4ABC-8322-CA8246D64B3F,F168205F-B2ED-4563-A211-DA59223830AB,TCGA-AG-3909-01A-01D-1115-02,HG18,TCGA-AG-3909,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IIIB,1115-02,TRUE,29
13722.58cfa830e4b0c9d6adf6bf16,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4257-01A,DA112431-5579-4FD1-A230-9144B359B0E9,Stomach,79,97B44B05-97EB-486C-94DB-42838831DE0B,465E5E4D-A801-4BBC-9E1C-004C7718571F,TCGA-BR-4257-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4257,TCGA-STAD,NA,Asterand,Russia,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,8
13722.58cfa830e4b0c9d6adf6be44,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,TCGA-AF-2691-01A,830FD359-ABD4-4C99-89E4-2D6BB9CE5637,Colorectal,48,CE252C3D-5CF3-46BC-A181-3714D1C65E4E,64EDFE90-619C-42A0-BBE1-EB78B4D5C26D,TCGA-AF-2691-01A-01D-1167-02,HG18,TCGA-AF-2691,TCGA-READ,NA,Christiana Healthcare,None,T1,N0,Rectal Adenocarcinoma,Stage I,1167-02,TRUE,10
13722.58cfa830e4b0c9d6adf6bf3c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4256-01A,7B0D69CA-13A6-46E0-839C-E433BBEDE3AD,Stomach,80,61C7AAB0-51D9-4706-A37C-D5058007DAF1,30AF7950-11F7-43BF-9A1D-98A57F416397,TCGA-BR-4256-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4256,TCGA-STAD,NA,Asterand,Russia,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,6
13722.58cfa830e4b0c9d6adf6bf72,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4363-01A,66BCA2F8-F269-454D-ABE2-CE51A0704645,Stomach,60,06EC6231-EE0E-4C15-AF9F-5B9E5BF557B8,D62228AE-B0AB-4C31-9FD7-F9D48B140CDC,TCGA-BR-4363-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4363,TCGA-STAD,NA,Asterand,Russia,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1154-02,TRUE,7
13722.58cfa830e4b0c9d6adf6bf6a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6452-01A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Stomach,78,76144F2F-2498-430D-B33C-F000394C427E,460DE564-5AAB-46B0-8174-36AF18D2DF4C,TCGA-BR-6452-01A-12D-1798-02,HG19_Broad_variant,TCGA-BR-6452,TCGA-STAD,NA,Asterand,Russia,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1798-02,TRUE,9
13722.58cfa830e4b0c9d6adf6bec5,1.85,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A032-01A,0BB786EE-07CF-4853-9B49-EC95CD14E282,Colorectal,68,AE3C8931-C06F-466A-B6BF-440007E13387,AF7D94D6-C414-4812-A329-8856C086087E,TCGA-AG-A032-01A-01D-A077-02,HG18,TCGA-AG-A032,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IIIB,A077-02,TRUE,8
13722.58cfa830e4b0c9d6adf6bfa8,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6454-01A,AC2CBCE4-4BA8-42C9-AC61-70F42995588E,Stomach,58,E7D94421-7A3B-4100-9CBF-1B1F2EC07737,6F5506E4-8375-4F62-8B85-64FD729C6136,TCGA-BR-6454-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6454,TCGA-STAD,NA,Asterand,Russia,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1798-02,TRUE,13
13722.58cfa830e4b0c9d6adf6bfd6,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3728-01A,856A490C-C6DA-48FE-88B5-9FDE0F481365,Colorectal,73,019EB82B-4A2D-4E67-99A6-FE10B0ABCB70,DF699DEA-C800-47D0-A526-A6C7A610041A,TCGA-AG-3728-01A-01D-1115-02,HG18,TCGA-AG-3728,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IIIB,1115-02,TRUE,49
13722.58cfa830e4b0c9d6adf6c010,1.95,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K0-01A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Uterus,48,11C43948-E7C9-4436-A654-82FA8033B625,3296C785-7C20-487D-BAEC-C66022E77E53,TCGA-B5-A0K0-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,54
13722.58cfa830e4b0c9d6adf6c024,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AX-A0J1-01A,EC7A9D74-8B3F-4747-8926-1739A016AB2B,Uterus,80,AC14E378-2DE1-458A-B8CD-7C60131AA927,3612DB54-D93C-47FB-A5E7-3BA3CE404A3C,TCGA-AX-A0J1-01A-11D-A043-02,HG19_Broad_variant,TCGA-AX-A0J1,TCGA-UCEC,NA,Gynecologic Oncology Group,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,47
13722.58cfa830e4b0c9d6adf6c05e,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3999-01A,60778DA8-D99E-4E51-96A2-3E900B3978D9,Colorectal,61,022BA0B0-F8CC-474C-9FB9-7928B45FD756,1C65913D-665D-455E-9F40-8464E5EA0D55,TCGA-AG-3999-01A-01D-1115-02,HG18,TCGA-AG-3999,TCGA-READ,NA,Indivumed,Germany,T3,N2,Rectal Adenocarcinoma,Stage IIIC,1115-02,TRUE,28
13722.58cfa830e4b0c9d6adf6c106,1.86,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TJ-01A,F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00,Uterus,59,AC35307B-AC7F-49FC-A237-5E03AB2E2276,C20AA17E-3866-4864-A4AE-44ACFD746221,TCGA-BS-A0TJ-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TJ,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c11c,1.83,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TD-01A,FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38,Uterus,65,8BB3A057-8958-4F62-AF81-976DA2E92DF7,3EF9C5ED-860A-4FF2-AA76-C53E9EB2453E,TCGA-BS-A0TD-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TD,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c1ba,1.97,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0UT-01A,E2B1D0DE-5221-44A1-8FAD-9708A3CADA14,Uterus,62,824D0DBC-293F-4893-A68C-24DEDD437EA5,12674687-D555-40DB-ACC9-7638F85D0661,TCGA-BS-A0UT-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UT,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,13
13722.58cfa830e4b0c9d6adf6c13a,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0U8-01A,FB7475DF-30CC-4316-B9AC-37CBEEB6BA2B,Uterus,55,E3E23393-8597-4091-A343-CD544111C63B,89AB037F-B001-486F-A7EB-37AF8FBD0677,TCGA-BS-A0U8-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0U8,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,18
13722.58cfa830e4b0c9d6adf6c1b2,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MO-01A,734EF97F-807C-480E-8DF9-FEAF041032D2,Uterus,63,7582CBB9-42D3-496C-991D-D76BEA4C434C,9AD06738-F4A2-47A8-972E-BF8C817326A6,TCGA-BG-A0MO-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0MO,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,35
13722.58cfa830e4b0c9d6adf6c167,2.17,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0Z9-01A,86F9ECA0-D1EA-4375-A6BC-055E44B3198A,Thyroid,57,AA8578FE-EDB2-4137-B363-FEB2C27D475A,B761F912-BDF6-4F1F-8CD0-0AE9DFC57A59,TCGA-BJ-A0Z9-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z9,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III,A10R-02,TRUE,19
13722.58cfa830e4b0c9d6adf6c064,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-4005-01A,866DE12B-E4DF-4F19-B62E-E3FD85D4EC08,Colorectal,64,5B98C136-7BC3-411C-B07D-F0CF657F834D,284653D0-67A2-4ABF-9F75-1F045D0DAA70,TCGA-AG-4005-01A-01D-1115-02,HG18_Broad_variant,TCGA-AG-4005,TCGA-READ,NA,Indivumed,Germany,T3,N2,Rectal Adenocarcinoma,Stage IV,1115-02,TRUE,33
13722.58cfa830e4b0c9d6adf6c107,2.03,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TA-01A,AD3D8420-F562-4CBE-AC82-C968BD4F782D,Uterus,58,B6A042B6-F94A-4ACC-98CB-A1A2FE72B9AD,896590DE-B00E-40A3-912D-D625F3581AD8,TCGA-BS-A0TA-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TA,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c20b,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4078-01A,C7353D6A-82A2-4A0D-8CD4-8C8957943EDB,Head and Neck,83,2027EDE3-13F5-40F6-BEF6-16704981D676,66A9CFF2-397E-415E-BF54-9A75CCC80BDE,TCGA-BA-4078-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4078,TCGA-HNSC,276,UNC,None,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c258,2.11,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0Z5-01A,0FE3B19A-F5E4-497E-92DA-32FF6C77B066,Thyroid,58,D17746B4-EDEA-45DB-9AD1-5EE4973F007C,0AB5F114-C3CC-4DB4-87DF-1B339DDC54C2,TCGA-BJ-A0Z5-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z5,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A10R-02,TRUE,28
13722.58cfa830e4b0c9d6adf6c226,1.92,Alive,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0UV-01A,B19425AB-A82F-4C2A-BF58-D1BD30511D74,Uterus,55,30945527-528A-448E-8DB4-2E0C31C9016D,A0F51177-4C00-4F97-8CD4-2E05B63B00DE,TCGA-BS-A0UV-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0UV,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c392,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5799-01A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Stomach,45,A3180E0E-EB99-49DD-8252-5FEA05A9885F,74F06FDA-C4D0-4542-AC92-68677B595800,TCGA-CD-5799-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5799,TCGA-STAD,NA,ILSbio,Vietnam,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1598-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c4f9,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4369-01A,FE9A5FCF-FF99-4DD1-8CC7-ED9F4B9D952B,Stomach,75,39B440B3-F888-488A-A0CC-D7410DC73093,7220D8C0-DF8F-4A72-8338-795181BD8A47,TCGA-BR-4369-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4369,TCGA-STAD,NA,Asterand,Russia,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1154-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c3a8,1.9,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5798-01A,E42F45C6-FD00-44CF-A210-C8803DA326A1,Stomach,82,72855D36-60BE-498F-96E9-0F10DC05B3A0,F9D13E07-70F4-48F3-B49E-06984C9E39EE,TCGA-CD-5798-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5798,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II,1598-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c4fd,2,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5800-01A,EEB114EA-ECEE-49EE-A162-B3B7BC0A60CD,Stomach,51,B23E2D58-E61B-4B94-B4D8-407418351167,5EF4C8F7-B17A-48DA-AAF2-EF2FA32619A9,TCGA-CD-5800-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5800,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II,1598-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c31b,1.89,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TI-01A,DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1,Uterus,64,2F52C850-8E70-4EAB-88F3-D35DC55E385B,E1707EDD-FAC5-4213-BA50-2538F9F90EE5,TCGA-BS-A0TI-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TI,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa830e4b0c9d6adf6c27a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,TCGA-AF-2689-01A,335D0351-3740-4847-9FF4-BE2F078C70F7,Colorectal,41,8BEE44CB-3FE4-47A8-BD1B-90A59EA606BE,9AB254E9-6A35-46C6-BFB1-36247B20ABD6,TCGA-AF-2689-01A-01D-1167-02,HG18_Broad_variant,TCGA-AF-2689,TCGA-READ,NA,Christiana Healthcare,None,T3,N2,Rectal Adenocarcinoma,Stage IV,1167-02,TRUE,90
13722.58cfa831e4b0c9d6adf6c548,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4747-01A,56EB96A4-D2C2-42FB-B26C-1A80012BCB8E,Colorectal,47,D3DAA95A-19B5-4822-BCBE-35CEEC12FDF1,7E2021D4-E528-4EB1-A7A0-71D6BE77A71D,TCGA-CM-4747-01A-01D-1405-02,HG18,TCGA-CM-4747,TCGA-COAD,NA,MSKCC,None,T4a,N1b,Colon Adenocarcinoma,Stage IVA,1405-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c588,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4748-01A,CD845618-4CC4-49C2-9055-C171D4C24EE1,Colorectal,53,1A465792-4DA7-4D37-9352-73E76ECFF4D2,3E7170B8-B0ED-4077-A65A-B6E399719A93,TCGA-CM-4748-01A-01D-1405-02,HG18,TCGA-CM-4748,TCGA-COAD,NA,MSKCC,None,T4a,N1a,Colon Mucinous Adenocarcinoma,Stage IIIB,1405-02,TRUE,36
13722.58cfa831e4b0c9d6adf6c605,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-5329-01A,02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D,Head and Neck,46,D22E9B65-495B-4D42-926A-01BF2C436D76,63CE8A9C-2CC5-41D9-B24D-3FB88343B693,TCGA-CQ-5329-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5329,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1681-02,TRUE,28
13722.58cfa831e4b0c9d6adf6c61f,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4436-01A,7938CA55-766E-4277-9E7E-603FFA02E570,Stomach,57,21F40CF9-D89F-4FEC-BE65-1740AB39DAE4,9215C180-AC30-4585-9AF3-4EF1D718E187,TCGA-CG-4436-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4436,TCGA-STAD,NA,Indivumed,Germany,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1154-02,TRUE,12
13722.58cfa831e4b0c9d6adf6c6d2,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-CS-4938-01B,334F715E-08DC-4A29-B8E4-B010B829C478,Brain,31,99104139-6CB5-44F7-8314-A4DDF02DE7D4,7FE72196-9DE8-4A43-87F2-D2E8F74B0007,TCGA-CS-4938-01B-11D-1891-02,HG19_Broad_variant,TCGA-CS-4938,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Astrocytoma,Not available,1891-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c646,1.9,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-5327-01A,5A03E2B6-4C8B-479A-9036-9859AF031DA4,Head and Neck,61,93D283A7-E866-4F23-81F7-942DEE5009B8,55F0F300-E472-4254-9BDA-76AD94EA8C13,TCGA-CQ-5327-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5327,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,24
13722.58cfa831e4b0c9d6adf6c526,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4746-01A,C0B8C55C-B993-481D-AEEA-9EBFA64EE20E,Colorectal,61,85991716-6807-4F31-BE63-BF80CEC40CC2,32AAA8D7-1ABF-4AEF-8067-BE801C95D30B,TCGA-CM-4746-01A-01D-1405-02,HG18,TCGA-CM-4746,TCGA-COAD,NA,MSKCC,None,T2,N0,Colon Adenocarcinoma,Stage I,1405-02,TRUE,30
13722.58cfa831e4b0c9d6adf6c726,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6825-01A,42BC2336-2408-441A-83B9-AADC9700F750,Head and Neck,73,D9E2F5AA-A6E2-491A-9DBC-E5D10B4ABA58,8B36C904-50A1-4B17-94A2-F9331A5FED1E,TCGA-D6-6825-01A-21D-1911-02,HG19_Broad_variant,TCGA-D6-6825,TCGA-HNSC,NA,Greater Poland Cancer Center,Poland,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,1911-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c95a,1.97,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,TCGA-DJ-A1QF-01A,FCA0C7D9-5E6F-4AA7-BA04-5DF2EB8BA398,Thyroid,61,E4B53CA1-D395-4FEA-A962-DFBD2B373A6B,FA0BE982-CE22-449F-9D2B-E688196BA8AE,TCGA-DJ-A1QF-01A-12D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QF,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II,A14U-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c7ff,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16X-01A,22618073-4EF0-4C3A-97B9-90BA1CAA1D72,Uterus,54,6421D807-9BEC-4AD4-8B75-8F9DD594A977,E652FF84-B885-4245-86E5-70ADE972FD67,TCGA-D1-A16X-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16X,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c97a,1.91,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QN-01A,2012869D-C169-4CEA-AA09-C892FB79BBAA,Thyroid,42,884C1978-00CF-4E48-BEF8-F03CA67D6C02,F5D0FC17-824D-42F7-931B-E23CD68B9E2F,TCGA-DJ-A1QN-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QN,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c94b,1.8,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QO-01A,F2AD720E-579F-4E2C-A3F0-17877CA91067,Thyroid,69,03811796-0ECE-4408-82F7-B449A631D2FB,9E0C97ED-7482-4400-B66A-72AB48BA11A2,TCGA-DJ-A1QO-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QO,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III,A14U-02,TRUE,24
13722.58cfa831e4b0c9d6adf6c9c9,1.61,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QH-01A,F3C73DC9-6280-4619-A629-B575FDBDB0CA,Thyroid,58,B1775A45-D30D-42C3-91D8-53C662B4A974,31F3AA22-9E90-4FF7-872C-0EED3DB18545,TCGA-DJ-A1QH-01A-21D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QH,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N1a,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III,A14U-02,TRUE,24
13722.58cfa831e4b0c9d6adf6cab0,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13U-01A,8C5AEF43-341E-4A37-84EB-FD730EB957C7,Thyroid,60,CD19D6BB-21A4-409A-A7BA-A4521A03ABD3,B80A7146-1AB2-49BD-A3B2-7F6650840195,TCGA-DJ-A13U-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13U,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A10R-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c9ed,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13P-01A,CA95A11C-B54C-409E-B9A0-DA850945033D,Thyroid,52,EFAD8B07-B295-468F-A836-F94029AEC777,528EC19A-8218-4E8F-B1E7-8A149F54A6BE,TCGA-DJ-A13P-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13P,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II,A10R-02,TRUE,21
13722.58cfa831e4b0c9d6adf6cada,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6542-01A,CD69D509-A652-4257-A8D3-767296BBB4EC,Brain,25,D00791AB-AA9D-406B-934C-E6946A430BB2,6EF0AE20-9197-4162-9A35-E235071A83B5,TCGA-DU-6542-01A-11D-1891-02,HG19_Broad_variant,TCGA-DU-6542,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Oligoastrocytoma,Not available,1891-02,TRUE,4
13722.58cfa831e4b0c9d6adf6caa0,1.86,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QM-01A,3597AF5E-65FF-40A7-95FC-DACC26CBCA14,Thyroid,42,B4215B1F-3918-43D6-8862-380C35F891EC,A070BCA4-DDFA-4BE7-A635-69A2BA97FFE9,TCGA-DJ-A1QM-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QM,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1a,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A14U-02,TRUE,14
13722.58cfa831e4b0c9d6adf6cca2,1.87,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-EQ-5647-01A,2D291FA3-F0FD-4BC1-91A6-783863714190,Stomach,86,400FED84-FE61-4F7A-9DCC-6C32131106CD,ABD8CB7C-0FEC-4D00-950D-5A190A0D75F4,TCGA-EQ-5647-01A-01D-1598-02,HG19_Broad_variant,TCGA-EQ-5647,TCGA-STAD,19,Christiana Healthcare,United States,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1598-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cd18,1.71,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25N-01A,EBCCFB5F-C0A8-4263-AAFF-B5DD83585191,Thyroid,28,0CD93B1F-1CBB-4C1E-A4F6-940F95C41683,1A00F009-28F5-406B-8F47-4BB9D55D25D6,TCGA-ET-A25N-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25N,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,12
13722.58cfa831e4b0c9d6adf6cd74,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25K-01A,2F9ED09D-2626-4C23-BA47-1850D36F812A,Thyroid,36,343311B1-D586-4F92-9984-32AF1AFB1F62,663173D3-A9EE-4E73-8444-52F01727BE6D,TCGA-ET-A25K-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25K,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,9
13722.58cfa831e4b0c9d6adf6cdb8,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-6691-01A,E4D9B696-3311-44E7-9191-FDE56C080A00,Brain,23,87800B98-1FD3-4A09-AC98-3125962BFA72,B4968770-4D21-4C51-9ECA-47E23D5C240E,TCGA-FG-6691-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6691,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Astrocytoma,Not available,1891-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cda0,2.05,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A233-01A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Thyroid,18,76A6F76D-F33E-4B4A-B0EE-FB863345F194,4336BC49-7D28-4EB6-8B41-F43127ED8EC1,TCGA-FE-A233-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A233,TCGA-THCA,NA,Ohio State University,United States,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,24
13722.58cfa831e4b0c9d6adf6cd82,2.05,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A230-01A,B1D71782-2443-43F3-BD0E-8B7220515CB6,Thyroid,30,12FC3F30-08FB-47C6-92F1-009D961C1E94,001C6478-B20D-40D8-AF62-C45C64269129,TCGA-FE-A230-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A230,TCGA-THCA,NA,Ohio State University,United States,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,15
13722.58cfa831e4b0c9d6adf6cdcc,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-6689-01A,8D07B1E8-5D1D-4A43-B616-D29DD58CE5FE,Brain,30,D81C3F19-BBCF-4071-8BA4-CB8C505307D7,2FD05E93-48E8-460E-80E0-C3262EAEE72B,TCGA-FG-6689-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6689,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Astrocytoma,Not available,1891-02,TRUE,7
13722.58cfa832e4b0c9d6adf6ce97,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2EF-01A,2A142731-119C-495D-AD30-EB0B48BACB46,Bladder,50,981F581E-32AF-486B-9B60-0C8F1047C879,CE2F4DE7-C8AE-4103-8084-5F783B1087A7,TCGA-G2-A2EF-01A-12D-A18D-02,HG19_Broad_variant,TCGA-G2-A2EF,TCGA-BLCA,NA,MD Anderson,United States,Not available,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A18D-02,TRUE,20
13722.58cfa832e4b0c9d6adf6cedf,1.98,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1YD-01A,8A3659A8-2A85-4BAB-8BF3-55795922474C,Thyroid,53,AD5054BB-96D0-47CC-BB8C-F36E58784A31,CD27AF7E-F458-49BA-8C82-D18BDE252DB2,TCGA-EM-A1YD-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YD,TCGA-THCA,NA,University Health Network,Canada,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14U-02,TRUE,13
13722.58cfa832e4b0c9d6adf6cf91,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6365-01A,6845076E-E940-4437-8618-81DB4A447544,Prostate,71,95D6E1D3-91C1-40E5-986D-1C5ABB33A03F,CD30C4FA-8BBF-4A8A-A1F7-4FA0D45CA380,TCGA-G9-6365-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6365,TCGA-PRAD,NA,Roswell Park,United States,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,10
13722.58cfa832e4b0c9d6adf6cf6e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6384-01A,A279D5AA-51F7-4E75-9E14-B206B97EC4BD,Prostate,53,1ABCBE00-5A6F-4E0F-A61C-D158545C2293,1F750885-56C4-4953-8D22-BC7719F57F9F,TCGA-G9-6384-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6384,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,6
13722.58cfa82ee4b0c9d6adf6b001,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4430-01A,3A23CDB5-2327-45AC-B0B5-D4AFE038C757,Lung,59,122AAA4F-8FD5-4C41-BFF8-8A45BDFB3F81,C14A77D1-DB59-434E-BD3C-DBBE647D790C,TCGA-05-4430-01A-02D-1203-02,HG19_Broad_variant,TCGA-05-4430,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1203-02,TRUE,15
13722.58cfa82ee4b0c9d6adf6b020,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4432-01A,E737F650-B72D-44E7-B750-558A56716803,Lung,66,2A675528-1ABC-4220-A61A-25109850CE0D,A4E437A5-1603-4AE4-89C2-CD741FDE5015,TCGA-05-4432-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4432,TCGA-LUAD,NA,Indivumed,Germany,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1203-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b676,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4666-01A,4C31127E-D095-4978-9DAC-35153C27F6ED,Lung,52,5BAE2E45-6DBC-458C-A66F-702EB1AF7357,AC0D75F8-B4C5-40A8-9044-0B74722424D8,TCGA-73-4666-01A-01D-1203-02,GRCh37,TCGA-73-4666,TCGA-LUAD,NA,Roswell Park,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV,1203-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b678,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4670-01A,1B354837-4925-4480-AC32-6B44D0957314,Lung,69,646402AF-BA5F-438C-AE63-213EBD58B16D,D2FFA731-14A2-4A83-964E-C9969080263C,TCGA-73-4670-01A-01D-1203-02,GRCh37,TCGA-73-4670,TCGA-LUAD,NA,Roswell Park,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV,1203-02,TRUE,11
13722.58cfa82fe4b0c9d6adf6b6f6,1.8,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6591-01A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Lung,63,0791E7AA-E97C-4DD0-9615-09EC7090F684,C57EF4F0-5BE8-4761-9763-5052EFDFD7D5,TCGA-50-6591-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6591,TCGA-LUAD,119,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV,1751-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b834,2.23,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0RA-01A,AFD710B8-D172-4AC4-9973-E969DB1ED231,Uterus,68,4ED231EE-0E54-4AC5-8278-1061AD3972A2,01EFCC42-CCFA-4D41-87BE-CA8F1C551823,TCGA-A5-A0RA-01A-21D-A101-02,HG19_Broad_variant,TCGA-A5-A0RA,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,28
13722.58cfa82fe4b0c9d6adf6b84e,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0R8-01A,06D16B6B-9CA6-4CEC-A785-F27AA4323CEC,Uterus,81,5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA,289CE7E4-AF92-4857-9D07-7CF334C40542,TCGA-A5-A0R8-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R8,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,18
13722.58cfa82fe4b0c9d6adf6b86c,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0VP-01A,2DB0FB62-64CE-457C-9E22-DD05EF59F684,Uterus,74,F1FBE4AC-F3FD-4609-9A2B-507820ABE77E,E23FE404-0449-453D-971C-6E940B546119,TCGA-A5-A0VP-01A-21D-A101-02,HG19_Broad_variant,TCGA-A5-A0VP,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,19
13722.58cfa82fe4b0c9d6adf6b882,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2678-01A,3A785E32-7960-4C72-84C4-FB42C4DD86F1,Colorectal,43,20ECCD8A-DFAF-40E4-8128-D77AA41680C4,83E77250-E68B-4ECA-9592-4424151E0D79,TCGA-A6-2678-01A-01D-1167-02,HG18,TCGA-A6-2678,TCGA-COAD,NA,Christiana Healthcare,None,T3,N1,Colon Adenocarcinoma,Stage IIIB,1167-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b95e,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3548-01A,2DCED66C-1F0D-4039-A5E5-54CCA77C16E9,Colorectal,71,633AFC4C-4A35-420E-9CE6-FF4670E28395,B5E87744-9963-4DBA-84C8-B61048169517,TCGA-AA-3548-01A-01D-1167-02,HG18,TCGA-AA-3548,TCGA-COAD,NA,Indivumed,Germany,T3,N2,Colon Adenocarcinoma,Stage IIIC,1167-02,TRUE,28
13722.58cfa82fe4b0c9d6adf6b965,1.9,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3529-01A,BFB07784-693B-4C25-874E-4AD6E04A5D46,Colorectal,78,B083E3CB-0AF1-44EA-854D-85FD99B75AD5,B8C9B915-BD7E-41FA-B5E1-4A28478EDC6E,TCGA-AA-3529-01A-02D-1547-02,HG18,TCGA-AA-3529,TCGA-COAD,0,Indivumed,Germany,T3,N2,Colon Adenocarcinoma,Stage IIIC,1547-02,FALSE,16
13722.58cfa82fe4b0c9d6adf6b97e,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3681-01A,ABB0D53F-F74E-45DC-8FBB-40863016F3C6,Colorectal,77,190FECAB-1EF1-43FA-87A2-104014EB2CE2,85305E56-627C-4471-BD16-6818AD3751C2,TCGA-AA-3681-01A-01D-1637-02,HG18,TCGA-AA-3681,TCGA-COAD,NA,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage III,1637-02,FALSE,14
13722.58cfa82fe4b0c9d6adf6b982,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3861-01A,5DA56982-6DE7-4994-AA9E-3B01200B2959,Colorectal,72,390070D8-EF9B-46FE-93EE-9CF01A642A92,3FF478FA-97AF-4122-AC93-1BF1DD21BCB3,TCGA-AA-3861-01A-01D-1167-02,HG18,TCGA-AA-3861,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage IIA,1167-02,TRUE,12
13722.58cfa830e4b0c9d6adf6ba6c,1.65,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A010-01A,0712566E-3371-4715-95F1-5B792E72D758,Colorectal,46,46FB1711-E385-49A4-BF15-7990123CBE6B,30FCD977-8C62-4925-BC84-5894A12BABDB,TCGA-AA-A010-01A-01D-A077-02,HG18,TCGA-AA-A010,TCGA-COAD,NA,Indivumed,Germany,T4,N0,Colon Adenocarcinoma,Stage IIB,A077-02,TRUE,11
13722.58cfa830e4b0c9d6adf6bbe4,1.72,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A002-01A,CB005C69-7301-41CE-B534-C9751F1436C5,Colorectal,35,B918B56C-5C78-4CEE-85A7-7C88501E88AD,901C5D59-CE0A-44AE-91AE-9C253E99B68E,TCGA-AG-A002-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A002,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage I,A077-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c52c,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CK-4951-01A,2DB3C23D-C591-4EA0-B0A8-ED9C4343C80E,Colorectal,79,EA9E7E8C-4151-4CFC-8631-5880C6F1A21F,C501681C-26B5-4385-AE24-BEC8FB230C51,TCGA-CK-4951-01A-01D-1405-02,HG18,TCGA-CK-4951,TCGA-COAD,NA,Harvard,None,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA,1405-02,TRUE,24
13722.58cfa82fe4b0c9d6adf6b657,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5778-01A,8FDBD88F-19AE-4AB8-BCD7-6BFA1BBDE742,Lung,60,92514FD2-A178-42E8-8929-0910558E7F87,BC8FFDB4-AB99-44B7-95B0-7BC2F8110B76,TCGA-64-5778-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5778,TCGA-LUAD,NA,Fox Chase,United States,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB,1623-02,TRUE,28
13722.58cfa82fe4b0c9d6adf6b664,1.8,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6594-01A,8504FD86-A70A-4CBA-9EC8-25C9E60CA549,Lung,79,DAB00804-E92F-43F1-9348-16F3015B5DCE,9AED6934-5553-4BAC-AD76-BA2DDAE0DC72,TCGA-50-6594-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6594,TCGA-LUAD,370,University of Pittsburgh,United States,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1751-02,TRUE,16
13722.58cfa82fe4b0c9d6adf6b6b7,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5781-01A,41C4C704-825E-49F5-9D54-DBD7D30725E0,Lung,55,B32F509D-91E5-4601-B8B3-4B0A5212C22B,69DEF564-A4D8-4820-9ED6-F17AF2CAB0A7,TCGA-64-5781-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5781,TCGA-LUAD,NA,Fox Chase,United States,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1623-02,TRUE,24
13722.58cfa82fe4b0c9d6adf6b852,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0R9-01A,284174FD-1320-4617-9E99-75BD75DF9BF3,Uterus,51,986AC6AC-087F-412B-BB0C-9BE10D104989,6BBEF031-7106-4D36-86A9-F8A2333448BB,TCGA-A5-A0R9-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R9,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b85e,1.9,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2680-01A,FF1407C6-9174-4BAE-A19B-D34CA71B898C,Colorectal,72,D664F620-CFEE-4700-B00E-68B65387883C,22A3FC8C-A661-4B3D-A4BA-B35DFDBE24BC,TCGA-A6-2680-01A-01D-1405-02,HG18,TCGA-A6-2680,TCGA-COAD,NA,Christiana Healthcare,None,T3,N0,Colon Adenocarcinoma,Stage II,1405-02,TRUE,18
13722.58cfa82fe4b0c9d6adf6b86e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2671-01A,565E2726-4942-4726-89D3-C5E3797F7204,Colorectal,85,81505915-6C01-4299-AE89-964DC20D93CB,82E23BAF-DA11-4175-BEE0-81C0C0137D72,TCGA-A6-2671-01A-01D-1405-02,HG18,TCGA-A6-2671,TCGA-COAD,NA,Christiana Healthcare,None,T3,N2,Colon Adenocarcinoma,Stage IV,1405-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b866,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2682-01A,77A44132-AF22-4115-9FA2-78F2F74BF687,Colorectal,70,F10F139D-1D7F-4923-8129-F103F5D3163B,F8B17713-D431-4418-A6F7-DC6DE3077212,TCGA-A6-2682-01A-01D-1405-02,HG18_Broad_variant,TCGA-A6-2682,TCGA-COAD,424,Christiana Healthcare,United States,T4b,N1,Colon Adenocarcinoma,Stage IV,1405-02,TRUE,26
13722.58cfa82fe4b0c9d6adf6b874,2,Alive,FEMALE,Not available,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0VQ-01A,23489245-48D7-4F19-8A42-E23B1181412B,Uterus,62,952CB6A5-7527-470A-978E-EDD44E3A368F,97FE43D0-30DF-45A1-83F0-B4ED5EDF76AE,TCGA-A5-A0VQ-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0VQ,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,10
13722.58cfa82fe4b0c9d6adf6b938,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5779-01A,1C58D9B8-17A2-4FC6-9898-FE6F47BD2C2A,Lung,61,4131DA8F-3C6C-43E1-A7EB-81CB8988F524,AE15BEF8-478B-432E-B429-643A75BD2EB8,TCGA-64-5779-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5779,TCGA-LUAD,NA,Fox Chase,United States,T2,N2,Lung Acinar Adenocarcinoma,Stage IIIA,1623-02,TRUE,44
13722.58cfa82fe4b0c9d6adf6b8c4,1.9,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4510-01A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Lung,51,9A479D32-13A4-46C2-B26D-34CB6051A891,3324FA3E-B195-4974-A15B-0C8D8AC2EFA9,TCGA-49-4510-01A-01D-1203-02,GRCh37,TCGA-49-4510,TCGA-LUAD,896,Johns Hopkins,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1203-02,TRUE,10
13722.58cfa82fe4b0c9d6adf6ba02,1.78,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01I-01A,86D18004-9478-4E46-83B4-4FBE445CCB70,Colorectal,76,FBA03796-B9C8-4042-9720-F21660CFEC28,DAED1A71-909A-42D8-87B4-6760B54D91AF,TCGA-AA-A01I-01A-02D-A077-02,HG18,TCGA-AA-A01I,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,A077-02,TRUE,16
13722.58cfa830e4b0c9d6adf6baaa,1.95,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GD-01A,1486A031-B74D-4976-8B0B-4569E6978F49,Uterus,75,F449F50A-7664-4DDC-87AA-6A061EE7190C,069406A8-56D7-4E93-8570-7880A99D6C2D,TCGA-A5-A0GD-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GD,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,45
13722.58cfa830e4b0c9d6adf6bbc2,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-4008-01A,72802851-9340-4C5F-A90B-23B7AFD7577A,Colorectal,63,D803F092-3340-485D-9964-D6554D210E2E,CD36B70F-6819-4136-ADB5-8024E27B05A6,TCGA-AG-4008-01A-01D-1115-02,HG18,TCGA-AG-4008,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,1115-02,TRUE,37
13722.58cfa830e4b0c9d6adf6bc92,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3902-01A,BCFE4FE9-D090-49F9-85A7-2B472E0F7453,Colorectal,61,F52423C2-7780-4470-8E27-5982201CCB83,A8A88775-9775-4087-8C03-9B5BC771F983,TCGA-AG-3902-01A-01D-1115-02,HG18,TCGA-AG-3902,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,1115-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bd3c,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3892-01A,DED3FEB2-1079-4520-A7CA-F5B5FC73D7C5,Colorectal,57,D5B6919D-5654-486F-95B0-D89CB1893614,8B81AA70-5B77-4BE9-8438-AE0928339E21,TCGA-AG-3892-01A-01D-1115-02,HG18,TCGA-AG-3892,TCGA-READ,NA,Indivumed,Germany,T1,N0,Rectal Adenocarcinoma,Stage I,1115-02,TRUE,37
13722.58cfa830e4b0c9d6adf6bd7c,NA,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,TCGA-BF-A1PV-01A,EFF78AF6-0F68-49B9-866B-0D511606F2B1,Skin,74,090DEBB2-290D-49DD-B642-7F01C99A795C,BC0B690D-7C05-4B68-B2F2-5D38EA621A02,TCGA-BF-A1PV-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PV,TCGA-SKCM,NA,Cureline,Russia,T4b,N0,Not available,Stage IIC,A18Z-02,TRUE,20
13722.58cfa830e4b0c9d6adf6be10,1.95,Alive,FEMALE,WHITE,Not available,Breast Invasive Carcinoma,TCGA-BH-A0HX-01A,3B01D064-8C00-4972-9F07-407EAC8E7534,Breast,54,989C2DF5-5183-4DAA-A8DA-FC9AB18A437C,11821020-0E93-4479-85F8-306976DE6722,TCGA-BH-A0HX-01A-21D-A060-02,HG19_Broad_variant,TCGA-BH-A0HX,TCGA-BRCA,NA,University of Pittsburgh,None,T2,N1a,Infiltrating Ductal Carcinoma,Stage IIB,A060-02,TRUE,8
13722.58cfa830e4b0c9d6adf6be3a,1.98,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A18Z-01A,0D497FAF-2C1C-4173-A5FE-770CCA73323C,Thyroid,58,19DEE039-9C98-4D4A-8BAF-EEA1B6DDA8EB,815C53C3-8ADD-4612-B93C-3ED4BFA530AA,TCGA-BJ-A18Z-01A-21D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Z,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A13U-02,TRUE,33
13722.58cfa830e4b0c9d6adf6be3c,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A18Y-01A,ACB3B9DB-16E9-40F5-87A9-9DF9D4CEEE54,Thyroid,29,5D1D84D0-9A03-4381-9CF1-E460B3617AAA,56D2A069-7969-40F1-A237-E4FE7E62C84C,TCGA-BJ-A18Y-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A18Y,TCGA-THCA,NA,University of Pittsburgh,United States,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bdf4,1.73,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A014-01A,51C37449-6A2E-4C3D-A7CC-06F901E1224F,Colorectal,86,FBFA61FE-4FB7-4B2A-9BF0-33140FD41873,7771CB7E-1405-4B8E-86B5-0E06A0EB7FD1,TCGA-AG-A014-01A-02D-A077-02,HG18_Broad_variant,TCGA-AG-A014,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage I,A077-02,TRUE,35
13722.58cfa830e4b0c9d6adf6bdc0,1.93,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A186-01A,FE4DB898-3A9F-4DFF-ADCB-7B8C30137350,Uterus,61,B1645A83-57B7-4357-B977-63A5B6AEE39E,ECF410AD-B160-4F00-A165-38529FAE974B,TCGA-BG-A186-01A-11D-A12F-02,HG19_Broad_variant,TCGA-BG-A186,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,16
13722.58cfa830e4b0c9d6adf6bbc4,1.72,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A008-01A,E7503A51-6647-4CC2-80DD-645D0DF4DB43,Colorectal,50,AC02CD55-BC05-4329-8845-E09D088E3CB4,999D82E8-B92F-4397-A9F9-9AFBFD8A249C,TCGA-AG-A008-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A008,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Mucinous Adenocarcinoma,Stage I,A077-02,TRUE,12
13722.58cfa830e4b0c9d6adf6be8d,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BK-A0CB-01A,59E9029A-8DDD-4447-B35A-72BC39F82A30,Uterus,60,7678C70D-A298-4472-89A0-427AF1E93D28,F186159C-DCE6-467C-AAAF-BB08FBAE6827,TCGA-BK-A0CB-01A-32D-A101-02,HG19_Broad_variant,TCGA-BK-A0CB,TCGA-UCEC,NA,Christiana Healthcare,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bee6,2.28,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AX-A0IU-01A,7E64EA6C-A3DB-48EB-91BE-131361510A92,Uterus,79,DC4B3695-CE62-48D5-9F1D-7DD70D049C97,24746F36-88BC-44B0-955A-55A2CC98E17C,TCGA-AX-A0IU-01A-11D-A101-02,HG19_Broad_variant,TCGA-AX-A0IU,TCGA-UCEC,NA,Gynecologic Oncology Group,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A101-02,TRUE,16
13722.58cfa830e4b0c9d6adf6bec0,1.9,Alive,FEMALE,Not available,Not available,Breast Invasive Carcinoma,TCGA-AR-A0TU-01A,DFE6DB17-CF45-488E-BD3C-B8433D7343CA,Breast,35,1E629A73-68CD-449D-A1C0-B856BE4143E6,E00819A1-4A65-4289-9DDE-0800FC6C69F6,TCGA-AR-A0TU-01A-31D-A106-02,HG19_Broad_variant,TCGA-AR-A0TU,TCGA-BRCA,NA,Mayo,None,T2,N0,Infiltrating Ductal Carcinoma,Stage IIA,A106-02,FALSE,6
13722.58cfa830e4b0c9d6adf6bf2e,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4255-01A,956017BA-5E4B-42C7-B93D-42316874BA93,Stomach,76,A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F,11EA17E5-60EF-4695-866B-B328A51D15A9,TCGA-BR-4255-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4255,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1128-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bf83,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6453-01A,AE633E83-303F-4A90-AC3B-34458FD9BEEF,Stomach,54,A8F3B148-5929-4025-81A1-6595D49F2279,EE3446DC-7278-47AF-8F65-F63A1D423644,TCGA-BR-6453-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6453,TCGA-STAD,NA,Asterand,Russia,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1798-02,TRUE,5
13722.58cfa830e4b0c9d6adf6bf30,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4191-01A,74F859CF-6DF5-4E96-AE6B-CFAAB691D5FD,Stomach,72,E5A1A598-5896-46F9-8DCA-BA19AC138D14,125C563B-A1CE-4FFC-8D8D-19C7CA2E1049,TCGA-BR-4191-01A-02D-1128-02,HG19_Broad_variant,TCGA-BR-4191,TCGA-STAD,NA,Asterand,Russia,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,17
13722.58cfa830e4b0c9d6adf6be96,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4681-01A,6FBC2B46-6762-4778-AA7E-782162C5397C,Colorectal,79,6171DB74-FE5A-4495-8B6A-724BE0CBA79E,37179766-A54A-4FA0-9E6E-5A33ABF3AC45,TCGA-AZ-4681-01A-01D-1405-02,HG18,TCGA-AZ-4681,TCGA-COAD,NA,University of Pittsburgh,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1405-02,TRUE,26
13722.58cfa830e4b0c9d6adf6bfa4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6457-01A,05CE16D4-A999-491A-91AD-9449A57228FF,Stomach,69,BADB9AE0-9C44-41D4-848B-EE03B6FCA503,85EEEBBE-BDBB-4FE7-8CCD-401E818EEB29,TCGA-BR-6457-01A-21D-1798-02,HG19_Broad_variant,TCGA-BR-6457,TCGA-STAD,NA,Asterand,Ukraine,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1798-02,TRUE,6
13722.58cfa830e4b0c9d6adf6bf74,1.86,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LD-01A,1200C8B7-A058-4C01-BBE2-04EC09A65245,Uterus,63,649DADDA-5823-4B0D-B5A2-49F501ADC029,3D587F43-D9C5-4E3B-B245-60BB0AE92808,TCGA-AP-A0LD-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LD,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,36
13722.58cfa82fe4b0c9d6adf6b700,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5775-01A,C8544FB3-B26E-4672-BB81-A271DB724B04,Lung,71,5449BCED-1356-4DE5-9352-349725656C5C,11AEF70D-D22B-4936-BD8C-863BDBD4940E,TCGA-64-5775-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5775,TCGA-LUAD,62,Fox Chase,United States,T4,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1623-02,TRUE,20
13722.58cfa830e4b0c9d6adf6bfc0,1.87,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0JS-01A,0DA7BBD4-ED8D-474B-B494-CB93C5FA811E,Uterus,54,D0B88B1C-150D-4ABC-9F9E-8C51CB208EFA,D2DD7ED4-03F6-463E-94BD-6CF98D80E8FD,TCGA-B5-A0JS-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JS,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,18
13722.58cfa830e4b0c9d6adf6bffc,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3890-01A,E2D395F8-BF13-4FE4-8031-683B0EEDD875,Colorectal,62,DB70A6DD-DE09-4ED7-916C-708B21734500,12064771-AE96-441D-BE8B-EE49B63F1E4E,TCGA-AG-3890-01A-01D-1115-02,HG18,TCGA-AG-3890,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage I,1115-02,TRUE,19
13722.58cfa830e4b0c9d6adf6c022,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZE-01A,AB8C9101-ADEB-4C43-A8BB-B089EBD711F6,Thyroid,63,695C5627-F442-4A86-9702-EF35DEFD8C8C,ED0B1C86-A516-422F-92C4-7C535E709989,TCGA-BJ-A0ZE-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZE,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A10R-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c12f,2.08,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MU-01A,A7329910-B1C7-4A18-B28E-8FAD79121339,Uterus,78,F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0,0BB10C9F-C337-4E2E-A661-9CE12C8BEB35,TCGA-BG-A0MU-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0MU,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,29
13722.58cfa830e4b0c9d6adf6bff8,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3887-01A,8C7CCDB0-7653-4A8D-86B6-DE39AFC40765,Colorectal,68,7F10DD13-E2C3-4F27-8673-FF5CD1632B2B,5986038D-2696-4F89-A5F5-C8173BA7D70F,TCGA-AG-3887-01A-01D-1115-02,HG18,TCGA-AG-3887,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Mucinous Adenocarcinoma,Stage IIA,1115-02,TRUE,22
13722.58cfa830e4b0c9d6adf6c164,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5151-01A,A55FB87D-F606-48A5-82F5-09EACBACF41B,Head and Neck,72,63384A6A-9686-44EE-8C8F-22923968C9DE,5B29B8E2-23E6-4E6E-815C-B8D0EF534B14,TCGA-BA-5151-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5151,TCGA-HNSC,NA,UNC,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,19
13722.58cfa830e4b0c9d6adf6c1cc,NA,Alive,FEMALE,WHITE,Not available,Skin Cutaneous Melanoma,TCGA-BF-A1PU-01A,3DD5A206-D7F3-42F1-B9CC-4B31C76D495D,Skin,46,D9C8128A-5990-43C8-AC08-CBDF035213D6,AAC0230D-759F-4B2E-9904-3F7822E6B13C,TCGA-BF-A1PU-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PU,TCGA-SKCM,NA,Cureline,Russia,T4b,N0,Not available,Stage IIC,A18Z-02,TRUE,15
13722.58cfa830e4b0c9d6adf6c21a,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5153-01A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Head and Neck,51,2DC7070A-9C70-4BB1-9634-8C934BB9C8D1,F14D0AA8-E7BB-4E0E-B887-DA7B6FA0BC86,TCGA-BA-5153-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-5153,TCGA-HNSC,1762,UNC,None,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c36c,1.9,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5803-01A,33901C6F-9180-4A19-866C-F4AC6BEC76DA,Stomach,78,EB71264D-C896-4910-BF46-D6F129B83941,EABD49CE-0F0C-443D-9BF4-0ADD2C2532B2,TCGA-CD-5803-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5803,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1598-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c2ca,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0RY-01A,F299AD43-BB16-46CE-9617-48CC6C6F29E7,Uterus,68,260692E1-9B2C-4F8B-952D-1B95C042E659,8DB9ED84-C708-4075-B93D-CC58E84E6D99,TCGA-BG-A0RY-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0RY,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,36
13722.58cfa830e4b0c9d6adf6c03c,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-4001-01A,D846228F-67AF-4B3B-9796-DBC263C2054C,Colorectal,74,6160C363-B050-4B3B-9909-4EBC33ED3A1A,05B6BA78-DDE8-4E68-9622-7B618A083CC8,TCGA-AG-4001-01A-02D-1115-02,HG18,TCGA-AG-4001,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,1115-02,TRUE,27
13722.58cfa831e4b0c9d6adf6c36d,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5802-01A,0AECAC64-5982-4D76-8F31-958F6A00951D,Stomach,58,93C38FFB-27AC-4C91-939D-7102EE72F404,B0BEA59D-9484-4FF9-BC14-0DD1882EF6BE,TCGA-CD-5802-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5802,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1598-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c560,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5767-01A,8DC53431-44AB-485E-B4E6-C3D06509506D,Prostate,66,A87E6352-C469-484D-87FC-FABDBA237D01,02D28407-4AE4-4DA6-ABB5-6D6A4BB3D8D3,TCGA-CH-5767-01A-11D-1784-02,HG19_Broad_variant,TCGA-CH-5767,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c4b4,2.02,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-CE-A13K-01A,A1227FFA-2733-4A43-BA82-834755453870,Thyroid,30,DAF2A444-AB89-48D4-9DA7-888AC3099AB7,7CEF35A1-E530-47C9-9A86-3EA2C970FCD3,TCGA-CE-A13K-01A-11D-A10R-02,HG19_Broad_variant,TCGA-CE-A13K,TCGA-THCA,NA,ILSbio,Vietnam,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c4e9,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4682-01B,E588714A-7753-4C3C-ABB6-EAF1AAB53AB3,Colorectal,61,A2412F6F-324E-4EF2-BD46-0D33596A033B,2007180A-F4AC-4300-A560-903ACEAC4F71,TCGA-AZ-4682-01B-01D-1405-02,HG18,TCGA-AZ-4682,TCGA-COAD,680,University of Pittsburgh,None,T3,N0,Colon Adenocarcinoma,Stage IVA,1405-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c5e4,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4437-01A,6244E506-D163-4D34-8FEC-6158191679CB,Stomach,83,A882F6C0-D12D-4D49-9A2A-3850EA736C37,B6D1C576-6AB8-4759-B1B0-6E18DC162962,TCGA-CG-4437-01A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4437,TCGA-STAD,NA,Indivumed,Germany,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1798-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c604,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-5330-01A,9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C,Head and Neck,69,A70301B0-F66D-49B7-B420-C1F56B90002D,AB6DC814-ECE0-497C-BC58-5FECE5D3DCE6,TCGA-CQ-5330-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5330,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c68a,1.82,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CU-A0YR-01A,811B3950-36E7-485F-BC48-ACA1EEE2DDEF,Bladder,83,B362FCFA-4E31-4321-9E17-11A8BAE839C3,0CB51232-CFEA-4F4F-A26A-173B1094A64B,TCGA-CU-A0YR-01A-12D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YR,TCGA-BLCA,NA,UNC,United States,T2,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A10R-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c678,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-5325-01A,408C5D54-7888-4955-8386-BF8819B48A6C,Head and Neck,65,8394A7F6-1BF6-473E-A155-3DA1A3DE244F,FFB4F8E1-B683-4A35-A5E7-15DBF610AE47,TCGA-CQ-5325-01A-01D-1681-02,HG19_Broad_variant,TCGA-CQ-5325,TCGA-HNSC,654,"University Health Network, Toronto",Canada,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,1681-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c662,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4750-01A,C777A777-373A-4773-9566-6C373261F00A,Colorectal,34,463D4B1E-2068-45DD-9631-FB9C7268FE6C,EE814BA4-311A-4ABC-B7A6-F32C68C50F2A,TCGA-CM-4750-01A-01D-1405-02,HG18,TCGA-CM-4750,TCGA-COAD,NA,MSKCC,United States,T1,N1b,Colon Adenocarcinoma,Stage IIIA,1405-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c794,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-6017-01A,23C4E2EB-142B-4FCC-A974-9A248AEC3F37,Head and Neck,55,6C07CD48-2269-4D42-9879-309EA4CD3A74,48A22F9A-2A18-4FCA-8271-44B3F7C3A628,TCGA-CN-6017-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6017,TCGA-HNSC,NA,University of Pittsburgh,United States,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,27
13722.58cfa831e4b0c9d6adf6c7ac,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6827-01A,3C5BC678-41E9-46B3-9686-5CD95659AB71,Head and Neck,55,C53D6135-C614-45F4-8F41-49B20ED4A549,E2CDC496-8A62-4501-98C0-2AF2CCF48988,TCGA-D6-6827-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6827,TCGA-HNSC,NA,Greater Poland Cancer Center,Poland,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,1911-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c804,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A2G6-01A,46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18,Uterus,53,2127E58B-BD7B-490E-B34B-4F626B2A4053,079C1D47-95AC-456B-8DD5-C89B4076E578,TCGA-D1-A2G6-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G6,TCGA-UCEC,258,Mayo Clinic,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A17E-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c876,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6826-01A,31243867-8E9F-46E9-A213-B83544EB8028,Head and Neck,64,1737989D-8463-4761-B111-53E4FD396375,07759CEA-B923-4D20-96DB-7952D50314C7,TCGA-D6-6826-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6826,TCGA-HNSC,NA,Greater Poland Cancer Center,Poland,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c7bc,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-6019-01A,EE3061EC-273C-4BEF-A325-35E9C469BF01,Head and Neck,61,AC349695-2219-4A67-ADD5-A94FF85794E1,2C509E96-12D7-4DBB-A02F-DCDCC6F76952,TCGA-CN-6019-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6019,TCGA-HNSC,NA,University of Pittsburgh,United States,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,49
13722.58cfa831e4b0c9d6adf6c866,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-D6-6823-01A,FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1,Head and Neck,50,2DA83450-04C2-44D0-AB8A-9CC876242D5A,FE15C318-C3B1-4541-A0DA-4E41D7E99FBB,TCGA-D6-6823-01A-11D-1911-02,HG19_Broad_variant,TCGA-D6-6823,TCGA-HNSC,NA,Greater Poland Cancer Center,Poland,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1911-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c8cc,1.89,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-5579-01A,8B5746F9-DBEE-40BD-9141-1081960CF286,Stomach,74,633DCE5B-7A88-46DC-AD06-8897A609675B,CFF33A88-0211-46EE-AB5B-78F56C63E2A6,TCGA-D7-5579-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5579,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA,1598-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c896,1.94,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13V-01A,99AC4F2E-2E63-4F1E-AF0F-8F23A2CAF999,Thyroid,21,A870F5CA-F049-48C1-AFAC-B788A3111086,DB0AC00C-ABED-4D02-B05B-A3CD87DCA75F,TCGA-DJ-A13V-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13V,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c8da,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A168-01A,41893E97-7E90-4B03-B738-260F288ADE4C,Uterus,67,B44C673E-9560-4B59-9FF3-34CE230CAD1C,4593D11C-3A35-4269-80EC-D282497CF71C,TCGA-D1-A168-01A-31D-A12F-02,HG19_Broad_variant,TCGA-D1-A168,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c949,1.93,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13O-01A,77D5B246-33BA-4A96-9D73-06ACA797653E,Thyroid,56,457B11C0-3C36-4907-8C76-60E3861EBABB,EC713290-9998-489B-9D1E-CC9D33CF5428,TCGA-DJ-A13O-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13O,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,31
13722.58cfa831e4b0c9d6adf6c9b0,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13M-01A,BA9DEC81-FFC0-453A-9621-94BEBA45FAB1,Thyroid,28,28913C64-8637-4537-AF8C-7315097A5AD1,8C708D3B-B312-4C27-898B-A0FE87110474,TCGA-DJ-A13M-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13M,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A10R-02,TRUE,32
13722.58cfa831e4b0c9d6adf6c730,1.87,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A17N-01A,001E0309-9C50-42B0-9E38-347883EE2CD3,Uterus,46,F93931BA-8333-4E22-A430-CA02D9DA3FFC,DB0F8EE9-33A0-46CC-8218-59E18B2F824F,TCGA-D1-A17N-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A17N,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,39
13722.58cfa831e4b0c9d6adf6c9e7,1.91,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QQ-01A,99EF2FEC-5A3C-4E42-8F78-7EAF9877E26D,Thyroid,43,64D1F58A-986F-4D4B-962E-DA59A48C988B,DDE34A05-A208-4F86-9803-0FB1EB858947,TCGA-DJ-A1QQ-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QQ,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,15
13722.58cfa831e4b0c9d6adf6ca25,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DE-A0Y2-01A,6AD260AD-769A-4F3C-BD07-927ADF6B2338,Thyroid,30,EB4FEEBB-293E-43E3-A2ED-344B17D180B3,E86091EB-6DCC-479B-BAFD-3DABA65787EC,TCGA-DE-A0Y2-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y2,TCGA-THCA,NA,University of North Carolina,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,19
13722.58cfa831e4b0c9d6adf6ca5e,1.98,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QG-01A,CB29E795-7618-4882-A7E0-69D39787B80C,Thyroid,62,D0A669AF-1A0A-451D-9D6F-9EEE15F7264C,EF88FE61-36C4-43CF-BD57-D15F7E264DF0,TCGA-DJ-A1QG-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QG,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A14U-02,TRUE,24
13722.58cfa831e4b0c9d6adf6ca60,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-6013-01A,714496C5-D221-4397-9C5A-CD2D22603E6F,Head and Neck,56,D018CD44-6B01-44F2-9181-81153225AAB8,2DE7DBC6-2A3E-4E67-BB96-552E27137618,TCGA-CN-6013-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6013,TCGA-HNSC,NA,University of Pittsburgh,United States,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,30
13722.58cfa831e4b0c9d6adf6cb5e,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7018-01A,F18DAB99-26B0-4727-89A9-7F16BD382356,Brain,57,FE98F78B-2C80-4999-B430-E1D95A53F356,02FCFCBB-05D7-4671-BDDF-DED65316FCC6,TCGA-DU-7018-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7018,TCGA-LGG,933,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,2022-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cb58,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-EB-A299-01A,90402C32-9548-432E-85B8-A4F80E14401E,Skin,63,5678AE8F-382C-4167-839E-A160CE6710C7,C164DE0A-E762-48BE-B940-9E5EA31AD026,TCGA-EB-A299-01A-21D-A18Y-02,HG19_Broad_variant,TCGA-EB-A299,TCGA-SKCM,NA,Asterand,Russia,T2b,N0,Not available,Stage IIA,A18Y-02,TRUE,15
13722.58cfa831e4b0c9d6adf6cc4a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-EB-A24C-01A,2F1BBE96-49D9-417B-BC9C-A09992489340,Skin,56,67D59A46-5944-4B23-AA7B-9561C6F7B956,B48D03D1-E323-4119-B62E-1952163AAB2A,TCGA-EB-A24C-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-EB-A24C,TCGA-SKCM,NA,Asterand,Ukraine,T4b,NX,Not available,Not available,A18Y-02,TRUE,16
13722.58cfa831e4b0c9d6adf6cc4e,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7007-01A,8E2DCC00-9F7E-4DEE-B24D-43C8B30294C5,Brain,33,E8E363D0-D9EA-478F-880C-7ADED5846237,A15321DD-20AE-4D64-9D89-C64A92468ECA,TCGA-DU-7007-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7007,TCGA-LGG,1915,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cc66,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-EB-A24D-01A,D7EE2693-39A8-4E3A-B6F6-E4729800E34E,Skin,72,A74E2FEC-291C-4967-AFE3-101955578225,0FD8F30A-936E-4A72-AA69-4DAC1E4BCE49,TCGA-EB-A24D-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-EB-A24D,TCGA-SKCM,NA,Asterand,Ukraine,T4a,N2b,Not available,Stage IIIB,A18Y-02,TRUE,12
13722.58cfa831e4b0c9d6adf6cdb1,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-6692-01A,5F10CD91-1E03-4016-B35A-8629A1A8FCC9,Brain,63,FDDB3709-5F1C-40C8-A39A-48329DFE9C97,5BB5BFCC-DB34-474C-95E6-3A84C3A7DBAA,TCGA-FG-6692-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6692,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Oligodendroglioma,Not available,1891-02,TRUE,6
13722.58cfa831e4b0c9d6adf6ccdc,1.93,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1YC-01A,0AD2A2B3-C1BB-4597-B28E-A6385F93D09C,Thyroid,71,17610B7B-F2EC-4B55-808C-1C2219A0D1BA,3D02FB7F-EB7D-49F9-BD40-20E9BDA1FBAB,TCGA-EM-A1YC-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YC,TCGA-THCA,NA,University Health Network,Canada,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A14U-02,TRUE,15
13722.58cfa831e4b0c9d6adf6cd9e,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A238-01A,DFFC4F7A-C67A-4AC5-A338-717DFFDE686D,Thyroid,36,D68C3B99-CB82-48BD-A1F8-BEE0A9A9E8C3,BA986EBD-8E2D-4BAF-AC16-FCEB1286F590,TCGA-FE-A238-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A238,TCGA-THCA,NA,Ohio State University,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,17
13722.58cfa831e4b0c9d6adf6cdc4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-6690-01A,AD202887-88B3-4E0F-A4C3-7E135D4CB258,Brain,70,F6C7B8C5-02DF-4B89-B527-F647762A98B7,BA96EFD0-90DE-4458-89DE-8B16639760B8,TCGA-FG-6690-01A-11D-1891-02,HG19_Broad_variant,TCGA-FG-6690,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Oligodendroglioma,Not available,1891-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cdb4,2.16,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A231-01A,7044DEE0-FD6C-4E75-B731-DC60A386A1AB,Thyroid,70,96C298EB-0699-42AE-B2EA-63A192353D69,056B3922-279A-4869-A933-0C53C1137450,TCGA-FE-A231-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A231,TCGA-THCA,NA,Ohio State University,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A14U-02,TRUE,28
13722.58cfa832e4b0c9d6adf6ce11,1.98,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1YE-01A,E632B443-CF6A-4592-96C6-C3493EC86FEA,Thyroid,47,A5DE766B-9CCC-4B56-8D9B-25704C1C91D0,4AE46D2E-BA86-426F-A127-4C1AAF92AB5B,TCGA-EM-A1YE-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YE,TCGA-THCA,NA,University Health Network,Canada,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14U-02,TRUE,21
13722.58cfa832e4b0c9d6adf6ce34,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A19T-01A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Skin,51,11E2F891-251A-4813-AA90-E944F350C54D,9C1427B0-B112-4BB7-89B3-27934F92E077,TCGA-ER-A19T-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A19T,TCGA-SKCM,270,University of Pittsburgh,United States,T4a,N3,Not available,Stage IV,A18Z-02,TRUE,19
13722.58cfa832e4b0c9d6adf6cf3c,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6373-01A,C3A509C6-35A6-4D17-A9FD-0AA8884B33A0,Prostate,68,18365C1F-9BC0-4865-B40D-DEF3EE73331C,A0563516-591D-4FC2-AF37-8BA62A071C58,TCGA-G9-6373-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6373,TCGA-PRAD,NA,Roswell Park,United States,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,8
13722.58cfa832e4b0c9d6adf6cee6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-FI-A2D0-01A,1B35D083-F7C9-47D2-9A9E-718788F9E39A,Uterus,55,A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717,9406B9B9-CC2D-470D-BFB6-2118C0B84982,TCGA-FI-A2D0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D0,TCGA-UCEC,NA,Washington University,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A17E-02,TRUE,13
13722.58cfa832e4b0c9d6adf6cf4e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6356-01A,1D7FFBE7-6139-412B-8739-8082A63A2B33,Prostate,60,C6E0F83F-ABA3-4705-ABAC-C81C885B53BA,E43C07B2-F48D-4780-9766-15CC08CE6FE2,TCGA-G9-6356-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6356,TCGA-PRAD,NA,Roswell Park,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,7
13722.58cfa832e4b0c9d6adf6cf6c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6496-01A,CE2B7E17-424E-4954-8A68-19D7F98D2E7E,Prostate,61,ECE85143-957D-4AD1-BFCC-B71307EFB911,10BB38BE-9E75-4793-89B5-7BB19D7AA4F8,TCGA-G9-6496-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6496,TCGA-PRAD,NA,Roswell Park,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,6
13722.58cfa832e4b0c9d6adf6d02e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6367-01A,9F751C9D-AD41-4F02-B7F8-12423857D418,Prostate,60,5BC98578-E4C7-4BE8-89DF-F26AA5D545A9,9667EB66-775F-4C37-9309-FF73E55D553B,TCGA-G9-6367-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6367,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,8
13722.58cfa832e4b0c9d6adf6d0c8,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-FS-A1ZN-01A,9D86940D-50FB-4D2F-8B1E-539196885F46,Skin,43,C6C66FAF-676B-4302-B825-143E1E72D04D,507A59F5-70A6-464C-ADA3-3E686414045A,TCGA-FS-A1ZN-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-FS-A1ZN,TCGA-SKCM,730,Essen,Germany,T4b,N1a,Not available,Stage IIIA,A18Y-02,TRUE,9
13722.58cfa832e4b0c9d6adf6d1a8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7472-01A,482D4078-7576-48CF-BF7C-29014935FD47,Brain,38,F05081A2-2465-4EA4-9EC3-319810FE2D45,A68374D7-4782-4FF5-B921-35D45468A4D1,TCGA-HT-7472-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7472,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligodendroglioma,Not available,2022-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c485,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4752-01A,7EA546CE-F48A-4D9C-96B4-A0124C692870,Colorectal,58,5703F0D8-DB96-40CE-8009-51D2EC188ABF,43756C1F-6ED2-468B-B0AD-D44A447C7709,TCGA-CM-4752-01A-01D-1405-02,HG18,TCGA-CM-4752,TCGA-COAD,NA,MSKCC,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1405-02,TRUE,30
13722.58cfa831e4b0c9d6adf6ca05,2.03,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DE-A0Y3-01B,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Thyroid,60,3AE03B86-1473-409C-8118-A91A73A36F60,F3099D9B-DBBE-46CB-BA22-DAD7F9428C4F,TCGA-DE-A0Y3-01B-11D-A10R-02,HG19_Broad_variant,TCGA-DE-A0Y3,TCGA-THCA,NA,University of North Carolina,United States,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC,A10R-02,TRUE,20
13722.58cfa82ee4b0c9d6adf6ae6a,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4398-01A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Lung,47,DA010683-C537-478F-8F95-E606B05DBC5C,CC8C5E2D-1878-49EC-9D63-D65EB4FE8256,TCGA-05-4398-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4398,TCGA-LUAD,NA,Indivumed,Germany,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,1203-02,TRUE,10
13722.58cfa82ee4b0c9d6adf6ae50,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4382-01A,3434B91A-C05F-460F-A078-7B1BB6E7085D,Lung,68,CCE6D71F-369E-467F-BD7E-03D20E97B7F3,EE1D241A-B371-433A-9AF7-F1C9074C155F,TCGA-05-4382-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4382,TCGA-LUAD,NA,Indivumed,None,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1203-02,TRUE,16
13722.58cfa82ee4b0c9d6adf6b02c,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4420-01A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Lung,41,4B202550-9744-4C6C-AD17-97F764EA3F18,A50583F2-BB90-4848-9A5F-EAF4656A1866,TCGA-05-4420-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4420,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1203-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b64a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4662-01A,294FF941-AEA1-4588-9A0E-E9F5393E2BB6,Lung,65,C7D727B6-47C6-4339-B9DD-5BAF41527BD4,DCC0A32E-EF17-4AA8-8321-A03137A61D72,TCGA-73-4662-01A-01D-1203-02,HG19_Broad_variant,TCGA-73-4662,TCGA-LUAD,NA,Roswell Park,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1203-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b659,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6592-01A,09918B81-4696-4CBA-A45A-5FE7407C2337,Lung,71,01F94091-EB70-40D3-9D56-70C4F847CB4C,F61D3411-6EED-4EDE-8BBA-A40AF0C9DA84,TCGA-50-6592-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-6592,TCGA-LUAD,777,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b66c,1.9,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-50-5946-01A,C95957A7-1A1A-4C8D-BB61-7C99B500F224,Lung,62,AD9A794F-52DD-4572-BF29-CD3D11BA6C24,F9F38A15-2964-4AE0-90AA-E5F3F7461AB3,TCGA-50-5946-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5946,TCGA-LUAD,NA,University of Pittsburgh,United States,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA,1751-02,TRUE,29
13722.58cfa82ee4b0c9d6adf6ae52,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4389-01A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Lung,70,ED61AC6A-F21F-4B88-928A-029340D4AEBD,575D4BEF-5610-41F4-B219-C9BBBA72F047,TCGA-05-4389-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4389,TCGA-LUAD,NA,Indivumed,Germany,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA,1203-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b6ba,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Lung Adenocarcinoma,TCGA-44-6778-01A,5D5CC436-6E57-4D23-A164-7F5153C2E666,Lung,59,15321297-7110-4E79-8D6F-94C95BC83C94,737A7A30-1F60-4D88-B94D-B5FCD996FED2,TCGA-44-6778-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6778,TCGA-LUAD,NA,Christiana Healthcare,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1853-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b704,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4659-01A,CD0DC947-B708-464E-BEB7-954C9D4583E7,Lung,66,C35A5ED1-1821-4077-BA1E-B972DFA3233B,277D2F7F-1A7F-4D39-BD15-0334CC02840E,TCGA-73-4659-01A-01D-1203-02,GRCh37,TCGA-73-4659,TCGA-LUAD,711,Roswell Park,United States,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1203-02,TRUE,6
13722.58cfa82fe4b0c9d6adf6b6aa,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6774-01A,33C71EAD-4C2A-476D-85EF-885DBBFC2CBD,Lung,56,79CF84B5-84FF-42E5-B438-697B35D272FC,6B977266-994D-4440-BC09-59FD8737F2D0,TCGA-44-6774-01A-21D-1853-02,HG19_Broad_variant,TCGA-44-6774,TCGA-LUAD,NA,Christiana Healthcare,United States,T1,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1853-02,TRUE,22
13722.58cfa82fe4b0c9d6adf6b64b,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-5126-01A,93766482-2F20-4C8F-BBD8-BDD203C37D5A,Lung,NA,39509EA1-E728-4350-B444-798C72ADE33A,7BCB1D5A-871F-472E-A964-9B68259D9716,TCGA-75-5126-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5126,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T3,N2,Lung Papillary Adenocarcinoma,Stage IIIA,1751-02,TRUE,4
13722.58cfa82fe4b0c9d6adf6b790,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6146-01A,0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5,Lung,64,AD66185F-983D-4416-B705-25D3D4D8B5A5,2D5C6425-E3F4-4389-9DDF-FDE694B4227E,TCGA-44-6146-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6146,TCGA-LUAD,NA,Christiana Healthcare,United States,T3,N0,Lung Mucinous Adenocarcinoma,Stage IIB,1751-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b7b6,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-3918-01A,6E3B6B72-142D-4B8D-A462-28A205796E41,Lung,60,2FF8BAFD-2AC5-4BFD-8C60-81519CD44166,81D8D7E2-65FA-4E92-B064-0D7D41C54E7F,TCGA-44-3918-01A-01D-1103-02,HG19_Broad_variant,TCGA-44-3918,TCGA-LUAD,NA,Christiana Healthcare,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1103-02,TRUE,22
13722.58cfa82fe4b0c9d6adf6b868,1.87,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0R7-01A,02B25675-094D-4098-96DA-51D121380FEC,Uterus,55,550C6341-260A-4156-B00C-0AE9031D647F,4C9B54D0-A58E-44CF-8937-913A34F0788C,TCGA-A5-A0R7-01A-31D-A101-02,HG19_Broad_variant,TCGA-A5-A0R7,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,9
13722.58cfa82fe4b0c9d6adf6b8fe,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-49-6744-01A,15340DD3-84AE-49FB-989A-EB212F3E73DA,Lung,64,A9D69D7E-298C-4AB6-B64F-1EDC58832CCD,7455D0A5-45DB-461F-9026-5A0FE3D55A6A,TCGA-49-6744-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6744,TCGA-LUAD,NA,Johns Hopkins,United States,T2a,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIA,1853-02,TRUE,18
13722.58cfa82fe4b0c9d6adf6b8b3,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5051-01A,E1C55BAC-BB41-4964-ADD5-ECD6BA04B58D,Lung,42,180EB213-0DDC-4F10-AB0E-B3AF92CDE3C3,80170E98-4886-4A34-BC88-F2B2F84743B2,TCGA-50-5051-01A-21D-1853-02,HG19_Broad_variant,TCGA-50-5051,TCGA-LUAD,NA,University of Pittsburgh,United States,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1853-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b90e,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4507-01A,50B2C647-AECD-4C81-AF22-0D8116593552,Lung,73,962F85FF-1F27-49E4-8C3D-798FACEA122F,EF299B98-6A9F-4022-8683-A9C830E7263C,TCGA-49-4507-01A-01D-1203-02,GRCh37,TCGA-49-4507,TCGA-LUAD,268,Johns Hopkins,United States,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1203-02,TRUE,11
13722.58cfa82fe4b0c9d6adf6b912,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4506-01A,B61ABDFD-B7A0-4E1A-B570-D1EAECAD3A9E,Lung,68,9EDEA53D-AD06-4B5D-BFF0-48E834C3684F,2270ABD6-565B-46B6-8154-505C5659A7C3,TCGA-49-4506-01A-01D-1203-02,HG19_Broad_variant,TCGA-49-4506,TCGA-LUAD,999,Johns Hopkins,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1203-02,TRUE,7
13722.58cfa82fe4b0c9d6adf6ba10,1.69,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01G-01A,6F2B5A14-569C-4084-8C67-B1A44D787897,Colorectal,63,A09ABC20-4F93-4130-A23A-8413E6C32FE5,D7D83B15-9EE5-4206-805D-AC3E5914BCC6,TCGA-AA-A01G-01A-01D-A077-02,HG18,TCGA-AA-A01G,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA,A077-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc52,1.72,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A011-01A,3BE106BC-BA42-4C70-9B50-697D89DB617D,Colorectal,80,B5DD8F49-26FC-48D9-A964-D8EBDCCA9E19,8C282A6C-3D47-4F9E-96C4-2C0852E7785B,TCGA-AG-A011-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A011,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,A077-02,TRUE,30
13722.58cfa830e4b0c9d6adf6bc62,1.72,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A00Y-01A,C7E09161-60D6-4DFF-A840-7CEC3BB7A30A,Colorectal,68,8EC6ADED-026E-47F5-91F1-2A75F07BD8D0,27B036A3-5277-4C0F-93EE-593FDA1441DC,TCGA-AG-A00Y-01A-02D-A077-02,HG18_Broad_variant,TCGA-AG-A00Y,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,A077-02,TRUE,40
13722.58cfa830e4b0c9d6adf6bc8c,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3896-01A,9AF35239-FFB9-4D4F-889E-F743DA271EEF,Colorectal,85,03B40342-3CCE-4A45-B2EC-8855AEB85100,D33D46C5-F3FD-4FD5-9CE2-06839BF33A37,TCGA-AG-3896-01A-01D-1115-02,HG18,TCGA-AG-3896,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage I,1115-02,TRUE,24
13722.58cfa830e4b0c9d6adf6bc90,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4308-01A,3D8FD9B2-9AA2-4C81-8843-535AE66D6140,Colorectal,47,6F0E65B2-7CA0-4F10-8952-B64900009001,1C7E82B6-A8EB-4593-B329-5299BC05140E,TCGA-AZ-4308-01A-01D-1405-02,HG18,TCGA-AZ-4308,TCGA-COAD,NA,University of Pittsburgh,None,T3,N1,Colon Adenocarcinoma,Stage IIIB,1405-02,TRUE,43
13722.58cfa830e4b0c9d6adf6bd64,1.73,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A00R-01A,CA22EDD4-EB7C-4677-84AA-6F0354459A19,Colorectal,64,F72EEAE9-F7F5-4576-A072-5021119117D6,AC9F45EC-C004-475F-8537-8977F20B0DE8,TCGA-AA-A00R-01A-01D-A077-02,HG18,TCGA-AA-A00R,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,A077-02,TRUE,15
13722.58cfa830e4b0c9d6adf6bd8c,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M0-01A,8BF0B156-6EB4-45E8-9CBB-0979EFBEA898,Uterus,66,E3F599DB-19CF-4086-8E5D-D3527119120F,78D21C64-205B-4C9C-A862-8A70348D2602,TCGA-BG-A0M0-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M0,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bda8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-BF-A1Q0-01A,633DDC04-C424-42C8-8E54-673968B130A7,Skin,80,B68CFB6B-4249-4855-8278-B18C0F561EFD,C94F7E24-8073-4786-BFC0-C45A37D85B2F,TCGA-BF-A1Q0-01A-21D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1Q0,TCGA-SKCM,NA,Cureline,Russia,T4b,N0,Not available,Stage IIC,A18Z-02,TRUE,28
13722.58cfa830e4b0c9d6adf6bd9b,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M3-01A,8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05,Uterus,74,1802CD6B-4D4A-45FA-B839-7450071E41EE,04E49830-378E-4EB2-B77C-70D6955627F7,TCGA-BG-A0M3-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M3,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,6
13722.58cfa830e4b0c9d6adf6be7e,2.02,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,TCGA-BJ-A192-01A,B55375C3-9EF2-4D2F-9C29-224E746931C4,Thyroid,54,582C3030-1F23-4535-9C8B-6B594E656AF4,6D770754-E14D-4E47-AE33-BE0FC9B40CE9,TCGA-BJ-A192-01A-31D-A13U-02,HG19_Broad_variant,TCGA-BJ-A192,TCGA-THCA,NA,University of Pittsburgh,United States,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A13U-02,TRUE,10
13722.58cfa830e4b0c9d6adf6be84,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A191-01A,2501EE46-8D38-448B-8765-E9C9706CBBE8,Thyroid,49,C92FC4E3-7A96-4000-A969-AA894CA58A33,B3EDF2BC-5E8F-435A-ADA1-F292722EDD9C,TCGA-BJ-A191-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BJ-A191,TCGA-THCA,NA,University of Pittsburgh,United States,T1b,N0,Other  specify,Stage I,A13U-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bec9,1.91,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LP-01A,EFAE3940-D3CC-4988-BDB4-FA05D977AFF5,Uterus,76,D67450C1-8848-4B28-9C16-83AA7132E8C8,C7A70C11-A05E-473D-929E-59A260FFBD97,TCGA-AP-A0LP-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LP,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bf21,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4279-01A,117EB38B-0C62-4336-A866-FA5BD013256A,Stomach,43,84AD647D-76B8-4EDA-8603-40220089BE34,01DC88B7-45FC-464C-A613-9793CD0C068B,TCGA-BR-4279-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4279,TCGA-STAD,NA,Asterand,Russia,T2a,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1128-02,TRUE,4
13722.58cfa830e4b0c9d6adf6bead,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3901-01A,1586CB0A-081A-4364-9470-46F9D0F0167D,Colorectal,67,93B755E6-5D6E-4542-8BAE-2121F44F590C,F5D4395A-5E00-4616-A402-CDCAD8702E1B,TCGA-AG-3901-01A-01D-1115-02,HG18,TCGA-AG-3901,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Mucinous Adenocarcinoma,Stage IIIB,1115-02,TRUE,33
13722.58cfa830e4b0c9d6adf6bf9f,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6458-01A,E516880B-C4E5-43CD-A358-BE0DB88564D7,Stomach,57,A30B45F5-C6E4-4975-A912-8313D93DFD27,2DD3E59B-4DBB-49B4-9DC4-A949FE48AA17,TCGA-BR-6458-01A-11D-1798-02,HG19_Broad_variant,TCGA-BR-6458,TCGA-STAD,NA,Asterand,Ukraine,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB,1798-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c01e,1.92,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0Z2-01A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Thyroid,57,B06B7493-F38A-493F-8B47-61E0FA4D111F,D8B6F131-76CA-45D3-8934-A6CDEA8153AD,TCGA-BJ-A0Z2-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0Z2,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC,A10R-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c01c,2,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K7-01A,2F0640BC-598C-4714-9E9B-7E0F2CA4567F,Uterus,64,51E8577D-6849-422E-8F37-2EA8C400BBE5,ED30E619-1EBE-4CCE-B7FD-93B552953B65,TCGA-B5-A0K7-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0K7,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,23
13722.58cfa830e4b0c9d6adf6c026,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZB-01A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Thyroid,66,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,EBAA6AE4-66C0-49A7-938C-620E24564846,TCGA-BJ-A0ZB-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZB,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A10R-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c050,2.06,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K6-01A,5CBA9441-6812-49C0-A0F6-7928ED4E5B81,Uterus,58,69BF0D3A-B7AE-4EE1-B7D1-18A32FCFA67C,A4364F57-81A8-4B96-BA31-1D8B1CC78C5D,TCGA-B5-A0K6-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K6,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,57
13722.58cfa830e4b0c9d6adf6c066,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3894-01A,065B26FC-6827-44D5-83D8-1100C63FCDA6,Colorectal,65,D6B7E2F3-01AD-4E77-87BB-9CBAEF03A5FB,339E9078-1166-45F6-A6BD-A2818B8918A1,TCGA-AG-3894-01A-01D-1115-02,HG18,TCGA-AG-3894,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage IIA,1115-02,TRUE,24
13722.58cfa830e4b0c9d6adf6c044,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3893-01A,ADD567B7-29EF-4122-8A54-57D36F735E78,Colorectal,74,7E16AFE9-DA05-451B-BD8C-86D75C8E475C,5815181B-A53B-4AAF-9817-168AC41DAD2A,TCGA-AG-3893-01A-01D-1115-02,HG18,TCGA-AG-3893,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IIIB,1115-02,TRUE,35
13722.58cfa830e4b0c9d6adf6c1b8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-BF-A1PZ-01A,455F982C-A067-46AC-BF89-3E535D0FFCA0,Skin,71,2A5EE782-122E-432B-98E0-0849B6F9A3D9,25D65D8B-ED75-47D6-B7F6-95CF26CCBE06,TCGA-BF-A1PZ-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-BF-A1PZ,TCGA-SKCM,NA,Cureline,Russia,T4a,N0,Not available,Stage IIB,A18Z-02,TRUE,20
13722.58cfa830e4b0c9d6adf6c1fc,1.97,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M2-01A,9731E0B3-C62D-43CB-8AE7-8F973D69AB19,Uterus,62,2AF18345-2A71-4574-AC8E-83DDEED3AD57,E59EB8B5-DA68-44B3-BB18-8C42F583B2BA,TCGA-BG-A0M2-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M2,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c23c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A2LB-01A,D17A5AB1-3789-4652-AFF5-D8F4F2291F9C,Bladder,73,7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A,FAD087E0-3752-4144-960B-659B59312C92,TCGA-BT-A2LB-01A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LB,TCGA-BLCA,NA,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A18D-02,TRUE,17
13722.58cfa830e4b0c9d6adf6c29e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4366-01A,525A6978-2D7B-4F3A-AC68-13FE8CBBBDCC,Stomach,87,8C2D2CCE-E071-42E8-89B2-77C56B4F3472,5AF4101A-F7F6-4014-BC9C-02446DA9CBDC,TCGA-BR-4366-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4366,TCGA-STAD,NA,Asterand,Russia,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1154-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c272,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZA-01A,4C513413-263E-4C7B-B997-7B688C47B698,Thyroid,67,A61A9EC7-B893-44A5-AB6F-A390C168BE88,F3A353BB-07C3-49D1-BED2-2F8F5A328E1C,TCGA-BJ-A0ZA-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZA,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II,A10R-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c384,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5801-01A,DF822EA3-E0E6-4AD3-A228-E20E3A737DAC,Stomach,69,9D0DF8D7-8D59-4983-9BBF-C6C106BDEFEC,F32CB4AA-D842-427A-8B7E-371764308512,TCGA-CD-5801-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5801,TCGA-STAD,NA,ILSbio,Vietnam,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1598-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c498,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4722-01A,B64BFCA1-033C-4501-A900-103AC105C084,Head and Neck,61,6E767FC9-0F5A-49EC-999A-CDA2DAEBA6FF,0CA196A7-5A71-4E70-8FA6-9506E1883032,TCGA-CN-4722-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4722,TCGA-HNSC,NA,University of Pittsburgh,None,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1431-02,TRUE,22
13722.58cfa831e4b0c9d6adf6c424,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4725-01A,3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B,Head and Neck,60,DD42AB2F-E936-4ACE-93D8-60375E03F2FE,C8B71532-685F-47AC-B019-B898A8D1670D,TCGA-CN-4725-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4725,TCGA-HNSC,NA,University of Pittsburgh,None,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1431-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c4a4,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CF-A1HR-01A,39EA19E1-4959-4F1B-9934-54BDAF766842,Bladder,62,6E77AB45-9C53-4A74-9581-043005C3E685,B048E28D-38FC-4E37-9C54-9C56526AD0E3,TCGA-CF-A1HR-01A-11D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HR,TCGA-BLCA,NA,ILSbio,Vietnam,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c514,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4735-01A,FE844945-3EA9-449E-993C-DF392FABCFD0,Head and Neck,52,FBB300FA-8793-42DA-A68E-4570AE2E5186,F759672A-62CA-49DC-BC4F-643E8A885787,TCGA-CN-4735-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4735,TCGA-HNSC,NA,University of Pittsburgh,None,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,16
13722.58cfa831e4b0c9d6adf6c57e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4729-01A,2FC960BD-01B0-422D-AD33-34520FA3DF0E,Head and Neck,73,1DA8FE25-AEE2-45FD-A1F3-3239A42E54B2,A49670C2-95A6-4DEB-BFC5-59B0FF37389E,TCGA-CN-4729-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4729,TCGA-HNSC,NA,University of Pittsburgh,None,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1431-02,TRUE,11
13722.58cfa830e4b0c9d6adf6c102,2.16,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K9-01A,4485CC98-5D58-4EB4-8325-7D1A617B6461,Uterus,88,52A96216-708F-43F2-A923-130A1C35922D,30D94271-91F3-4CF5-83C0-4708662115D0,TCGA-B5-A0K9-01A-21D-A101-02,HG19_Broad_variant,TCGA-B5-A0K9,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,26
13722.58cfa831e4b0c9d6adf6c651,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4736-01A,0FB3E5FF-54F0-43C5-9322-541BB7825E7F,Head and Neck,70,6DB0B6EE-23B3-43BF-8AA9-FDF641AFC673,8141905F-DE66-4DB2-A9F9-5819C953A465,TCGA-CN-4736-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4736,TCGA-HNSC,395,University of Pittsburgh,None,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c696,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-CS-6186-01A,9EE6E821-3AF2-42D7-9D14-F0CA455F338C,Brain,58,5F73FA4E-FC7D-4FC0-8436-2241E57B9B69,4143FB11-BA46-4129-8543-F72C015AE5C4,TCGA-CS-6186-01A-12D-2022-02,HG19_Broad_variant,TCGA-CS-6186,TCGA-LGG,538,Thomas Jefferson University,United States,Not available,Not available,Oligoastrocytoma,Not available,2022-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c810,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A2G0-01A,6F661F0D-F08B-486E-8BD7-4306E1593EB9,Uterus,70,134CD317-CBEB-4633-B540-B639454615F7,DF417E78-8258-40C2-8305-2FE14DCC8035,TCGA-D1-A2G0-01A-11D-A17E-02,HG19_Broad_variant,TCGA-D1-A2G0,TCGA-UCEC,NA,Mayo Clinic,United States,Not available,Not available,Mixed serous and endometrioid,Not available,A17E-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c77e,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-CS-5396-01A,B6C2C9BD-625B-4A98-830C-49C344F6CB5F,Brain,53,CE1ED4B3-AF89-4BBD-B9A6-EEFA007E4368,F2F5E5EE-B807-4CAF-99B3-68270C1F305E,TCGA-CS-5396-01A-02D-1465-02,HG19_Broad_variant,TCGA-CS-5396,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Oligodendroglioma,Not available,1465-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c8d6,1.92,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16B-01A,BCA1057A-1E96-404D-8A37-5A8DC1944EE7,Uterus,64,6A59FF6E-7CC6-4D46-8983-7D9E6A48CC19,D581BCAA-4EA7-4364-840B-E2D24F1916E4,TCGA-D1-A16B-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16B,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c8ce,1.92,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16Q-01A,7F4F3AED-69AF-421E-817B-B258DCC0BAC5,Uterus,54,BFE3DA05-506E-4837-AC72-A285FE079C58,23DF790A-0AB3-4EFB-AD9D-62AF1B79D941,TCGA-D1-A16Q-01A-12D-A12F-02,HG19_Broad_variant,TCGA-D1-A16Q,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,9
13722.58cfa831e4b0c9d6adf6c9da,2,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,TCGA-DJ-A13T-01A,0B170ED4-D919-466B-B765-47878B865AED,Thyroid,37,6883BA87-9184-40D7-840B-603B15D73F7A,76DCBA6C-0992-44BB-9492-3023A2430CC4,TCGA-DJ-A13T-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13T,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,16
13722.58cfa831e4b0c9d6adf6c96a,1.98,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QI-01A,3B1E2BD6-3D32-40F7-9B32-0DF32DFCBC72,Thyroid,63,C58506A1-8C6B-4CE8-99E0-F2D1234F95F5,3C049586-BD3C-490D-93DB-E344BD6A1AE8,TCGA-DJ-A1QI-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QI,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage II,A14U-02,TRUE,8
13722.58cfa831e4b0c9d6adf6ca37,1.9,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,TCGA-DB-5279-01A,85F77526-791E-47CD-904D-D1DBB49EAEAB,Brain,59,0096C7FB-34E3-4D0F-BA81-3559CC00080A,109052DB-CACF-4E14-8258-500E90B6B476,TCGA-DB-5279-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5279,TCGA-LGG,NA,Mayo Clinic - Rochester,United States,Not available,Not available,Oligodendroglioma,Not available,1465-02,TRUE,7
13722.58cfa831e4b0c9d6adf6ca54,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DB-5280-01A,4797C600-F024-42FE-B287-D919B24DCB79,Brain,43,D9B929FD-335C-46B1-B60D-B846C372AA6A,677B8F71-325E-49F9-B3D7-B6ADB6831ED5,TCGA-DB-5280-01A-01D-1465-02,HG19_Broad_variant,TCGA-DB-5280,TCGA-LGG,NA,Mayo Clinic - Rochester,United States,Not available,Not available,Oligoastrocytoma,Not available,1465-02,TRUE,7
13722.58cfa831e4b0c9d6adf6ca7c,1.95,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13X-01A,3B3C99AB-5336-4433-B682-E1A590221611,Thyroid,51,AC52BED3-FDD6-4281-89DE-D2F125BA038E,3E92A45C-FFFB-4C07-BD81-DB3EBF41841F,TCGA-DJ-A13X-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13X,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A10R-02,TRUE,14
13722.58cfa831e4b0c9d6adf6caaa,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-D1-A16D-01A,5693302A-4548-4C0B-8725-0CB7C67BC4F8,Uterus,49,007BDFD3-81B6-42C3-A4A6-C4DDAF1BE0AE,DCA0D1DE-E9A0-45CF-B709-A492D513C1C4,TCGA-D1-A16D-01A-11D-A12F-02,HG19_Broad_variant,TCGA-D1-A16D,TCGA-UCEC,NA,Mayo Clinic,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A12F-02,TRUE,22
13722.58cfa831e4b0c9d6adf6c9dc,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6392-01A,FCD9E1C4-BDDB-4856-844C-03DF48FBA499,Brain,35,14780BB2-67A9-4ACA-BCE4-12793FB1808E,E7B36F2D-9AB1-4A46-B669-65367B841752,TCGA-DU-6392-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6392,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,8
13722.58cfa831e4b0c9d6adf6caf0,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7006-01A,215E117C-4D76-463C-8F8A-FD6A28D23929,Brain,60,21E471E0-6B87-4D98-A7E0-DE0F34598460,FDA752F3-371F-460B-8D81-216E0AC53B0E,TCGA-DU-7006-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7006,TCGA-LGG,349,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cad6,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6408-01A,14375753-A69F-41E0-B910-2BB8E84CC43A,Brain,23,F68159AD-A0E9-4F9F-AD68-A29D53772982,57952871-E6FE-4C1F-87FE-404FADFC67C1,TCGA-DU-6408-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6408,TCGA-LGG,3470,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,1703-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cc15,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7290-01A,E00A9855-C15E-46EF-988F-25CA64EC4717,Brain,45,942B676C-CCFD-4005-A564-C48F558D5D3B,9A452E24-A4D1-4229-9256-6A30800A5DDF,TCGA-DU-7290-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7290,TCGA-LGG,315,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,9
13722.58cfa831e4b0c9d6adf6cc7c,1.91,Alive,MALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1CU-01A,4E80F403-0E10-4725-854D-F023C12EE1E2,Thyroid,31,C285C3AC-26D7-4481-BAAF-769F49AED55A,A9886789-6859-4FC9-812A-D9813FD1C20D,TCGA-EM-A1CU-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CU,TCGA-THCA,NA,University Health Network,Canada,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,19
13722.58cfa831e4b0c9d6adf6ccd0,1.87,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1YA-01A,567E4D90-5C5A-44F0-A462-90C831F3C096,Thyroid,74,D0880877-36CF-4DED-87B2-898C3446F90D,D1BD818E-62BF-4375-A171-ED388341014F,TCGA-EM-A1YA-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YA,TCGA-THCA,NA,University Health Network,Canada,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14U-02,TRUE,23
13722.58cfa831e4b0c9d6adf6cd3c,1.96,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25M-01A,8023D4C9-B56D-417A-9A52-D45B59C756ED,Thyroid,33,0C601625-ED21-47E5-BC3D-A0057D6A148F,7DE80DCB-BBFD-4D87-AD80-EE29258EFFD1,TCGA-ET-A25M-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25M,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,10
13722.58cfa831e4b0c9d6adf6cdc0,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-FI-A2CY-01A,B9AB4AB9-BA9C-4A01-9F61-55C82B924936,Uterus,60,047B688C-AA29-4A63-B555-9275AF4B0CEE,4BCC9DA0-4F58-4BB8-B660-D8591AD1CE18,TCGA-FI-A2CY-01A-11D-A17E-02,HG19_Broad_variant,TCGA-FI-A2CY,TCGA-UCEC,NA,Washington University,United States,Not available,Not available,Mixed serous and endometrioid,Not available,A17E-02,TRUE,12
13722.58cfa831e4b0c9d6adf6cdab,2.14,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A234-01A,E4C85BDD-7B7C-414F-9503-647D9B825915,Thyroid,26,8765B072-83E1-40B2-B1C9-15F38D799FC3,D4A41A96-02D5-455E-BB12-7225EBEA15A5,TCGA-FE-A234-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A234,TCGA-THCA,NA,Ohio State University,United States,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,13
13722.58cfa832e4b0c9d6adf6cea0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A2NF-01A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Skin,53,52EDD1DB-F1C3-4B87-B959-B5B095E52463,DB2D94A9-5B22-4163-AE7A-1DA11F7037A6,TCGA-ER-A2NF-01A-11D-A18Z-02,HG19_Broad_variant,TCGA-ER-A2NF,TCGA-SKCM,NA,University of Pittsburgh,None,T4b,N3,Not available,Stage IIIC,A18Z-02,TRUE,13
13722.58cfa832e4b0c9d6adf6cf3d,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6378-01A,12F225D0-CBFF-44EB-9183-BACC7F33B090,Prostate,54,940BBB5C-7280-41ED-9332-47C2072AE072,CA3B6408-29B5-4DB1-A56D-7B47F966177D,TCGA-G9-6378-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6378,TCGA-PRAD,NA,Roswell Park,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,8
13722.58cfa832e4b0c9d6adf6cfb6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6342-01A,00E41E6A-9FE7-44F9-978B-7B05B179506A,Prostate,61,2C85548B-D1FD-4FC8-9908-60205A42E080,0C765D21-A6AE-4FE8-9B80-7DEBA8459E76,TCGA-G9-6342-01A-11D-1957-02,HG19_Broad_variant,TCGA-G9-6342,TCGA-PRAD,NA,Roswell Park,United States,T3a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,7
13722.58cfa832e4b0c9d6adf6cfea,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6494-01A,0C459149-0DFE-4206-B50B-DB79180EBB57,Prostate,66,45DB5303-BBAB-4F8C-A2A2-9A9A9BFA2FD1,5BCBE988-68F6-48D0-8F2A-B34369A5FBB9,TCGA-G9-6494-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6494,TCGA-PRAD,NA,Roswell Park,United States,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,6
13722.58cfa832e4b0c9d6adf6cfc0,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-GF-A2C7-01A,285D8E2C-F183-49D5-BC1C-FD47C6670ACC,Skin,48,053CAF96-E851-401D-A5CC-214DBA82FE05,12E86E5E-AA64-4E6F-B5BC-846DDCBF4A64,TCGA-GF-A2C7-01A-11D-A18Y-02,HG19_Broad_variant,TCGA-GF-A2C7,TCGA-SKCM,NA,ABS - IUPUI,United States,T4b,N0,Not available,Stage IIC,A18Y-02,TRUE,20
13722.58cfa832e4b0c9d6adf6d20e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7468-01A,E6C55BA6-4C8A-4EA4-8DDE-74D01915DB02,Brain,30,D2775F99-CC96-4C72-94FF-E3BA985DC151,143CEFE3-F477-4CDE-AEA6-CE0610835570,TCGA-HT-7468-01A-11D-2022-02,HG19_Broad_variant,TCGA-HT-7468,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligodendroglioma,Not available,2022-02,TRUE,5
13722.58cfa832e4b0c9d6adf6d18e,NA,Dead,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-FI-A2D4-01A,490AE247-EE67-48D4-94ED-93DF5B9BBEFE,Uterus,44,A8393121-29DF-4525-BF4F-FCE0DEAF25F5,6DA2AADF-7B34-4F4F-93E4-0963248B3DEB,TCGA-FI-A2D4-01A-12D-A17E-02,HG19_Broad_variant,TCGA-FI-A2D4,TCGA-UCEC,243,Washington University,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A17E-02,TRUE,23
13722.58cfa82ee4b0c9d6adf6ae74,1.9,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4402-01A,722D6818-F1CB-49F4-B68A-FD0A31304681,Lung,57,07C1FCE4-EC48-47A4-8391-E553936B67F2,5E791B10-E5FD-412D-9F42-72CAC197F253,TCGA-05-4402-01A-01D-1203-02,GRCh37,TCGA-05-4402,TCGA-LUAD,244,Indivumed,Germany,T2,NX,Lung Adenocarcinoma Mixed Subtype,Stage IV,1203-02,TRUE,11
13722.58cfa82ee4b0c9d6adf6ae68,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4403-01A,CE15F31F-2BAD-4485-96FA-495BFA262E66,Lung,76,44B1D21C-0794-428C-BA01-82812D74DA2F,48F1FF7F-84F4-4420-96F9-DA1917577B6D,TCGA-05-4403-01A-01D-1203-02,GRCh37,TCGA-05-4403,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1203-02,TRUE,8
13722.58cfa82ee4b0c9d6adf6afe6,1.9,Dead,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4434-01A,D94FE32F-BEDD-4F4C-9FEB-FCB60D40F4BB,Lung,67,7A03048B-58B6-4CAE-B143-81C0A4977AC6,8A64C790-988A-4B51-8E5F-B4F746F2D9EB,TCGA-05-4434-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4434,TCGA-LUAD,457,Indivumed,Germany,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IV,1203-02,TRUE,11
13722.58cfa82fe4b0c9d6adf6b624,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-5146-01A,1D276B62-5E64-48FB-B2CE-5192B511FE37,Lung,NA,373C5231-B6AE-49DB-AC0D-D674A0C9C100,2578C781-0BDF-4CA2-A8FA-8B624489818B,TCGA-75-5146-01A-01D-1623-02,HG19_Broad_variant,TCGA-75-5146,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1623-02,TRUE,7
13722.58cfa82fe4b0c9d6adf6b617,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-35-4122-01A,44ADF4CB-2829-4153-80FD-A8B7EE0E654A,Lung,69,587F8383-3A48-49AF-8AC4-D86E6009C96B,DD8A0F54-0311-49FB-B270-ABF1AE9B56A5,TCGA-35-4122-01A-01D-1103-02,HG19_Broad_variant,TCGA-35-4122,TCGA-LUAD,NA,Cureline,Russia,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1103-02,TRUE,37
13722.58cfa82fe4b0c9d6adf6b67d,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4486-01A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Lung,72,5AE9B10F-347C-48C3-90CD-9290055CFE4B,EC0EE49C-D1D4-490D-BA82-CFAE6D451B8D,TCGA-49-4486-01A-01D-1203-02,GRCh37,TCGA-49-4486,TCGA-LUAD,2318,Johns Hopkins,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1203-02,TRUE,5
13722.58cfa82fe4b0c9d6adf6b726,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-5147-01A,D2824E6D-3784-45C2-9B0F-52B17356B5DA,Lung,NA,F9F9C1DD-8462-4560-82B8-AEA4309854C9,1291FD50-F1A9-4A2A-A2FD-2320ED01FB4E,TCGA-75-5147-01A-01D-1623-02,HG19_Broad_variant,TCGA-75-5147,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1623-02,TRUE,10
13722.58cfa82fe4b0c9d6adf6b7b0,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4494-01A,C6D78E27-E510-4F57-ABAE-19EFA6105A8D,Lung,77,7CA68089-C61F-4D31-8CC8-FB11AE70910A,8DF0AEB4-1455-4760-A230-54FE1551D08C,TCGA-49-4494-01A-01D-1203-02,GRCh37,TCGA-49-4494,TCGA-LUAD,1081,Johns Hopkins,United States,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1203-02,TRUE,7
13722.58cfa82fe4b0c9d6adf6b7d4,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-3919-01A,66ED89F6-8BA2-49D0-AF0F-4B6EBF2381BF,Lung,71,9DE8D353-3442-41D8-8BFE-A08C4975EACA,9C982400-B6C3-4D00-9981-BA06775FEF4F,TCGA-44-3919-01A-02D-1103-02,HG19_Broad_variant,TCGA-44-3919,TCGA-LUAD,NA,Christiana Healthcare,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1103-02,TRUE,47
13722.58cfa82fe4b0c9d6adf6b840,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2679-01A,0F74D992-00DA-4728-9564-086CA1B95921,Colorectal,73,1FCB9C83-18CB-42A4-8769-FDDB3541C95D,118D83B1-3464-40E3-8A77-270650CFED42,TCGA-A6-2679-01A-02D-1405-02,HG18,TCGA-A6-2679,TCGA-COAD,NA,Christiana Healthcare,None,T3,N0,Colon Adenocarcinoma,Stage IIB,1405-02,TRUE,33
13722.58cfa82fe4b0c9d6adf6b842,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2674-01A,57CDAA1C-4E94-4A28-AB3B-300C0457555F,Colorectal,71,8ACA008C-F55A-420A-82C7-ACD2CCA77D85,9FDFC199-B878-4049-994E-B5CA384678FB,TCGA-A6-2674-01A-02D-1167-02,HG18,TCGA-A6-2674,TCGA-COAD,NA,Christiana Healthcare,None,T3,N2,Colon Mucinous Adenocarcinoma,Stage IV,1167-02,TRUE,38
13722.58cfa82fe4b0c9d6adf6b8e8,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3510-01A,35C295C2-37D1-44B2-87A3-1039645E5BAE,Colorectal,70,C71C031C-3089-44E5-A49F-5284D7D300CE,DA2A173C-BBD3-4A90-8D1D-CD35CBE750F3,TCGA-AA-3510-01A-01D-1405-02,HG18,TCGA-AA-3510,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,1405-02,TRUE,19
13722.58cfa82fe4b0c9d6adf6b8b8,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-73-4675-01A,AE39E358-08D7-4367-AE68-82B469E791E4,Lung,59,1F5FA8FD-1DE8-4456-8935-71B5A8B54BD2,356D01E0-DF80-40C6-BA06-8CD4EDFBD1EC,TCGA-73-4675-01A-01D-1203-02,GRCh37,TCGA-73-4675,TCGA-LUAD,NA,Roswell Park,United States,T3,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1203-02,TRUE,9
13722.58cfa82fe4b0c9d6adf6b898,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2676-01A,89A6384E-1CEA-440B-9F17-D57CB0805174,Colorectal,75,CBBD1187-E8F7-4E63-A8E2-3C19863E89F5,D02407DB-AECE-475A-AA3F-00653B1E7BEE,TCGA-A6-2676-01A-01D-1167-02,HG18_Broad_variant,TCGA-A6-2676,TCGA-COAD,NA,Christiana Healthcare,None,T4,N0,Colon Adenocarcinoma,Stage IIB,1167-02,TRUE,23
13722.58cfa82fe4b0c9d6adf6b914,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4505-01A,088EDF89-D2B5-40C7-B066-DF3BD383F7EA,Lung,61,D1FB0862-8D9C-4BC4-AAC6-81DC4EED66C9,30B77A0C-3439-44E2-A586-5DF68C0D0002,TCGA-49-4505-01A-01D-1203-02,GRCh37,TCGA-49-4505,TCGA-LUAD,428,Johns Hopkins,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1203-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b89a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-2683-01A,FAFD4576-0709-49E1-926F-AD1EE09907EC,Colorectal,57,C24759F8-566B-42DA-A26D-BB0BF51EE15F,B22E3766-3FC6-4E77-86D0-0A10A810D313,TCGA-A6-2683-01A-01D-1167-02,HG18,TCGA-A6-2683,TCGA-COAD,NA,Christiana Healthcare,None,T4,N0,Colon Adenocarcinoma,Stage IV,1167-02,TRUE,15
13722.58cfa82fe4b0c9d6adf6b960,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3558-01A,A56D528B-238A-4556-92C8-7645304A2DA0,Colorectal,70,B0ACDAFA-A75C-48B9-812D-3FB449157F8B,B1AEDAAD-A964-4D7E-A641-F05AC4F174F2,TCGA-AA-3558-01A-01D-1167-02,HG18,TCGA-AA-3558,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,1167-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b974,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3675-01A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Colorectal,84,A4CE3727-4506-493B-95F4-2F11CEB09CEB,D611373E-EF0A-46E4-8D3E-0722F221E828,TCGA-AA-3675-01A-02D-1109-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,1109-02,TRUE,19
13722.58cfa82fe4b0c9d6adf6b940,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-3808-01A,4F9775F2-B663-4DAF-AA9E-50915CAE9407,Colorectal,73,037BA047-2228-43DE-8DF8-32920A689ECA,2B2625B5-FBDD-41C3-9BB3-71566C5FBBA4,TCGA-A6-3808-01A-01D-1167-02,HG18,TCGA-A6-3808,TCGA-COAD,NA,Christiana Healthcare,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1167-02,TRUE,20
13722.58cfa82fe4b0c9d6adf6b98e,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-50-5944-01A,1C339545-C08A-4A77-B8E9-A7E49E53853F,Lung,69,BF8FDF82-62B4-4B5D-93E7-CE153576FE49,71CD46A8-30B0-4452-860D-3ED173C461A7,TCGA-50-5944-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5944,TCGA-LUAD,NA,University of Pittsburgh,United States,T1,N0,Lung Acinar Adenocarcinoma,Stage IA,1751-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b9ca,1.72,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A00U-01A,091E3084-04EE-4497-893C-D46226DEC78F,Colorectal,50,2FC854D7-4F80-4C39-BD92-397E94FEE4A0,6765593B-17DC-4B0F-A20B-7F0FF67DFF64,TCGA-AA-A00U-01A-01D-A077-02,HG18,TCGA-AA-A00U,TCGA-COAD,NA,Indivumed,Germany,T3,N1,Colon Adenocarcinoma,Stage IIIB,A077-02,TRUE,11
13722.58cfa82fe4b0c9d6adf6b9d8,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3947-01A,654C6F5C-3E5C-49F0-B53F-87CD9797D7C9,Colorectal,60,5241539D-65AC-434D-8EAA-AE57F702C8CE,EE2FCBCE-108F-46EC-8C7A-12D34142820A,TCGA-AA-3947-01A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3947,TCGA-COAD,NA,Indivumed,Germany,T4,N0,Colon Mucinous Adenocarcinoma,Stage IIB,1167-02,TRUE,56
13722.58cfa82fe4b0c9d6adf6b9fe,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3968-01A,CAB7BDBC-0A11-4901-97C3-26B884F79CB5,Colorectal,55,E950BC59-116F-4366-8524-F0731B1C9A3D,193F15A1-6BE4-4992-AC6E-EF34CBB3B57A,TCGA-AA-3968-01A-01D-1167-02,HG18,TCGA-AA-3968,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,1167-02,TRUE,11
13722.58cfa830e4b0c9d6adf6ba6e,1.79,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01D-01A,E2EDBF3F-25D8-49AA-B656-2A59C3B99AEB,Colorectal,47,082DEF2F-4D99-4270-83E7-5A9A5C049C23,5BF3D0AB-D301-4EE7-84A1-83F596C29E6E,TCGA-AA-A01D-01A-01D-A077-02,HG18,TCGA-AA-A01D,TCGA-COAD,NA,Indivumed,Germany,T3,N2,Colon Mucinous Adenocarcinoma,Stage IIIC,A077-02,TRUE,15
13722.58cfa830e4b0c9d6adf6ba56,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3966-01A,BC42FE2D-1A33-428D-A601-B1871F4C8D9B,Colorectal,89,8C5799BF-DB65-40F6-9A67-ABD4DA4025F2,F1E05BF6-0B98-45F8-9F97-10ABE5957C99,TCGA-AA-3966-01A-01D-1109-02,HG18,TCGA-AA-3966,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Mucinous Adenocarcinoma,Stage IIA,1109-02,TRUE,20
13722.58cfa830e4b0c9d6adf6ba50,1.9,Dead,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A02K-01A,10881458-55B2-41D1-8358-4EE6CCB8EC85,Colorectal,50,685DF015-1B7B-4993-BF05-E3206619DFBA,7CC17F3D-27F5-484A-8E22-C9D0B5B27836,TCGA-AA-A02K-01A-21D-A079-02,HG18_Broad_variant,TCGA-AA-A02K,TCGA-COAD,426,Indivumed,Germany,T4,N2,Colon Adenocarcinoma,Stage IV,A079-02,TRUE,37
13722.58cfa830e4b0c9d6adf6bb0a,2.08,Alive,FEMALE,WHITE,HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0R6-01A,39609D3C-F5D3-4BC4-B356-1403C6DD1CB5,Uterus,64,836BD487-091B-4728-BCD7-8065E5B76465,FBE6A365-A19A-42F1-9198-63549F77CD9B,TCGA-A5-A0R6-01A-11D-A101-02,HG19_Broad_variant,TCGA-A5-A0R6,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A101-02,TRUE,22
13722.58cfa830e4b0c9d6adf6ba7c,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3509-01A,80E677B1-5EBE-4069-A1A5-1538FFEE6642,Colorectal,54,BA6E3333-3651-450E-A6EA-4E47CF0D18BF,ACCC21A8-D026-40E4-AA2C-C0F998A1D370,TCGA-AA-3509-01A-01D-1405-02,HG18,TCGA-AA-3509,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,1405-02,TRUE,37
13722.58cfa830e4b0c9d6adf6bac2,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4501-01A,0780EB43-D5B5-4C3D-9825-BEACBA5CC723,Lung,67,FC511A67-5383-4877-AEEF-36C0B7934B77,FA521F2B-4BB1-4A15-9101-422B2B65489A,TCGA-49-4501-01A-01D-1203-02,GRCh37,TCGA-49-4501,TCGA-LUAD,1421,Johns Hopkins,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1203-02,TRUE,4
13722.58cfa830e4b0c9d6adf6bb40,1.77,Dead,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A02R-01A,764C97C9-01D3-45CB-86BD-F8A52B5468DA,Colorectal,84,197245F6-A310-4AF4-9231-0AFEFC547ECD,A803F2CD-F90D-4E51-8D90-1E6AF6897413,TCGA-AA-A02R-01A-01D-A077-02,HG18,TCGA-AA-A02R,TCGA-COAD,670,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage IIA,A077-02,TRUE,27
13722.58cfa830e4b0c9d6adf6bb48,1.91,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A02Y-01A,A435FDF4-A89A-499E-9006-CBB5693EAB26,Colorectal,73,8537633B-6426-4B66-A2A3-FA942EEDF01B,CD188DB1-ED81-42A6-B550-07D4008143EE,TCGA-AA-A02Y-01A-43D-A079-02,HG18,TCGA-AA-A02Y,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,A079-02,TRUE,21
13722.58cfa830e4b0c9d6adf6bba5,1.78,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A02W-01A,73448B56-A6C6-4C98-A153-AB704261E073,Colorectal,73,B0F0EA02-B1DA-4613-A9B0-D18A07910010,4D2B2573-105C-4770-B8CF-9243B6D709EC,TCGA-AA-A02W-01A-01D-A077-02,HG18_Broad_variant,TCGA-AA-A02W,TCGA-COAD,NA,Indivumed,Germany,T2,N0,Colon Adenocarcinoma,Stage I,A077-02,TRUE,18
13722.58cfa830e4b0c9d6adf6bb5c,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3675-01A,41658CF8-0DE1-4A97-BB60-0F0107C84E00,Colorectal,84,A4CE3727-4506-493B-95F4-2F11CEB09CEB,42AD4E5A-8E58-47EC-9D1F-F65D5C22DA49,TCGA-AA-3675-01A-02D-1167-02,HG18,TCGA-AA-3675,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,1167-02,TRUE,8
13722.58cfa830e4b0c9d6adf6bbac,2.11,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A02O-01A,6FA41234-9077-4D05-A295-6820F3BEDF5B,Colorectal,82,2151DC9E-F76A-4CFF-8A20-B7C107D59C27,519A6BBF-68D8-4275-854A-5216FC4DFD15,TCGA-AA-A02O-01A-21D-A079-02,HG18,TCGA-AA-A02O,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,A079-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bb88,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3956-01A,7B47489F-C3CC-4388-B5D7-C7C02790A5F6,Colorectal,65,DC1FFDA5-5B8F-4227-BE04-321643F73731,63EEF7A5-A1CC-4BB6-BA02-464D2DE89E2A,TCGA-AA-3956-01A-02D-1167-02,HG18,TCGA-AA-3956,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage IIA,1167-02,TRUE,18
13722.58cfa830e4b0c9d6adf6bc1e,2.07,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A01Y-01A,A91F7A8C-E0FE-403A-9EF0-F7679B2761CC,Colorectal,49,28B76ABF-6A5F-4D3B-87FE-18EA7139DEDF,D295156A-3A31-4540-B295-0B620340E4DB,TCGA-AG-A01Y-01A-41D-A079-02,HG18,TCGA-AG-A01Y,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage II,A079-02,TRUE,17
13722.58cfa830e4b0c9d6adf6bc2a,1.9,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3994-01A,750770DB-53CF-4021-A8C2-5E0DDB97FEF5,Colorectal,69,41933A62-1325-4089-80B5-06E3EBB238DA,FED1DBB6-D332-4239-A878-8587A7CE4D05,TCGA-AA-3994-01A-01D-1109-02,HG18,TCGA-AA-3994,TCGA-COAD,NA,Indivumed,Germany,T3,N1,Colon Mucinous Adenocarcinoma,Stage IIIB,1109-02,TRUE,20
13722.58cfa830e4b0c9d6adf6bc38,1.64,Alive,MALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-A01C-01A,80809D79-92E1-4D6C-BA2E-0A9589997792,Colorectal,75,1E191EED-2238-450E-A384-26DF9C569FD0,77F9EF43-7202-4C9B-9556-F00F0A66D2D4,TCGA-AA-A01C-01A-01D-A077-02,HG18,TCGA-AA-A01C,TCGA-COAD,NA,Indivumed,Germany,T2,N1,Colon Adenocarcinoma,Stage IIIA,A077-02,TRUE,8
13722.58cfa830e4b0c9d6adf6bc26,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-3810-01A,B728E6E8-A0E4-496B-904C-6F07C12E901F,Colorectal,62,F2BD44D3-A53C-4A10-9AE1-A93E762F174C,AD4275F1-789D-471C-88DD-B6E76069D856,TCGA-A6-3810-01A-01D-1167-02,HG18,TCGA-A6-3810,TCGA-COAD,NA,Christiana Healthcare,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1167-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc22,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3727-01A,E6827400-0D95-46B0-8874-6CE9E9D5011B,Colorectal,78,DA1CA84F-6C55-4536-9449-3C87E51EF85A,D8361FC2-8AB1-4D36-9009-237D905CF899,TCGA-AG-3727-01A-01D-1167-02,HG18_Broad_variant,TCGA-AG-3727,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage III,1167-02,TRUE,59
13722.58cfa830e4b0c9d6adf6bcc4,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4313-01A,1FD75C4D-E74C-410C-A150-814722C6C1CC,Colorectal,51,475F161C-2F7F-43A2-B187-DE6038752F39,F64D4985-D460-435C-8EC0-477D313A895A,TCGA-AZ-4313-01A-01D-1405-02,HG18,TCGA-AZ-4313,TCGA-COAD,NA,University of Pittsburgh,None,T1,N0,Colon Adenocarcinoma,Stage I,1405-02,TRUE,46
13722.58cfa830e4b0c9d6adf6bd5d,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3516-01A,D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8,Colorectal,74,4E4F7BEC-56AF-4888-B40B-A33218B010E8,3F9A934E-C9BE-4A5F-A1F5-EB51BED8DCDD,TCGA-AA-3516-01A-02D-1167-02,HG18,TCGA-AA-3516,TCGA-COAD,NA,Indivumed,Germany,T3,N2,Colon Mucinous Adenocarcinoma,Stage III,1167-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bcda,1.9,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3574-01A,0EDA7373-8335-455F-B90A-8C3540F28088,Colorectal,89,DA897A5D-B2CC-419F-ACD7-473B4928C5D5,5DAA6B90-B302-4B0E-A44B-0A6D3159DACE,TCGA-AG-3574-01A-01D-1167-02,HG18,TCGA-AG-3574,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage II,1167-02,TRUE,18
13722.58cfa830e4b0c9d6adf6bde2,1.78,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A01N-01A,1118490D-75AA-43CC-B2A2-C2AF61829FFC,Colorectal,68,0350E0DE-7B86-485A-A057-50E77D899ED9,49977602-A81B-4DDD-9354-8949BC3208CF,TCGA-AG-A01N-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A01N,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage IV,A077-02,TRUE,30
13722.58cfa830e4b0c9d6adf6bcc8,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3582-01A,DB1E3104-8BFD-4353-854A-C478BA1F7D07,Colorectal,75,1B1EF856-EA45-4857-8B4B-C4330FA930D8,CA0DD61C-D4F2-4ED9-91EF-11F7B1BE15AF,TCGA-AG-3582-01A-01D-1167-02,HG18_Broad_variant,TCGA-AG-3582,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IV,1167-02,TRUE,42
13722.58cfa830e4b0c9d6adf6bdf5,2,Alive,FEMALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A01W-01A,74543FA4-CE73-46E4-9C59-224E8242B4A2,Colorectal,67,C481ABBB-21EB-4393-AB8D-C27E3DA1B8F7,BC3C3340-5E36-4754-AF22-F08EF550BD07,TCGA-AG-A01W-01A-21D-A079-02,HG18,TCGA-AG-A01W,TCGA-READ,NA,Indivumed,Germany,T3,N0,Rectal Adenocarcinoma,Stage II,A079-02,TRUE,23
13722.58cfa830e4b0c9d6adf6be18,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4615-01A,BF69A4CE-EC7E-4752-A86D-DCC80E3C9A57,Colorectal,84,89811300-8202-4A82-8353-5B2B2B2ECFD4,90D11094-F492-4B05-81AB-E637AEC8F953,TCGA-AZ-4615-01A-01D-1405-02,HG18,TCGA-AZ-4615,TCGA-COAD,NA,University of Pittsburgh,None,T3,N1,Colon Adenocarcinoma,Stage IIIB,1405-02,TRUE,47
13722.58cfa830e4b0c9d6adf6bd00,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,TCGA-AF-2692-01A,71A32FCA-D48F-4EA3-8DF7-69F9DDA8FA91,Colorectal,54,3CA7589A-E887-4DA2-8D59-19FE5963AC21,CC1B3C2A-43B7-43CB-85F8-383A3C255D4B,TCGA-AF-2692-01A-01D-1167-02,HG18,TCGA-AF-2692,TCGA-READ,NA,Christiana Healthcare,United States,T3,N0,Not available,Stage IIA,1167-02,TRUE,9
13722.58cfa830e4b0c9d6adf6c11a,1.91,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TE-01A,09066FBF-6A1D-46C9-A4C5-C53340C3D1BA,Uterus,35,2D1226A1-1C88-422B-9A8D-316BEBEB65FD,250BF272-4CCD-41DB-ABD1-4FE2E304AB21,TCGA-BS-A0TE-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TE,TCGA-UCEC,146,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c147,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-B7-5818-01A,6E03B415-84A1-4B91-8717-1A41EDD4A255,Stomach,62,FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166,0EBF1A63-C6E4-49FE-B21B-AE46FF14261D,TCGA-B7-5818-01A-11D-1598-02,HG19_Broad_variant,TCGA-B7-5818,TCGA-STAD,NA,Cureline,Russia,T2,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IB,1598-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c124,1.87,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TC-01A,7B7D2D2B-ABE6-4F32-ADD0-3715096995D1,Uterus,69,C4C99327-B778-4E29-A111-75569AD38696,99E19D8C-EC6E-45D7-89E5-091D101BF466,TCGA-BS-A0TC-01A-11D-A101-02,HG19_Broad_variant,TCGA-BS-A0TC,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,10
13722.58cfa830e4b0c9d6adf6c170,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0TG-01A,13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75,Uterus,60,36E44603-A1EE-4A5B-9506-49A9358BF8D0,FABEC5F4-2EF2-41CB-A728-E21D6C49F3F7,TCGA-BS-A0TG-01A-32D-A101-02,HG19_Broad_variant,TCGA-BS-A0TG,TCGA-UCEC,NA,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,6
13722.58cfa830e4b0c9d6adf6c172,1.93,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BS-A0U7-01A,282DDC43-922D-4F1F-80C7-6BA2DE23B7BC,Uterus,63,803C6D51-0EBA-475A-9C3C-7B3401787907,652088F1-AB84-40C7-8B24-FD92A32DFA44,TCGA-BS-A0U7-01A-21D-A101-02,HG19_Broad_variant,TCGA-BS-A0U7,TCGA-UCEC,935,University of Hawaii,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa830e4b0c9d6adf6c1a1,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-B7-5816-01A,F07070C0-FD0A-4C19-BA1E-5F06B933CD7C,Stomach,51,1B4B19C1-75A6-4434-831E-ADCE44C54EB5,52F84358-E1B4-4837-8C3D-9B4E8DDB4FAB,TCGA-B7-5816-01A-21D-1598-02,HG19_Broad_variant,TCGA-B7-5816,TCGA-STAD,NA,Cureline,Russia,T4a,N0,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB,1598-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c1bc,1.72,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-A01L-01A,848A5838-8A06-45A9-A3D6-E4ED47B824AB,Colorectal,58,B034C90B-D0BD-466A-88BA-B61EFD36C6E4,337F94D6-ECFB-4653-A63C-49F0D1893BF0,TCGA-AG-A01L-01A-01D-A077-02,HG18_Broad_variant,TCGA-AG-A01L,TCGA-READ,NA,Indivumed,Germany,T3,N1,Rectal Adenocarcinoma,Stage IIIB,A077-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bffa,1.9,Alive,MALE,Not available,Not available,Rectum Adenocarcinoma,TCGA-AG-3878-01A,FDEEFF8E-1328-42A4-ACA0-A03B97421F1E,Colorectal,64,D2F28259-87A7-4BD8-84BC-832E551C1ACE,8F233F73-550A-4708-9C2C-BEA9347969F7,TCGA-AG-3878-01A-02D-1167-02,HG18,TCGA-AG-3878,TCGA-READ,NA,Indivumed,Germany,T2,N0,Rectal Adenocarcinoma,Stage I,1167-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c28a,1.8,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Rectum Adenocarcinoma,TCGA-AF-3913-01A,03A9DD9D-62AE-4ACD-9272-389274858F3D,Colorectal,60,B01C6CD1-68DA-437F-90E4-9A645E8F3470,44A5F915-BADF-4521-8102-1B353E302E80,TCGA-AF-3913-01A-02D-1115-02,HG18,TCGA-AF-3913,TCGA-READ,316,Christiana Healthcare,None,T3,N1,Rectal Adenocarcinoma,Stage IV,1115-02,TRUE,36
13722.58cfa831e4b0c9d6adf6c42a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A2LA-01A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Bladder,54,6ED52558-8039-4658-A245-78A29968CE2F,D08FDC4F-83B0-4885-A8CF-45F72E5E6BD2,TCGA-BT-A2LA-01A-11D-A18D-02,HG19_Broad_variant,TCGA-BT-A2LA,TCGA-BLCA,NA,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A18D-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c4a6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZJ-01A,8877B479-B62A-4794-B71E-418DE96DFF23,Thyroid,36,C6D64D80-C8AA-494A-8C0E-8640BEEBDFC9,D54FCA2A-0B8E-4A33-8B52-3FBF0E47D799,TCGA-BJ-A0ZJ-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BJ-A0ZJ,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A10R-02,TRUE,28
13722.58cfa831e4b0c9d6adf6c46a,1.9,Alive,FEMALE,ASIAN,Not available,Colon Adenocarcinoma,TCGA-CA-5256-01A,17633A60-E12B-4A7C-BD8A-C16341DDC606,Colorectal,54,D4D5DEB6-6CFB-4E25-9824-8F7DC8D5B451,A8F8AAD6-F8C5-4133-A651-454C047A19D0,TCGA-CA-5256-01A-01D-1405-02,HG18,TCGA-CA-5256,TCGA-COAD,NA,ILSbio,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1405-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c5ab,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4462-01A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Stomach,72,D4F28131-D917-449B-95DC-DC6BA2EEE81B,8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC,TCGA-CG-4462-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,Indivumed,Germany,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c5ae,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4455-01A,8A173D98-20A1-4C84-86C1-97818E1C665A,Stomach,72,4622DF2E-9B9E-4B17-ADE3-A602B50B1288,AFA14A3A-5E6B-4CBE-B660-65AA53E9D10F,TCGA-CG-4455-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,Indivumed,Germany,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II,1154-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c524,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-CM-4744-01A,CC15469C-7BAD-4E86-9DA3-AE0C72E9D380,Colorectal,69,A545FB9A-C386-4A80-9A25-660DC4F62904,6D073A6F-FB7B-4ED2-BD24-5233E019D64A,TCGA-CM-4744-01A-01D-1405-02,HG18,TCGA-CM-4744,TCGA-COAD,NA,MSKCC,None,T2,N0,Colon Adenocarcinoma,Stage I,1405-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c5c2,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4462-01A,E9EA3687-0DB3-47F3-8099-B4FC054397F1,Stomach,72,D4F28131-D917-449B-95DC-DC6BA2EEE81B,8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC,TCGA-CG-4462-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4462,TCGA-STAD,0,Indivumed,Germany,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1154-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c64c,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4455-01A,8A173D98-20A1-4C84-86C1-97818E1C665A,Stomach,72,4622DF2E-9B9E-4B17-ADE3-A602B50B1288,AFA14A3A-5E6B-4CBE-B660-65AA53E9D10F,TCGA-CG-4455-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4455,TCGA-STAD,NA,Indivumed,Germany,T2b,N1,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II,1154-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c6d8,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4460-01A,3C3D4EF0-019A-423E-89B2-4AC5A7B567AB,Stomach,66,14FE3057-C82E-4D66-9798-BCD042CF64D6,1AE6944B-600D-40A8-ADD3-16F99982CDFE,TCGA-CG-4460-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4460,TCGA-STAD,669,Indivumed,Germany,T4,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1154-02,TRUE,11
13722.58cfa831e4b0c9d6adf6cda9,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-7636-01A,B342E980-8383-4F1B-BF57-4098C37A536C,Brain,48,BF70C0A6-CA2D-4355-B5BA-738094382E28,CE49A704-BECD-4A35-978B-4E21572CC5B2,TCGA-FG-7636-01A-11D-2088-02,HG19_Broad_variant,TCGA-FG-7636,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Astrocytoma,Not available,2088-02,FALSE,7
13722.58cfa831e4b0c9d6adf6cd65,2.05,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A232-01A,5EB0D577-223B-4409-89D1-5C5D196AFFC3,Thyroid,44,213BE6EE-1E61-4FA0-9B73-66B696086397,AD42DF5B-2665-4CA1-8049-943F684B6BFD,TCGA-FE-A232-01A-11D-A14U-02,HG19_Broad_variant,TCGA-FE-A232,TCGA-THCA,NA,Ohio State University,United States,T3,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,27
13722.58cfa832e4b0c9d6adf6ce2a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FN-7833-01A,5B9D7565-A933-449D-8FFA-EC5F82DB2E77,Brain,25,CF2E4A0A-59C5-41DA-9F24-DE83EEB856E5,1C69F8E8-7D70-4BD1-8B42-7E93DC23DA7B,TCGA-FN-7833-01A-11D-2088-02,HG19_Broad_variant,TCGA-FN-7833,TCGA-LGG,NA,International Genomics Consortium,United States,Not available,Not available,Oligoastrocytoma,Not available,2088-02,FALSE,4
13722.58cfa832e4b0c9d6adf6d2a8,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7604-01A,019C5DE9-74FD-48B7-95A3-227532E16C5A,Brain,50,9CA3488A-91F8-4EB2-8B03-24E8629757E1,31412731-7A51-4E73-BFC4-0098275D633B,TCGA-HT-7604-01A-11D-2088-02,HG19_Broad_variant,TCGA-HT-7604,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Astrocytoma,Not available,2088-02,FALSE,10
13722.58cfa832e4b0c9d6adf6d28b,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7601-01A,E7FDF164-A85D-4FF5-9676-D2215CA35403,Brain,30,7F6B5679-49E1-498D-BD1F-A757CD7DB4CC,5F766AF5-08F5-4E10-AAED-4B582275CFC1,TCGA-HT-7601-01A-11D-2088-02,HG19_Broad_variant,TCGA-HT-7601,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Astrocytoma,Not available,2088-02,FALSE,4
13722.58cfa82ee4b0c9d6adf6afc4,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4418-01A,D2C1E896-6886-4122-BB48-5FBCD3F641F4,Lung,69,C9E092B2-D6C3-4161-BD9E-0FA4015BEBBB,AA7559AC-F8C0-40E5-A313-3914A6E4559A,TCGA-05-4418-01A-01D-1203-02,GRCh37,TCGA-05-4418,TCGA-LUAD,274,Indivumed,Germany,T3,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,1203-02,TRUE,6
13722.58cfa82fe4b0c9d6adf6ba20,1.9,Alive,FEMALE,Not available,Not available,Colon Adenocarcinoma,TCGA-AA-3664-01A,A06C09A8-0951-49F4-A765-5147BBCAE109,Colorectal,74,D448668C-90F3-40FA-9961-88407090DA31,4B4C0EDF-1012-4A6A-B01E-CDEB130FF2E6,TCGA-AA-3664-01A-01D-1167-02,HG18_Broad_variant,TCGA-AA-3664,TCGA-COAD,NA,Indivumed,Germany,T3,N0,Colon Adenocarcinoma,Stage II,1167-02,TRUE,41
13722.58cfa830e4b0c9d6adf6bc00,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-A6-3807-01A,5116E3B4-2BAC-40F5-8046-B9C1783FAAA5,Colorectal,53,1EB2A255-6EDD-4ADB-B52D-99DCEC590C5D,3A4293C1-0860-42F9-9D64-26B7298C2CDB,TCGA-A6-3807-01A-01D-1167-02,HG18,TCGA-A6-3807,TCGA-COAD,NA,Christiana Healthcare,None,T3,N2,Colon Adenocarcinoma,Stage IIIC,1167-02,TRUE,34
13722.58cfa830e4b0c9d6adf6bca6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Colon Adenocarcinoma,TCGA-AZ-4315-01A,DE287A25-981D-49F8-81AF-FE0300E4CD31,Colorectal,61,BA9E5603-BB1D-4AA8-93E4-40043164F143,FBEA9F07-A969-4396-8A17-A269BF1F8A2A,TCGA-AZ-4315-01A-01D-1405-02,HG18,TCGA-AZ-4315,TCGA-COAD,NA,University of Pittsburgh,None,T3,N0,Colon Adenocarcinoma,Stage IIA,1405-02,TRUE,39
13722.58cfa82ee4b0c9d6adf6ae48,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4384-01A,9A50E7E4-831D-489F-87D2-979E987561CC,Lung,66,E4416303-50B0-4316-BFEE-030C7B29FAC6,5253B1A2-8C57-414A-8E19-6E8390A6C18D,TCGA-05-4384-01A-01D-1751-02,HG19_Broad_variant,TCGA-05-4384,TCGA-LUAD,NA,Indivumed,Germany,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,1751-02,TRUE,60
13722.58cfa82fe4b0c9d6adf6b7de,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5931-01A,12CCD581-A921-41BC-BCEE-4E9BE54532CC,Lung,75,16A2D381-75A0-423B-AAC2-D5710AFB183B,5EA8E18D-2D34-4C6E-A89D-36DE5E91E80C,TCGA-50-5931-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5931,TCGA-LUAD,434,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,23
13722.58cfa82fe4b0c9d6adf6b7fc,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-38-6178-01A,EDF80622-AEA2-4B50-BB69-691D6708AA83,Lung,70,81FB5FA9-D901-4FAA-B909-376B8676D2BC,DE9A3263-6ACD-4BBB-9F91-D4E7FCBEFA04,TCGA-38-6178-01A-11D-1751-02,HG19_Broad_variant,TCGA-38-6178,TCGA-LUAD,NA,UNC,United States,T2b,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1751-02,TRUE,35
13722.58cfa82fe4b0c9d6adf6b800,1.9,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-38-4632-01A,875333AB-9048-462D-AAA2-693AD127E3CC,Lung,42,D994817A-474E-4F92-8A78-7586CAA85D52,77D4D914-9C77-401B-BD71-9CF71A58DCE7,TCGA-38-4632-01A-01D-1751-02,HG19_Broad_variant,TCGA-38-4632,TCGA-LUAD,1357,UNC,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV,1751-02,TRUE,45
13722.58cfa82fe4b0c9d6adf6b756,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6835-01A,2F09479F-87FC-4C34-8E2C-333E970A3681,Lung,81,EFD3F14F-F785-4AEC-9EFD-6DD8E9C41EBA,A4DC40A6-EE0F-4637-937F-406F5FC8579F,TCGA-91-6835-01A-11D-1853-02,HG19_Broad_variant,TCGA-91-6835,TCGA-LUAD,NA,ABS - IUPUI,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1853-02,TRUE,16
13722.58cfa82fe4b0c9d6adf6b9e2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5815-01A,A65700C2-E58C-4FD4-AEB1-5686B8F4D212,Lung,74,4420AAE3-3F44-4852-974D-74F155B99FE4,7DC45930-978E-42B5-8ECB-942F3C6DA727,TCGA-64-5815-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5815,TCGA-LUAD,NA,Fox Chase,United States,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1623-02,TRUE,55
13722.58cfa830e4b0c9d6adf6bd86,2.11,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0LX-01A,AC1D3946-FE6C-4BD8-B02C-638799CB0F67,Uterus,57,99CDF3A0-90DC-4992-B75A-11DD41928D43,B294F25A-93D9-49A6-8FD3-6D2B0BBEF27C,TCGA-BG-A0LX-01A-11D-A043-02,HG19_Broad_variant,TCGA-BG-A0LX,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,24
13722.58cfa830e4b0c9d6adf6bdd6,2.08,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MC-01A,884FD57D-BD8E-40E7-82F6-0BA1C71101A9,Uterus,74,46B48BF8-346B-4F25-916E-26A3CDDFA00D,9376C8CD-BD9D-4576-BBE3-7D771914AFA3,TCGA-BG-A0MC-01A-21D-A043-02,HG19_Broad_variant,TCGA-BG-A0MC,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc5a,2,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LH-01A,7DCE4215-01F6-43E9-9378-9E22C26C23A2,Uterus,60,4C657AD4-2C53-4EA9-82B5-52996E74E3FF,FCA1C7F5-E456-4574-9716-79770E6DAE8C,TCGA-AP-A0LH-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LH,TCGA-UCEC,1106,MSKCC,None,Not available,Not available,Mixed serous and endometrioid,Not available,A043-02,TRUE,28
13722.58cfa830e4b0c9d6adf6bec7,2.09,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LJ-01A,B4A520AE-F259-48C8-823E-C10B9B8A133A,Uterus,42,BE3ED392-4D9F-4EAF-8A56-D251846DF4DA,2A88E054-E64F-4C5F-97F0-53F95D64FC04,TCGA-AP-A0LJ-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LJ,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,14
13722.58cfa830e4b0c9d6adf6be90,2,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BL-A13I-01A,EBC094A6-CDC9-4C02-B8EC-A181B25A364D,Bladder,57,62C2BA8F-02E3-4100-86BC-5958038B4983,7C09CFF3-3162-4952-93AD-8A7D89F07266,TCGA-BL-A13I-01A-11D-A13U-02,HG19_Broad_variant,TCGA-BL-A13I,TCGA-BLCA,223,Christiana Healthcare,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,19
13722.58cfa830e4b0c9d6adf6bef8,1.88,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A28W-01A,A6D37F61-BECA-46EA-A59A-62257475AC77,Thyroid,32,32AEF736-82A4-4813-A272-86EF160E7D56,229AD821-4BB0-4046-B5E6-6193005D3C8A,TCGA-BJ-A28W-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28W,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,10
13722.58cfa830e4b0c9d6adf6bf60,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4357-01A,BEC83DFF-2BBA-4467-92AA-5DC3DB9E0EAF,Stomach,58,81C87C27-47C7-4DC7-BF92-E0037433DF30,93F60FA6-0D34-441E-8F61-80306E10D046,TCGA-BR-4357-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4357,TCGA-STAD,NA,Asterand,Russia,T3,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1154-02,TRUE,6
13722.58cfa830e4b0c9d6adf6bf8f,1.95,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0K0-01A,29C8F468-5AC1-4D6C-8376-E36E6D246926,Uterus,48,11C43948-E7C9-4436-A654-82FA8033B625,3296C785-7C20-487D-BAEC-C66022E77E53,TCGA-B5-A0K0-01A-11D-A043-02,HG19_Broad_variant,TCGA-B5-A0K0,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,30
13722.58cfa830e4b0c9d6adf6c1f2,1.91,Dead,MALE,Not available,Not available,Bladder Urothelial Carcinoma,TCGA-BT-A20N-01A,EBEDAB7C-DD7C-448E-8324-78C86F13BE8B,Bladder,72,89EC2DFD-7A0C-4631-958D-D5492BC89F8D,CE801D11-240F-4510-8010-E3D7DA8247FC,TCGA-BT-A20N-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20N,TCGA-BLCA,795,University of Pittsburgh,None,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A14U-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bf14,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4267-01A,0D0F0200-25B8-483B-B04A-82A7833B4D30,Stomach,51,32D28ED3-2E33-4D83-8DE6-82E156B33211,F0DB5AF5-091F-4CDC-9917-BEFD658BF454,TCGA-BR-4267-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4267,TCGA-STAD,NA,Asterand,None,T2a,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1128-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c1fa,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5559-01A,17B17D91-C3DF-4B89-9C10-4DB069AFF656,Head and Neck,71,FBEA64F9-B46B-4AF1-BFB2-1791D93977B6,61532C84-EDD9-492D-AF89-99086F87381E,TCGA-BA-5559-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5559,TCGA-HNSC,NA,UNC,None,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1509-02,TRUE,24
13722.58cfa82fe4b0c9d6adf6b99a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-5774-01A,FD3FC273-C035-40EA-A459-FF4806F5D592,Lung,60,252C5D60-7033-44C3-8AB5-4604670A80F4,83902D13-5FD4-4640-B20F-3A8110F6D5EC,TCGA-64-5774-01A-01D-1623-02,HG19_Broad_variant,TCGA-64-5774,TCGA-LUAD,NA,Fox Chase,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1623-02,TRUE,57
13722.58cfa830e4b0c9d6adf6c290,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4294-01A,ACAB1362-C8A0-448B-8533-0CD84D97959C,Stomach,65,CB5D3EDE-205D-43F6-A3E3-DB287FB1783B,97DB8928-FACC-4095-984F-07C52A759DB4,TCGA-BR-4294-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4294,TCGA-STAD,NA,Asterand,Russia,T2a,NX,Stomach  Intestinal Adenocarcinoma  Tubular Type,Not available,1128-02,TRUE,3
13722.58cfa830e4b0c9d6adf6c22c,1.87,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A0S7-01A,68BC786E-07C7-4964-BC88-5E2A8633626A,Bladder,75,A9B73851-4609-4DF7-8EB8-45A56F4B2DD6,F415813D-F975-492B-9E4E-55CE47C967B9,TCGA-BT-A0S7-01A-11D-A10R-02,HG19_Broad_variant,TCGA-BT-A0S7,TCGA-BLCA,200,University of Pittsburgh,United States,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A10R-02,TRUE,14
13722.58cfa830e4b0c9d6adf6c2d0,1.93,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-CE-A27D-01A,75A93F0E-CD41-43C6-A303-FF37E31395E9,Thyroid,28,1807CEEE-28E1-4E8D-A1C4-6F6AD60EE310,CE991BB3-A63D-40C1-BFAF-3C4498D2C6EE,TCGA-CE-A27D-01A-11D-A16N-02,HG19_Broad_variant,TCGA-CE-A27D,TCGA-THCA,NA,ILSbio,Vietnam,T2,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,10
13722.58cfa830e4b0c9d6adf6c312,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6706-01A,93AEBBD4-19CF-495A-B8CE-3C4A3FEBA152,Stomach,63,C6BC78E9-87F1-4BE1-8EEB-17B2F59093E3,29893248-F981-4565-8754-AC75FB8C2586,TCGA-BR-6706-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6706,TCGA-STAD,NA,Asterand,Ukraine,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1880-02,TRUE,8
13722.58cfa830e4b0c9d6adf6c2d6,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6707-01A,DF3DF249-86C2-43D4-ABE1-796CD7DF653F,Stomach,75,36F691AA-B737-4369-AD62-84F987F697A6,AA430360-2BE7-4C92-A10C-52588D8A6061,TCGA-BR-6707-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6707,TCGA-STAD,NA,Asterand,Ukraine,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1880-02,TRUE,3
13722.58cfa830e4b0c9d6adf6c2e4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6802-01A,7C831A1D-3253-4AF4-A0FF-7FE9FF9AF1CE,Stomach,65,E3BF04C2-961F-4511-AF63-5A0E8AE6377B,0B4F4B0B-EF5C-4717-875A-7B8C5342DBC4,TCGA-BR-6802-01A-11D-1880-02,HG19_Broad_variant,TCGA-BR-6802,TCGA-STAD,NA,Asterand,Russia,T3,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1880-02,TRUE,2
13722.58cfa831e4b0c9d6adf6c37a,1.9,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5813-01A,152B9D8A-19FD-4665-B9E4-4FEDFB1608CD,Stomach,60,09E42E33-D2EC-406C-9A42-36D9D2EBD6C6,2118F0C5-3178-40EA-850D-C3F6F8752DD9,TCGA-CD-5813-01A-11D-1598-02,HG19_Broad_variant,TCGA-CD-5813,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage II,1598-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c3c4,1.88,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20O-01A,C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC,Bladder,75,5ECD84AD-44FD-4599-BF3D-AB725E0404EC,13596E86-7CD8-4A07-941F-E936D0004F6B,TCGA-BT-A20O-01A-21D-A14U-02,HG19_Broad_variant,TCGA-BT-A20O,TCGA-BLCA,370,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A14U-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c465,1.9,Dead,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5733-01A,8A9AFA5E-63CE-41EB-AAFB-B0B03653DA5A,Stomach,83,315E485B-3069-4ADC-8AB5-BEDCC0642930,73EA65AA-3677-425F-B084-1FC3BEBA2D03,TCGA-CG-5733-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5733,TCGA-STAD,641,Indivumed,Germany,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1598-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c3a0,1.71,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20U-01A,83B41D35-69B1-4218-BE1A-8821D8A6899C,Bladder,70,D29E555F-8467-45C8-9124-0E6A757B1ADF,8D4442E9-3312-4607-A59F-49538B19FA71,TCGA-BT-A20U-01A-11D-A14U-02,HG19_Broad_variant,TCGA-BT-A20U,TCGA-BLCA,455,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A14U-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c4b7,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4253-01A,411257A4-A148-4606-8C8B-F9F1240E40ED,Stomach,80,C536B8DF-6FE3-425E-82E8-36299A6BA2B9,B7CE561B-B51B-4C85-822D-58DF663DE8EA,TCGA-BR-4253-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4253,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1128-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c542,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5754-01A,0AAD0ABD-750A-400D-A34F-491DA996D46C,Prostate,65,BE645D37-B3E1-4D09-91CB-6231E25ACEB8,2C0EF4A5-DC20-45E7-B8EE-7525D77128B6,TCGA-CH-5754-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5754,TCGA-PRAD,NA,Indivumed,Germany,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,2
13722.58cfa831e4b0c9d6adf6c556,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5752-01A,D8F56D75-51AB-4A86-A502-C86E1DCD1EFF,Prostate,66,94A01526-7771-4A05-A9CE-9694B73DF3A7,490FC467-7E7E-40A1-98D0-ABA46EC71F53,TCGA-CH-5752-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5752,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c56a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5765-01A,716EB429-D7AF-4D4F-BD8D-AFCFF1A323EE,Prostate,55,E2359111-B056-4676-A8B6-C5CEA259B478,B7EFFFED-73EC-4139-A359-41B239F2978D,TCGA-CH-5765-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5765,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c632,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4441-01A,37E22429-EFD7-4D6A-B79A-9D8C7BE2170C,Stomach,83,60937697-57BA-4D03-9545-B0E321215448,DE856FF9-FEF4-4AA8-9418-F29EB79932B0,TCGA-CG-4441-01A-01D-1798-02,HG19_Broad_variant,TCGA-CG-4441,TCGA-STAD,426,Indivumed,Germany,T2,N2,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,1798-02,TRUE,4
13722.58cfa831e4b0c9d6adf6c6ce,1.9,Alive,MALE,Not available,Not available,Brain Lower Grade Glioma,TCGA-CS-6290-01A,42FE260F-520B-4FAC-8C09-D2B31AED59FB,Brain,31,6148F31E-CDBA-481B-BCD7-B3AEE05925B1,D31BD4D8-DF61-4B6B-9304-17B22FDD023B,TCGA-CS-6290-01A-11D-1703-02,HG19_Broad_variant,TCGA-CS-6290,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c67c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4739-01A,7E3B90C1-8772-4E12-8050-A156558BEB82,Head and Neck,71,F450DBE6-4972-4C49-AF97-963BCD0D0DA0,3B0BED92-ED76-451D-B605-A79FAE296DDE,TCGA-CN-4739-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4739,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c6d0,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-CS-4941-01A,FC222F23-B3B2-4AC0-BC61-E8E8FA5CC160,Brain,67,4E5AEE62-DF39-4A74-917C-C3AB154F8D0E,8CA32F59-BA52-49E8-BA72-D2761ED47099,TCGA-CS-4941-01A-01D-1465-02,HG19_Broad_variant,TCGA-CS-4941,TCGA-LGG,234,Thomas Jefferson University,United States,Not available,Not available,Astrocytoma,Not available,1465-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c6f4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5977-01A,50239D1D-B3A4-4240-AB83-B24BA67B1299,Head and Neck,66,84756AB5-9CB6-4DBD-848C-A85804F22AA1,140E6B2E-7EDD-417D-B720-58BEAB50AEA5,TCGA-CV-5977-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5977,TCGA-HNSC,NA,MD Anderson Cancer Center,None,T3,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c752,1.9,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6939-01A,E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382,Head and Neck,60,1ED822F5-FEA5-46DE-9681-EC484DE734D8,8BB4510A-C148-4A9E-8ECF-6F8C8E9309CA,TCGA-CV-6939-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6939,TCGA-HNSC,666,MD Anderson Cancer Center,United States,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c7d0,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6945-01A,15714E69-E075-4688-8F51-C7102FE4CA07,Head and Neck,41,55849997-67DE-4FC6-B7BF-9D02D15920C9,FC2ACD2E-751C-4252-85A1-6C5A8E980964,TCGA-CV-6945-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6945,TCGA-HNSC,366,MD Anderson Cancer Center,United States,T4a,N2,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,16
13722.58cfa831e4b0c9d6adf6c850,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6948-01A,FCF0DC48-B889-4593-A15B-AA715AAE7BF5,Head and Neck,79,21844F33-DD12-4940-B42D-2F9FABB2F7BA,8FEEA708-D971-4FD0-8542-1E31A9DFF8EA,TCGA-CV-6948-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6948,TCGA-HNSC,1289,MD Anderson Cancer Center,United States,T4a,N3,Head and Neck Squamous Cell Carcinoma,Stage IVB,1911-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c86a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6003-01A,417B357E-C90E-4B63-AE7A-4B782038FFD3,Head and Neck,50,6892F7E3-630E-45B5-8C30-139161461A85,9DF426C5-E45E-428B-A63C-11D4C1BEB4B2,TCGA-CV-6003-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-6003,TCGA-HNSC,NA,MD Anderson Cancer Center,None,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III,1681-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c8c0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-5971-01A,1465B7EC-8D2B-47DD-8387-977EED44CC86,Head and Neck,60,82589B3F-BD41-4ABE-9469-7DD48447DDDC,5739D7DE-98D4-4591-B8B1-E0E9AA9B05DF,TCGA-CV-5971-01A-11D-1681-02,HG19_Broad_variant,TCGA-CV-5971,TCGA-HNSC,NA,MD Anderson Cancer Center,None,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c898,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-5854-01A,B95AFB1A-A1DF-4D85-AD34-191928E28A77,Brain,57,D5BAA53A-958C-4163-A388-D3C957C891F9,4716DB1C-94F8-40AE-B89B-EA41E6A7E8CE,TCGA-DU-5854-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5854,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,7
13722.58cfa831e4b0c9d6adf6c8d8,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CV-6951-01A,91728CD6-ED91-49DC-9279-FAEDBE211A9D,Head and Neck,57,9EE0F161-0976-4697-BF69-7E42E7149FEB,90F9C6C1-B7E9-48E4-9A02-C5FAB56AFD95,TCGA-CV-6951-01A-11D-1911-02,HG19_Broad_variant,TCGA-CV-6951,TCGA-HNSC,915,MD Anderson Cancer Center,United States,T4a,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1911-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c945,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6818-01A,AA2934F9-8783-428E-88A6-1D04B93FA1FD,Stomach,53,953E155F-D9E1-41C8-BA12-351A38195D22,21E75BA4-E4C1-4D8A-BFA2-E4698B4FB46B,TCGA-D7-6818-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6818,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,1880-02,TRUE,15
13722.58cfa831e4b0c9d6adf6caee,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-E1-5303-01A,44A5C3B4-62A7-407B-B492-7069E1A43A26,Brain,38,150856F7-77DA-4AA5-A28B-310A505AEA24,287AB664-A970-437E-A7F9-EF6C20D2266E,TCGA-E1-5303-01A-01D-1465-02,HG19_Broad_variant,TCGA-E1-5303,TCGA-LGG,2052,Duke,United States,Not available,Not available,Astrocytoma,Not available,1465-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cb22,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-E5-A2PC-01A,4107AE6F-502C-4BDC-BF14-E4B3711CBA38,Bladder,61,2195B75E-157F-4547-9705-1E7E75666CA8,FABA82E6-FF3D-468C-91EC-A88794619697,TCGA-E5-A2PC-01A-11D-A204-02,HG19_Broad_variant,TCGA-E5-A2PC,TCGA-BLCA,NA,Roswell Park,United States,T2b,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A204-02,TRUE,21
13722.58cfa831e4b0c9d6adf6cba5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7331-01A,B424B73A-2DFA-473F-AB56-AB382CD1CDEF,Prostate,64,5AA2E382-C8DF-44E3-8802-994188B11D55,F2DA114D-161B-46CD-BAA7-46E63DBC5D5C,TCGA-EJ-7331-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7331,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,2
13722.58cfa831e4b0c9d6adf6cbb5,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5507-01A,607200F5-DF80-4F5D-90FB-FDC455A7415B,Prostate,54,F93327F7-0290-4915-97BB-E31BAE2697DD,D2336094-05BD-4E89-84A3-91D641DC31D0,TCGA-EJ-5507-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5507,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6cbc9,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5514-01A,F82D53B1-3DF8-4249-A615-464C9F4E0A32,Prostate,66,29AD80A4-B429-495C-885E-A92CFE2E4501,6F8F8AAC-C0DE-46F6-A7CF-502893CC57CB,TCGA-EJ-5514-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5514,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,2
13722.58cfa831e4b0c9d6adf6cbf4,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7782-01A,1426B4BF-F4A5-477C-BBBB-E0E656549764,Prostate,71,951C894E-9354-45AD-834A-FFC04441A3A9,47FB5E53-DD88-4B25-B6EF-C1ABE55FD5BA,TCGA-EJ-7782-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7782,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,5
13722.58cfa831e4b0c9d6adf6cbf9,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7785-01A,2DEF2A53-D2E8-46F0-8B07-F32DBF1833A4,Prostate,54,63EBD9B1-F118-4315-8722-708F47A07063,196C6111-FF69-40F1-A7AA-973C5AC9106E,TCGA-EJ-7785-01A-11D-2111-02,HG19_Broad_variant,TCGA-EJ-7785,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,8
13722.58cfa831e4b0c9d6adf6cc60,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5501-01A,8DF0C1E8-966C-4F46-AD15-FAE9E745A32E,Prostate,55,A1E37A0A-67F5-4A19-A540-A45CB89C4203,759BD886-73F1-4DEF-A446-98DAAC2C5B88,TCGA-EJ-5501-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5501,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6cbeb,2.05,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1CW-01A,22EB9F00-6869-4D8F-B657-DFD64F81E9E9,Thyroid,39,7045F3E1-5239-4159-9B38-31E4168853D0,2CC2002C-4F0A-47A6-AA0A-35FE1B545A7A,TCGA-EM-A1CW-01A-21D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CW,TCGA-THCA,NA,University Health Network,Canada,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A13U-02,TRUE,21
13722.58cfa831e4b0c9d6adf6cc90,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5518-01A,2B35C119-CDC1-49E2-8229-CA5CDE9E63D0,Prostate,66,F12FA61C-FF1B-48E2-BE19-1D52D50DC261,BD026793-2032-4D13-9A6A-A189583A537C,TCGA-EJ-5518-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5518,TCGA-PRAD,NA,University of Pittsburgh,United States,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,5
13722.58cfa831e4b0c9d6adf6ccc0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5531-01A,ADF3C2F7-D5F9-41C3-BD8C-7F9F1F22FF73,Prostate,62,48F3A8B8-110C-49AB-BD85-CE33328C2CF6,90219925-E6E8-40BC-8DD0-BD76F942B48C,TCGA-EJ-5531-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5531,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6ccf0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5512-01A,C28F931F-5AB2-4899-9FE9-54024F082D92,Prostate,46,D0B41403-8458-45E1-946E-21054FBA65B8,D5F126D6-7AAF-425A-BBEA-E7587A25529D,TCGA-EJ-5512-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5512,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cd06,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5496-01A,6755C231-355F-4CC3-85F1-6306C7F5D44B,Prostate,59,D0873929-EAC8-42E2-AF6F-DF3CB9CE698C,0A4FA030-2417-4F6F-8B86-5036FCA48F1E,TCGA-EJ-5496-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5496,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,3
13722.58cfa831e4b0c9d6adf6cd2c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5495-01A,962DD3D5-8501-4658-8CB9-2424B476124C,Prostate,68,8E53414F-455E-4665-AE0E-9E7405262A96,5644F0E3-3A3B-411A-B28D-C93C3BBD8F86,TCGA-EJ-5495-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5495,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,6
13722.58cfa831e4b0c9d6adf6cd23,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-F1-6874-01A,106F3344-F699-4B2C-8F62-4AC6C948DDE4,Stomach,79,C28FEBB9-E845-462F-B6A0-CB565EE6A049,273DDC2E-8E77-4F81-85C2-B9A8583D9E1D,TCGA-F1-6874-01A-11D-1880-02,HG19_Broad_variant,TCGA-F1-6874,TCGA-STAD,NA,UNC,United States,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1880-02,TRUE,6
13722.58cfa832e4b0c9d6adf6ce14,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5511-01A,F8A42FEB-FBC9-4A13-BAD5-1DCEFCA2A9BF,Prostate,55,1DA89009-5DBE-4D62-9406-36330F47B738,5D753860-8965-45E5-A919-C076B53334D4,TCGA-EJ-5511-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5511,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa831e4b0c9d6adf6cd6c,1.93,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A25R-01A,097B9CF1-EC0C-487C-9ADE-2BDAB12EB4CA,Thyroid,51,C29162A3-F162-4D32-AB9A-421BE1FEB13C,77A80565-1BC9-4F0A-AFB3-23955FE283EB,TCGA-ET-A25R-01A-11D-A16N-02,HG19_Broad_variant,TCGA-ET-A25R,TCGA-THCA,NA,Johns Hopkins,United States,T3,NX,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III,A16N-02,TRUE,8
13722.58cfa832e4b0c9d6adf6ce46,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5504-01A,E1C3D1BD-CF8F-4FA4-AC8E-BF9E54F7AAD4,Prostate,65,7D0C0A85-8459-43A3-AC22-F447BB042149,FB332EAD-214E-4D76-BD3C-0774D906F68B,TCGA-EJ-5504-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5504,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N1,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cdaf,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A22Z-01A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Thyroid,61,D206D300-E0CE-4A40-AF1F-45A685346A6E,B7A31BAC-FD92-47AF-8C9C-E78E3FC1609A,TCGA-FE-A22Z-01A-11D-A16N-02,HG19_Broad_variant,TCGA-FE-A22Z,TCGA-THCA,NA,Ohio State University,United States,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA,A16N-02,TRUE,8
13722.58cfa832e4b0c9d6adf6cfac,1.8,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-GE-A2C6-01A,7DEEDEBA-F05B-453C-9DF1-EEB20B0EC72E,Thyroid,33,D717EECF-11DC-4E15-851A-9EA18332A48B,A5FA44A2-8101-4A0C-982C-57337853BACA,TCGA-GE-A2C6-01A-11D-A16N-02,HG19_Broad_variant,TCGA-GE-A2C6,TCGA-THCA,NA,ABS - IUPUI,United States,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A16N-02,TRUE,13
13722.58cfa832e4b0c9d6adf6d082,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7210-01A,6A5AF80E-07AD-4CD3-AAAB-5DB1090835D9,Prostate,74,9069FC65-9BAE-49F3-9329-B78C8CC6CF1E,D414D851-0AF6-4C8F-8E40-CCA9FDF79488,TCGA-HC-7210-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7210,TCGA-PRAD,NA,International Genomics Consortium,United States,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,6
13722.58cfa832e4b0c9d6adf6d0f5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7209-01A,582D1177-73B0-4A9C-8505-70D6B402BD01,Prostate,60,AA7850AC-FB78-433B-8D55-A24C05935DB5,3C59E423-E1A6-4C67-8A88-63A0817B856E,TCGA-HC-7209-01A-11D-2111-02,HG19_Broad_variant,TCGA-HC-7209,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,10
13722.58cfa832e4b0c9d6adf6d1bb,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5509-01A,13CE70A8-785C-4B59-B073-41922CB201F9,Prostate,63,99A7115E-046B-488E-95D2-48C35BD29867,4F3831BE-6C1C-4786-B953-2612753C1E5C,TCGA-EJ-5509-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5509,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,3
13722.58cfa832e4b0c9d6adf6d1d2,NA,Alive,MALE,Not available,Not available,Bladder Urothelial Carcinoma,TCGA-HQ-A2OE-01A,353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C,Bladder,69,65DBBE08-4645-4552-9A1A-E6F79A621013,B04D2557-D084-4445-97BB-10A6CB59DC6B,TCGA-HQ-A2OE-01A-11D-A204-02,HG19_Broad_variant,TCGA-HQ-A2OE,TCGA-BLCA,NA,Ontario Institute for Cancer Research (OICR),Canada,T2a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Not available,A204-02,TRUE,28
13722.58cfa832e4b0c9d6adf6d114,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-G2-A2ES-01A,72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38,Bladder,85,C2288290-F17A-435C-90E7-5A4913F0C076,52FA3B0A-B5C7-4A74-A798-0DB359029147,TCGA-G2-A2ES-01A-11D-A17R-02,HG19_Broad_variant,TCGA-G2-A2ES,TCGA-BLCA,NA,MD Anderson,United States,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A17R-02,TRUE,14
13722.58cfa82fe4b0c9d6adf6b5f0,2,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5933-01A,7A0EA814-F0DE-4BC4-A81A-DAA000559369,Lung,72,D2355F3A-E2CE-4791-B1FB-B570850681DF,1D83B47D-66A8-4AE9-81BB-BDC03FA64AC6,TCGA-50-5933-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5933,TCGA-LUAD,2393,University of Pittsburgh,United States,T4,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIB,1751-02,TRUE,14
13722.58cfa82ee4b0c9d6adf6ae5c,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4397-01A,6DFD47D2-831A-4386-9051-F78199A16BB5,Lung,65,C4C061CD-E926-400B-B18C-B47C234337CA,5D48DDB3-ED53-49CB-99B9-B75FCECCA1B4,TCGA-05-4397-01A-01D-1203-02,HG19_Broad_variant,TCGA-05-4397,TCGA-LUAD,731,Indivumed,Germany,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1203-02,TRUE,19
13722.58cfa82ee4b0c9d6adf6b038,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4424-01A,66763A0C-6CDA-4832-A0CC-E7B496D78EAA,Lung,70,A4D06D63-8DA9-4C3C-A75D-4079C2238AA8,D1052F23-44EC-4C05-A164-6FBD72DFC9E2,TCGA-05-4424-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4424,TCGA-LUAD,NA,Indivumed,Germany,T3,N0,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1853-02,TRUE,22
13722.58cfa82fe4b0c9d6adf6b6be,1.9,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-55-6543-01A,E68219B0-A9C2-49DF-8F0D-DB5EA97FD2DC,Lung,60,8D9491E7-9B14-4988-8FA7-E6AF041120BD,1D88DA12-E71A-4F44-8D71-DA8957BDFCD4,TCGA-55-6543-01A-11D-1751-02,HG19_Broad_variant,TCGA-55-6543,TCGA-LUAD,NA,International Genomics Consortium,United States,T1b,N0,Lung Bronchioloalveolar Carcinoma Mucinous,Stage IA,1751-02,TRUE,18
13722.58cfa82ee4b0c9d6adf6b014,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4433-01A,AEA68827-DC0F-484D-A00D-06DEEAA4B3CE,Lung,82,1E9DAC94-1A10-47D0-AE92-81D38A264376,61B1812A-9455-437F-ACF7-D1AC3FA9F215,TCGA-05-4433-01A-22D-1853-02,HG19_Broad_variant,TCGA-05-4433,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1853-02,TRUE,19
13722.58cfa82fe4b0c9d6adf6b6dc,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5935-01A,100430C8-1446-45C8-AF36-B6DBB3DDD0C1,Lung,86,98687ADB-F8E9-4E6E-BC1B-396A3DDFAC96,6F0D56B0-E246-4566-AFFB-B8DD5E88B5BA,TCGA-50-5935-01A-11D-1751-02,HG19_Broad_variant,TCGA-50-5935,TCGA-LUAD,653,University of Pittsburgh,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1751-02,TRUE,15
13722.58cfa82fe4b0c9d6adf6b6d2,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-3396-01A,3BD6BADB-27FF-4D8D-B206-4D28DC264862,Lung,74,B560DF97-986B-4A88-A0F1-C38A30080EDB,ECCC6A5C-BB25-4591-996A-EE2A7507F771,TCGA-44-3396-01A-01D-1203-02,HG19_Broad_variant,TCGA-44-3396,TCGA-LUAD,NA,Christiana Healthcare,United States,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1203-02,TRUE,37
13722.58cfa82fe4b0c9d6adf6b728,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6147-01A,889AEC8E-14BA-48D9-8FE1-F2416E82B333,Lung,67,43F5270A-F2F2-4DD9-83B5-486B805E35B8,E9CE62EF-711E-4252-AC93-97B69C39041A,TCGA-44-6147-01A-11D-1751-02,HG19_Broad_variant,TCGA-44-6147,TCGA-LUAD,NA,Christiana Healthcare,United States,T1b,NX,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1751-02,TRUE,21
13722.58cfa82fe4b0c9d6adf6b70a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-67-6216-01A,CCECCE70-DD54-4C5B-BF9F-CA87D290CB00,Lung,57,4EAA4B4A-E9DB-4E65-97D6-7FA1A205DA95,1003F495-01FE-47ED-A717-B8769F0FA3A3,TCGA-67-6216-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6216,TCGA-LUAD,NA,St Joseph's Medical Center (MD),United States,T1a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1751-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b780,1.9,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5045-01A,9EE20C0D-A1C3-47F3-ABDA-131B3F190F52,Lung,57,BDD75BCA-6224-4743-A367-CB1FF01E8121,42839A7D-81DB-428A-AB3B-072ACD26CA91,TCGA-50-5045-01A-01D-1623-02,HG19_Broad_variant,TCGA-50-5045,TCGA-LUAD,2174,University of Pittsburgh,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1623-02,TRUE,17
13722.58cfa82fe4b0c9d6adf6b82d,1.9,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-44-6779-01A,CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB,Lung,50,5E04D394-7A40-4E89-BA20-892774DCB469,DB5F07FE-8DC0-4259-A6B1-E75B6F1188C5,TCGA-44-6779-01A-11D-1853-02,HG19_Broad_variant,TCGA-44-6779,TCGA-LUAD,500,Christiana Healthcare,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1853-02,TRUE,13
13722.58cfa82fe4b0c9d6adf6b762,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-5125-01A,205759A6-6391-491B-9857-0080C3A5871E,Lung,NA,73A77977-FAB0-486F-8D15-BE8B30C8808A,02DE68CC-AD50-45FD-BB4D-819D6E0F55F5,TCGA-75-5125-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5125,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1751-02,TRUE,4
13722.58cfa82fe4b0c9d6adf6b864,2.18,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0GU-01A,ADC22472-E31D-419F-AEAE-CB01B9423343,Uterus,58,074D4466-E072-42CD-9A6C-A595DC9363E7,BB726D7A-6861-48AA-9BFD-5DF8DAAA1538,TCGA-A5-A0GU-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0GU,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,59
13722.58cfa82fe4b0c9d6adf6b760,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-5122-01A,78AE716B-0CA5-4C01-A053-D41288385FCD,Lung,NA,DD9C2F71-145A-4F7F-8B64-095B1FC75C3D,4ADD8465-F06A-4752-8B9F-A6F790F727B1,TCGA-75-5122-01A-01D-1751-02,HG19_Broad_variant,TCGA-75-5122,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,8
13722.58cfa82fe4b0c9d6adf6b9a8,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-67-6215-01A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Lung,52,3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632,483EF1DC-150E-4623-BA11-772ADE84E4E4,TCGA-67-6215-01A-11D-1751-02,HG19_Broad_variant,TCGA-67-6215,TCGA-LUAD,NA,St Joseph's Medical Center (MD),United States,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1751-02,TRUE,9
13722.58cfa830e4b0c9d6adf6bada,1.9,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-49-6745-01A,9C7875AD-AB71-4D48-B2E3-E4C7A46393E9,Lung,82,357F3EFE-E2C9-432A-A2B6-75A5FDBAE3BE,A88D69EF-BE3C-4341-AD6C-0F035685862F,TCGA-49-6745-01A-11D-1853-02,HG19_Broad_variant,TCGA-49-6745,TCGA-LUAD,NA,Johns Hopkins,United States,T2a,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1853-02,TRUE,16
13722.58cfa82fe4b0c9d6adf6b9e8,1.93,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-A5-A0G9-01A,45D58088-D3F4-4EB0-B75C-BCB98C0981DC,Uterus,79,117A5B33-42C5-4A52-BABE-D9712F3E7472,0DE57B60-95AF-48E2-85CA-58135A314355,TCGA-A5-A0G9-01A-11D-A043-02,HG19_Broad_variant,TCGA-A5-A0G9,TCGA-UCEC,NA,Cedars Sinai,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,25
13722.58cfa830e4b0c9d6adf6bc7c,2.03,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LQ-01A,252500D2-86A3-4090-A57F-1E8C3D44C573,Uterus,59,B75648DC-B25B-4EE6-850A-7D1F3A353E83,F8D9DE13-1935-483C-B2F4-B1CD8D61613F,TCGA-AP-A0LQ-01A-12D-A101-02,HG19_Broad_variant,TCGA-AP-A0LQ,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,14
13722.58cfa830e4b0c9d6adf6bc8a,2.03,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0L8-01A,9AA8C2B4-DB32-4899-BF0C-D578CB175E90,Uterus,70,D1A7A58F-7A35-4A94-A337-051AE56DED00,2BE44D5B-CCD6-4DD5-B0C7-C7813B526B94,TCGA-AP-A0L8-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0L8,TCGA-UCEC,1484,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A043-02,TRUE,41
13722.58cfa830e4b0c9d6adf6bd9a,1.94,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M6-01A,002724FA-7051-49FA-9C58-4BCB7EBA4AC6,Uterus,73,66E4B080-E6EF-4531-9B69-1B27F15C5669,61C058D9-E5DC-4D74-B378-28B8F0A2BF78,TCGA-BG-A0M6-01A-31D-A101-02,HG19_Broad_variant,TCGA-BG-A0M6,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A101-02,TRUE,13
13722.58cfa830e4b0c9d6adf6bc82,1.85,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LI-01A,E1E8DC66-467C-48A5-BE56-3DB4F665B9F1,Uterus,67,981D9E3B-63C5-41E9-827F-7F1D268D62F4,D80E9147-7A64-4AB0-891A-2D97D0634EAB,TCGA-AP-A0LI-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LI,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A043-02,TRUE,49
13722.58cfa830e4b0c9d6adf6bdb3,1.87,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0MG-01A,9CDE90C8-2BE0-4328-A032-FF1DC19E66FD,Uterus,73,96B6826D-8A4C-45F5-8CD3-B5988AA5FD0E,755BD772-9331-402B-832B-2933AAECFC71,TCGA-BG-A0MG-01A-21D-A101-02,HG19_Broad_variant,TCGA-BG-A0MG,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,12
13722.58cfa830e4b0c9d6adf6be68,1.81,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A28Z-01A,6BA76174-620E-4851-857A-D0ADBFD6F3E6,Thyroid,46,D9689254-AFE2-4544-AF54-E02670BD5EBD,F353E9F5-A869-4BE1-ACC4-A832D77285D4,TCGA-BJ-A28Z-01A-11D-A16N-02,HG19_Broad_variant,TCGA-BJ-A28Z,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A16N-02,TRUE,13
13722.58cfa830e4b0c9d6adf6be55,2.07,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-AP-A0LT-01A,43714E9A-E9C4-4206-AF92-1D00D2A8AE35,Uterus,57,C94DD7A5-DD58-4702-A7D1-8199D3F8C9CC,B057AD28-5D99-48BC-B642-7E548914F1B1,TCGA-AP-A0LT-01A-11D-A043-02,HG19_Broad_variant,TCGA-AP-A0LT,TCGA-UCEC,NA,MSKCC,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,37
13722.58cfa830e4b0c9d6adf6be38,1.95,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0JY-01A,61935424-44D0-4211-81C1-C925E436EAC5,Uterus,50,95F418CE-FCD9-4402-BC24-1520F45CB6B7,88CE0037-F3F9-4F45-BF14-36A58FF61A3D,TCGA-B5-A0JY-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JY,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,16
13722.58cfa830e4b0c9d6adf6bf3d,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4187-01A,12071070-D06B-4C7B-A7B1-77C84963ABE6,Stomach,56,144FB4ED-63BB-4908-B678-6026E09566A3,57CF858D-FF3F-4528-96DB-5A820C9B78DE,TCGA-BR-4187-01A-01D-1128-02,HG19_Broad_variant,TCGA-BR-4187,TCGA-STAD,NA,Asterand,Russia,TX,NX,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1128-02,TRUE,15
13722.58cfa830e4b0c9d6adf6bf7e,1.92,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0JV-01A,233E947A-D5E2-48E5-A8CE-5DA1ABB20681,Uterus,63,42199E5A-9F4F-4445-9E6E-114D47BA67FA,7132C5C6-9DC5-42A8-863F-D82280266427,TCGA-B5-A0JV-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JV,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c1aa,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5555-01A,8970F713-4A7A-4125-892C-6A34139371D8,Head and Neck,54,2920CA1C-6035-4350-ADA4-C60D485DBFFF,4AB42DF9-A215-4965-A125-CC0C4122FF06,TCGA-BA-5555-01A-01D-1509-02,HG19_Broad_variant,TCGA-BA-5555,TCGA-HNSC,NA,UNC,None,T3,N2c,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,13
13722.58cfa830e4b0c9d6adf6c1b6,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4076-01A,7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70,Head and Neck,39,FD99FD83-4040-4738-8A5A-E42D36ECFE0E,54F77A3E-290A-4073-8012-4873579E95E9,TCGA-BA-4076-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4076,TCGA-HNSC,415,UNC,None,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,36
13722.58cfa830e4b0c9d6adf6c1f6,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Uterine Corpus Endometrial Carcinoma,TCGA-BG-A0M4-01A,73E5310D-BA8C-4CBC-AA4F-E06206F898F4,Uterus,60,E6E7E411-45CF-47A1-BCF0-7AE800A61A8D,238A1E43-B716-479B-82C8-0E62A30F9BE9,TCGA-BG-A0M4-01A-11D-A101-02,HG19_Broad_variant,TCGA-BG-A0M4,TCGA-UCEC,NA,University of Pittsburgh,None,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A101-02,TRUE,15
13722.58cfa830e4b0c9d6adf6c1c0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BB-4225-01A,C1F50A22-38DF-41CC-A1F4-F7985504A7AC,Head and Neck,73,AC42070B-F4D6-47BE-96AA-A713D66A0072,F7E6BD4D-3E7C-427E-8618-FAFB3731E597,TCGA-BB-4225-01A-01D-1431-02,HG19_Broad_variant,TCGA-BB-4225,TCGA-HNSC,NA,Johns Hopkins,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,1431-02,TRUE,9
13722.58cfa830e4b0c9d6adf6c2c6,1.95,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CF-A1HS-01A,A73C0842-39C5-4C2C-AA6A-F31341A4F36E,Bladder,75,0A01E5BA-5549-4027-9E84-1BBB163A8F07,B8F18CDA-053F-4E40-8978-7524A4C0B49A,TCGA-CF-A1HS-01A-11D-A13U-02,HG19_Broad_variant,TCGA-CF-A1HS,TCGA-BLCA,NA,ILSbio,Vietnam,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,12
13722.58cfa830e4b0c9d6adf6c29a,2.12,Alive,FEMALE,WHITE,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0JR-01A,A766D113-BC3F-4448-A4E5-F391FB0C0E22,Uterus,73,07381A09-5CBD-4744-86EC-41A81E470204,E4F782AB-1668-4730-95D9-CB28E3CF61FD,TCGA-B5-A0JR-01A-13D-A043-02,HG19_Broad_variant,TCGA-B5-A0JR,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Endometrioid endometrial adenocarcinoma,Not available,A043-02,TRUE,30
13722.58cfa830e4b0c9d6adf6c2ce,2.09,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Uterine Corpus Endometrial Carcinoma,TCGA-B5-A0JN-01A,B60F22AC-A659-4F33-B01D-820E86A9A5C9,Uterus,84,684C6894-FD49-4934-8962-9628ECE734FB,EB2131FF-4AE0-4814-81F3-A480A0DEBB2E,TCGA-B5-A0JN-01A-11D-A101-02,HG19_Broad_variant,TCGA-B5-A0JN,TCGA-UCEC,NA,Duke,United States,Not available,Not available,Serous endometrial adenocarcinoma,Not available,A101-02,TRUE,24
13722.58cfa831e4b0c9d6adf6c401,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5791-01A,829BED0C-C40D-44FD-AEE8-6C7589DB60F9,Prostate,72,C14B5C15-994B-4739-870B-A50984D274A1,500F071A-6697-4880-BBD0-9054CCAE108A,TCGA-CH-5791-01A-11D-1572-02,HG19_Broad_variant,TCGA-CH-5791,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c4f6,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5730-01A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Stomach,80,2986F11F-3C18-4621-8406-D46614537ED4,9E9AC3CA-F6EC-497E-938D-F6FEA03CC75C,TCGA-CG-5730-01A-11D-1598-02,HG19_Broad_variant,TCGA-CG-5730,TCGA-STAD,NA,Indivumed,Germany,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1598-02,TRUE,8
13722.58cfa831e4b0c9d6adf6c4be,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4367-01A,D139BD0C-2EEB-44EC-856B-E77CB03D294E,Stomach,78,1506E790-C21C-4419-B11B-14250C947FB5,174658D3-1933-47FD-A883-5F4AFA169778,TCGA-BR-4367-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4367,TCGA-STAD,NA,Asterand,Russia,TX,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Not available,1154-02,TRUE,11
13722.58cfa831e4b0c9d6adf6c426,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4727-01A,12D05E8F-8D13-47C1-B713-2250F6ABCEF9,Head and Neck,56,F102AEF0-94B8-4D26-8055-35B76DA9DD5F,E42C764C-98DB-4E55-A625-B1443E6C4B3A,TCGA-CN-4727-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4727,TCGA-HNSC,NA,University of Pittsburgh,United States,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,10
13722.58cfa831e4b0c9d6adf6c580,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4368-01A,449BF2BE-B20E-4AD0-9FFB-910D83114018,Stomach,78,87239062-9EA0-4987-AD13-5A2DDED4FF82,1AED45C5-BB15-43D4-9C04-291B7C5B4428,TCGA-BR-4368-01A-01D-1154-02,HG19_Broad_variant,TCGA-BR-4368,TCGA-STAD,NA,Asterand,Russia,T4,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1154-02,TRUE,7
13722.58cfa830e4b0c9d6adf6c184,1.9,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4075-01A,6FA62461-E721-415A-8B0F-363B84292B82,Head and Neck,49,4DC36C31-35D8-4263-B141-C734545540A9,4B0B38F4-AC21-4F3E-8A8E-A69FBA619629,TCGA-BA-4075-01A-01D-1431-02,HG19_Broad_variant,TCGA-BA-4075,TCGA-HNSC,283,UNC,None,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1431-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c54a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4730-01A,35C1F2C6-771C-4533-82DF-F8E2EC7107D7,Head and Neck,62,8270C53E-F2CF-4F57-A1AC-A8BA978CC1C8,094C2014-ABA2-4C11-B076-27EA61C7A48E,TCGA-CN-4730-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4730,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c5e7,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5367-01A,61D0709C-D148-413B-A7B5-C0C82ED2F32F,Head and Neck,60,379F9E65-54F3-4566-B018-3F3EEE6A4DF4,1380173D-316F-4821-8B98-654AD1050A38,TCGA-CN-5367-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5367,TCGA-HNSC,352,University of Pittsburgh,None,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,22
13722.58cfa831e4b0c9d6adf6c600,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,Indivumed,Germany,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1154-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c59a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4737-01A,1F744ADA-6DE1-446D-B62C-76A7FC8B40AF,Head and Neck,19,BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA,43003723-9C58-4B5E-8F47-56B4BDA476A0,TCGA-CN-4737-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4737,TCGA-HNSC,NA,University of Pittsburgh,None,T2,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,23
13722.58cfa831e4b0c9d6adf6c5f5,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5355-01A,45A10908-19E6-421A-8903-1440BFA57C9D,Head and Neck,64,63535469-D402-4BA2-9AB5-986E6ED80F55,180BC055-9C10-4B84-80C4-3DF00742719D,TCGA-CN-5355-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5355,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,12
13722.58cfa831e4b0c9d6adf6c640,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4466-01A,2F1B96B2-7031-4F7D-9490-14728D320F3E,Stomach,81,0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9,623D5E6A-A5D3-4580-BEF7-04673D42A1D0,TCGA-CG-4466-01A-01D-1154-02,HG19_Broad_variant,TCGA-CG-4466,TCGA-STAD,NA,Indivumed,Germany,T2a,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,1154-02,TRUE,15
13722.58cfa831e4b0c9d6adf6c634,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5361-01A,044579EF-16A6-4F00-B951-EDC423D8A14F,Head and Neck,80,C807171A-4433-4246-A454-C5CF768DA8AA,A4E6D494-865F-4F60-B9C6-13C9C0CEA6AB,TCGA-CN-5361-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5361,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N2a,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,29
13722.58cfa831e4b0c9d6adf6c619,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-5356-01A,E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425,Head and Neck,56,BCB5DA85-78D6-4519-9740-378587B1BD37,199B42E1-301A-49AD-A364-BBF4FAD8B049,TCGA-CN-5356-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-5356,TCGA-HNSC,NA,University of Pittsburgh,None,T3,N0,Head and Neck Squamous Cell Carcinoma,Stage III,1431-02,TRUE,21
13722.58cfa831e4b0c9d6adf6c64e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4741-01A,277B02E9-DED5-4980-845D-AF53690000AC,Head and Neck,75,03C9108A-5139-4BAC-9641-C7DBBEDEF420,FAA30C0B-E008-4313-A2AB-1D641F98E2B9,TCGA-CN-4741-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4741,TCGA-HNSC,NA,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1431-02,TRUE,20
13722.58cfa831e4b0c9d6adf6c642,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4734-01A,B80FDC9A-341D-4277-9664-8E8F770D9DDD,Head and Neck,70,20614787-1E55-40F0-88DE-080640EB8A03,EA9125C8-3F3B-47CE-AD79-802692B1FB4A,TCGA-CN-4734-01A-01D-1431-02,HG19_Broad_variant,TCGA-CN-4734,TCGA-HNSC,NA,University of Pittsburgh,None,T2,N0,Head and Neck Squamous Cell Carcinoma,Stage II,1431-02,TRUE,18
13722.58cfa831e4b0c9d6adf6c688,1.91,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CU-A0YO-01A,4A9EF220-922C-49CF-BBED-D173B214ED31,Bladder,84,9E190462-39FC-41B2-B1D6-2DA150412FCF,A407711E-26FF-4C0C-9391-326A51614BB7,TCGA-CU-A0YO-01A-11D-A10R-02,HG19_Broad_variant,TCGA-CU-A0YO,TCGA-BLCA,149,UNC,United States,T3a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A10R-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c684,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-4738-01A,97640EF0-0259-4244-95BA-48D28C60B372,Head and Neck,53,8277E744-0508-47D5-9CEA-11DCF7F56D35,0EABE3ED-367B-4055-8700-0036E6A0FB1D,TCGA-CN-4738-01A-02D-1509-02,HG19_Broad_variant,TCGA-CN-4738,TCGA-HNSC,436,University of Pittsburgh,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,1509-02,TRUE,19
13722.58cfa831e4b0c9d6adf6c801,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CN-6018-01A,55838E1F-07E8-49CA-89D6-46216BABC6F7,Head and Neck,85,1A3E8C8B-9E99-499A-9BA7-4CDFC11B106D,7F0998E4-AF05-42C5-962C-5EA4D8993EB0,TCGA-CN-6018-01A-11D-1681-02,HG19_Broad_variant,TCGA-CN-6018,TCGA-HNSC,NA,University of Pittsburgh,United States,T4a,N2b,Head and Neck Squamous Cell Carcinoma,Stage IVA,1681-02,TRUE,25
13722.58cfa831e4b0c9d6adf6c900,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6399-01A,4EF429BE-C345-4258-9B42-B56E215E1A2C,Brain,54,41555F97-0269-4F3D-AB13-6B0AE08D1FF5,329097BC-E434-4EA7-B0AC-EFF202C58C6F,TCGA-DU-6399-01A-12D-1703-02,HG19_Broad_variant,TCGA-DU-6399,TCGA-LGG,2000,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,1703-02,TRUE,2
13722.58cfa831e4b0c9d6adf6c914,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AA-01A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Bladder,57,577700D1-C366-41EF-8A0D-E50DEEFB5E3C,6482BD80-A3F1-4169-A9F2-B45A9445035C,TCGA-DK-A1AA-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AA,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,13
13722.58cfa831e4b0c9d6adf6c94f,1.88,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-5578-01A,A3C1F9A2-9174-48CF-81DC-2AFCFDC4BA9C,Stomach,80,E88D8673-C0BE-4549-8DAF-100187608F17,A00E8607-F965-421B-B0ED-57C09488F514,TCGA-D7-5578-01A-01D-1598-02,HG19_Broad_variant,TCGA-D7-5578,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T3,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIA,1598-02,TRUE,6
13722.58cfa831e4b0c9d6adf6c985,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13W-01A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Thyroid,45,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,8A15A4FE-F286-422D-9D50-33ABBD885250,TCGA-DJ-A13W-01A-11D-A10R-02,HG19_Broad_variant,TCGA-DJ-A13W,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A10R-02,TRUE,14
13722.58cfa831e4b0c9d6adf6c976,1.95,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,CACE3242-E727-4E1F-9427-B952E10C9B12,TCGA-DK-A1A6-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A6,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13U-02,TRUE,12
13722.58cfa831e4b0c9d6adf6ca21,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QD-01A,DA201150-748E-4B74-BB35-10C995E26079,Thyroid,20,A8307181-67CE-4A79-8D23-76CEEE1D2761,781162AA-AAFA-4C44-B9AF-727917E8C9F4,TCGA-DJ-A1QD-01A-11D-A14U-02,HG19_Broad_variant,TCGA-DJ-A1QD,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A14U-02,TRUE,19
13722.58cfa831e4b0c9d6adf6ca90,1.8,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-5872-01A,48607130-C09A-491D-882F-7D2591D13182,Brain,43,048550EE-189D-483D-B07F-B77F10278420,CF245938-DD0C-42FE-9A39-09F29FF12F23,TCGA-DU-5872-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5872,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Oligoastrocytoma,Not available,1703-02,TRUE,4
13722.58cfa831e4b0c9d6adf6ca7f,1.91,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,C4A751AF-E8CC-452A-9B5B-99D4B0AC585D,TCGA-DK-A1A5-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1A5,TCGA-BLCA,65,Memorial Sloan Kettering,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A13U-02,TRUE,25
13722.58cfa831e4b0c9d6adf6cbfe,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6405-01A,9239A22E-80B1-49A2-B0D5-CBAB7E415254,Brain,51,54BFF4F3-312D-4E1A-8327-F08F5A270EAC,9593D4DE-0DAB-4D1E-B86C-AF91CAC938E6,TCGA-DU-6405-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6405,TCGA-LGG,605,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cc03,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7010-01A,834E560A-A506-456D-BAF2-A206CA058153,Brain,58,A6DA348E-A70C-4620-BFCB-2AFBE893284B,3EF3E4F1-9B47-4F11-9024-85242ECEE397,TCGA-DU-7010-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7010,TCGA-LGG,456,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,9
13722.58cfa831e4b0c9d6adf6cc13,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6402-01A,152F028E-EE29-40E0-8E75-5CAFFFACBD45,Brain,52,0E594B0A-05E4-40C8-80BA-0D4BB08E437D,A60A9995-6A02-4035-9C3E-2FEE0E6E87C5,TCGA-DU-6402-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6402,TCGA-LGG,214,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,7
13722.58cfa831e4b0c9d6adf6cc24,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7292-01A,145F87A3-5E86-4A87-8E49-B166A2271D02,Brain,69,BD3011C5-FCF0-4B28-8D82-1175F69B118B,A3B00BDD-7250-4E6F-8F83-6CC01D672EF4,TCGA-DU-7292-01A-11D-2022-02,HG19_Broad_variant,TCGA-DU-7292,TCGA-LGG,242,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,2022-02,TRUE,4
13722.58cfa831e4b0c9d6adf6cc0b,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6403-01A,8DAA29C0-F652-4130-A004-5183BBE30C63,Brain,60,664226B3-6C8B-4E0A-A75B-955D65E62DA9,97CFB7E8-82E2-43BD-A458-376AD3CD7CFE,TCGA-DU-6403-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-6403,TCGA-LGG,354,Henry Ford Hospital,United States,Not available,Not available,Oligoastrocytoma,Not available,1703-02,TRUE,3
13722.58cfa831e4b0c9d6adf6ccde,1.89,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1CV-01A,762EDDB5-1B47-4B79-B20A-1EDFB07C0705,Thyroid,32,95D077B1-E4F3-48EA-84BC-F663FD438693,DEC98438-085F-40C3-8751-D50BA12C8584,TCGA-EM-A1CV-01A-11D-A13U-02,HG19_Broad_variant,TCGA-EM-A1CV,TCGA-THCA,NA,University Health Network,Canada,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A13U-02,TRUE,22
13722.58cfa832e4b0c9d6adf6cf22,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6364-01A,F8D8B417-5945-42A5-850A-FBC04B4F0E61,Prostate,72,242C8BCB-F8D3-4D3A-ABB1-0AB5D74D3BCB,6E0AAA4D-9ACC-4E63-AC7E-5B478D6406B5,TCGA-G9-6364-01A-21D-1784-02,HG19_Broad_variant,TCGA-G9-6364,TCGA-PRAD,NA,Roswell Park,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,9
13722.58cfa832e4b0c9d6adf6cec4,1.93,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A1YB-01A,B43A4F92-7A13-4558-A97E-7B3FEB2D70C9,Thyroid,73,13C7182D-EF93-48A7-9569-EED7714CEC40,59B09269-9CB6-4AD9-874D-5237896747A1,TCGA-EM-A1YB-01A-11D-A14U-02,HG19_Broad_variant,TCGA-EM-A1YB,TCGA-THCA,NA,University Health Network,Canada,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14U-02,TRUE,21
13722.58cfa832e4b0c9d6adf6cf96,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6351-01A,F59B9C65-46E8-4CC3-AA71-8844F6C2273C,Prostate,51,92436584-12D6-4CF2-9AB1-CDF98E4E8260,DE6145E0-8D30-4CA1-A169-0BDC7E5BC57A,TCGA-G9-6351-01A-21D-1957-02,HG19_Broad_variant,TCGA-G9-6351,TCGA-PRAD,NA,Roswell Park,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1957-02,TRUE,16
13722.58cfa832e4b0c9d6adf6cfbe,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6385-01A,E82A04CF-E81E-43C6-9CD9-0E29FA0F00AE,Prostate,66,CFE4B1FA-B658-49D3-87AD-6DF7D75A58DF,00D3CD80-E6C2-4408-8F10-3656BD371157,TCGA-G9-6385-01A-11D-1784-02,HG19_Broad_variant,TCGA-G9-6385,TCGA-PRAD,NA,Roswell Park,United States,T2c,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1784-02,TRUE,7
13722.58cfa832e4b0c9d6adf6d0dd,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HW-7495-01A,49967A57-7C12-46BB-8D71-CEBBB17C9935,Brain,45,1CCC7965-99A5-420A-B5AB-F9853B50E3B1,07DDE76E-E126-4D66-BA85-059F076B7D04,TCGA-HW-7495-01A-11D-2022-02,HG19_Broad_variant,TCGA-HW-7495,TCGA-LGG,NA,MSKCC,United States,Not available,Not available,Oligodendroglioma,Not available,2022-02,TRUE,7
13722.58cfa832e4b0c9d6adf6d1da,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HI-7169-01A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Prostate,55,AEEF0836-305C-465C-A9CA-6C1825353AE7,58543208-CB10-466F-A0FC-6C5202B8F13D,TCGA-HI-7169-01A-11D-2111-02,HG19_Broad_variant,TCGA-HI-7169,TCGA-PRAD,NA,Fox Chase,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,6
13722.58cfa832e4b0c9d6adf6d1c5,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HI-7171-01A,931FEB14-3F69-41C1-8435-5FD4FB775BDF,Prostate,56,B9D6C505-4D71-4189-925F-36914241B831,5A0710CB-B515-48F7-94B1-5DCD72B30F3F,TCGA-HI-7171-01A-12D-2111-02,HG19_Broad_variant,TCGA-HI-7171,TCGA-PRAD,1329,Fox Chase,United States,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,2111-02,TRUE,2
13722.58cfa82fe4b0c9d6adf6b7ee,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6829-01A,1427CD18-5AD3-491A-9981-908E31AE49DB,Lung,78,9B416640-9AEC-4B0D-AA88-B94287375950,E6E4F55E-8C3A-45E9-8F3B-9FDFE9D2965D,TCGA-91-6829-01A-21D-1853-02,HG19_Broad_variant,TCGA-91-6829,TCGA-LUAD,1258,ABS - IUPUI,United States,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB,1853-02,TRUE,32
13722.58cfa82fe4b0c9d6adf6b668,1.9,Alive,MALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-55-6642-01A,474B86D9-D897-467D-85D4-51DFA26EA107,Lung,63,08D8F333-08F9-4268-99B7-61F7B057F542,93AF51CC-26FF-4904-84BC-2DFFB317D86A,TCGA-55-6642-01A-11D-1853-02,HG19_Broad_variant,TCGA-55-6642,TCGA-LUAD,NA,International Genomics Consortium,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1853-02,TRUE,17
13722.58cfa831e4b0c9d6adf6c48e,1.93,Alive,FEMALE,Not available,Not available,Bladder Urothelial Carcinoma,TCGA-C4-A0F6-01A,4FF9B4F2-6D04-4FED-8796-155902A8BF28,Bladder,82,905D2BF1-08CB-4260-8188-00B60D881CF2,1765E178-12BD-4682-AB4A-368C4DCB5AEE,TCGA-C4-A0F6-01A-11D-A10R-02,HG19_Broad_variant,TCGA-C4-A0F6,TCGA-BLCA,NA,Indivumed,Germany,T3b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A10R-02,TRUE,38
13722.58cfa831e4b0c9d6adf6c95b,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-5847-01A,92A7C445-2217-400A-BDCD-DF41502416B6,Brain,34,C68FC12C-C538-4A89-9F6E-C0800A5A6B53,F83FB674-A46C-47DE-BAD8-36605068D2E2,TCGA-DU-5847-01A-11D-1703-02,HG19_Broad_variant,TCGA-DU-5847,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Astrocytoma,Not available,1703-02,TRUE,5
13722.58cfa831e4b0c9d6adf6c9d0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6820-01A,1142251C-28EB-48BF-9C54-7126D4557605,Stomach,64,490660D7-5512-4DBF-893A-B6B8C27CA407,B53083C4-6000-4B71-92CE-B2299D0EA2D3,TCGA-D7-6820-01A-11D-1880-02,HG19_Broad_variant,TCGA-D7-6820,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N1,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB,1880-02,TRUE,4
13722.58cfa831e4b0c9d6adf6ca0c,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AE-01A,493A4FF2-37A5-4B79-928D-83DBFE534556,Bladder,84,67865453-D515-4D63-84E8-CFB2686A211D,885B8E06-182F-437B-9183-B454643A64EC,TCGA-DK-A1AE-01A-11D-A13U-02,HG19_Broad_variant,TCGA-DK-A1AE,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13U-02,TRUE,21
13722.58cfa831e4b0c9d6adf6cc92,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5510-01A,4A3D9EFE-F24E-4135-8A70-E202651E7A81,Prostate,48,3EAE6B68-D333-4B36-9E70-D2BED19C1DFA,495CB006-3042-4F8A-9AFA-9C10415DBB26,TCGA-EJ-5510-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5510,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4
13722.58cfa832e4b0c9d6adf6ceda,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5505-01A,1EA3B879-5451-49FB-B930-16E9B5627F18,Prostate,57,A31147E1-4A52-4233-BC27-B0DFA6708DC6,3AB7712C-40E4-4752-AC1D-0CB9D7345413,TCGA-EJ-5505-01A-01D-1572-02,HG19_Broad_variant,TCGA-EJ-5505,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1572-02,TRUE,4